Method for controlling parasitic plants

By using a composition of specific compounds and amino acid fermentation by-products, the suicide germination of parasitic plants or inhibit its growth is solved, and the problem of difficulty in preventing and controlling parasitic plants in the prior art is achieved and effective protection of food production is achieved.

CN119012914APending Publication Date: 2024-11-22AJINOMOTO CO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380032699.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-04
Filing Date
2023-04-04
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to effectively prevent and control the harm of parasitic plants such as monsoonaceae to food production, especially because the seeds of these plants are small and large in number, which makes it difficult to control soil pollution after soil pollution.

Method used

A composition is developed that contains specific compounds (General Formula I and General Formula II) and amino acid fermentation byproducts to prevent and control parasitic plants by inducing suicide germination or inhibiting their germination. The composition includes specific compound structures and amino acids for use on the seeds of a parasitic plant, inducing suicide or inhibiting its growth.

Benefits of technology

This method can effectively prevent and control parasitic plants, especially the genus Scrophulariae, Scrophulariae and Coniferae, reducing the harm to grain production and improving the prevention and control efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005072297890000121
    Figure BDA0005072297890000121
  • Figure BDA0005072297890000131
    Figure BDA0005072297890000131
  • Figure BDA0005072297890000132
    Figure BDA0005072297890000132
Patent Text Reader

Abstract

The present invention provides a technique useful in the agronomic horticultural field, such as a technique for controlling parasitic plants. Parasitic plants are controlled by using a compound which may have the same or opposite function as strigolactone, such as an amino acid derivative having a D ring.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a technology useful in the field of agronomy and horticulture, such as a technology for controlling parasitic plants. Background Art

[0002] Orobanchaceae plants such as Striga, Orobanche, Scrophulariaceae, Cuscuta, etc., are parasitic plants that cause adverse effects on food production and are a problem worldwide. For example, Striga parasitizes on major cereals such as sorghum, corn, and rice, and Orobanche parasitizes on major vegetables such as tomatoes, potatoes, tobacco, eggplants, and broad beans, causing greater harm. The total amount of losses caused by these parasitic plants in Africa is about 1 trillion yen. The seeds of Striga, Orobanche, etc. are very small, and Striga, etc. produce about 100,000 seeds at a time, so once the soil is contaminated, it becomes very difficult to prevent and control. Therefore, it is necessary to develop a technology for preventing and controlling Orobanchaceae plants.

[0003] For example, there is known a technique for controlling Orobanchaceae plants by inducing suicide germination of Orobanchaceae plants by using strigolactone or a compound that may have a similar function (Patent Document 1 and Non-Patent Document 1).

[0004] Prior art literature

[0005] Patent Literature

[0006] Patent Document 1: WO2012 / 043813

[0007] Non-patent literature

[0008] Non-patent literature 1: Uraguchi et al., (2018) Science, 362, 1301-1305. Afemt omolar-range suicide germination stimulant for the parasitic plant Striga hermonthica. Summary of the invention

[0009] Technical problem solved by the invention

[0010] The technical problem of the present invention is to provide a technology useful in the field of agronomy and horticulture, such as a technology for controlling parasitic plants.

[0011] Technical means of solving problems

[0012] The present inventors have conducted intensive studies to solve the above-mentioned technical problems, and as a result, have found a group of compounds that may have the same or opposite functions as strigolactone, thereby completing the present invention.

[0013] 1. A composition for controlling parasitic plants, comprising the following components (A), (B) or (C):

[0014] (A) a compound represented by the following general formula (I);

[0015] (B) a compound represented by the following general formula (II);

[0016] (C) amino acid fermentation byproducts,

[0017] In formula (I),

[0018] X represents an interatomic bond or an oxycarbonyl group (OC(=O)),

[0019] Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (N Me),

[0020] R1 represents a hydrogen atom (H) or a methyl group,

[0021] R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2),

[0022] In formula (R2-1),

[0023] n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5,

[0024] In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group,

[0025] In formula (R2-2),

[0026] a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms,

[0027] R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms,

[0028] In formula (II),

[0029] X1 represents an interatomic bond or a methyleneoxy group (CH2O),

[0030] X2 represents an interatomic bond or a carbonyl group (C(=O)),

[0031] Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom,

[0032] R1 represents a hydrogen atom (H) or a methyl group,

[0033] R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2),

[0034] bc represents CH-CH2 or C=CH.

[0035] 2. The composition, which controls the parasitic plant by inducing suicide germination of the parasitic plant or inhibiting germination of the parasitic plant.

[0036] 3. The composition, wherein:

[0037] The parasitic plant is a plant of the family Orobanchaceae, a plant of the family Scrophulariaceae or a plant of the family Convolvulaceae.

[0038] 4. The composition, wherein

[0039] The parasitic plant is a plant of the genus Striga, the genus Orobanche, the genus Phelipanche, the genus Alectra or the genus Cuscuta.

[0040] 5. The composition, wherein

[0041] The parasitic plants are Striga asiatica, Striga gesnerioides, Striga hermonthica, Striga aspera, Striga asiatica, Striga curviflora, Striga parviflora, Striga angustifolia, Striga latericea, Striga aequinoctialis, Striga angolensis, Striga bilabiate, Striga brachycalyx, Striga chrsantha, Striga dalzielii, Striga elegans, Striga forbesii, Striga gastonii, Striga gracillima, Striga hallaei, Striga hirsuta, Striga junodii, Striga klingii, Striga lepidagathidis, Striga lutea, Striga macrantha, Striga passargei, Striga pinnatifida, Striga primuloides, Striga yemenica, Striga pubiflora, Orobanche ramosa, Orobanche minor, Orobanche crenata, Orobanche cumana, Orobanche foetida, Orobanche aegyptiaca, Orobanche cernua, Phelipanche ramosa, Phelipanche aegyptiaca, Alectra voge lii, Alectra picta, Alectra sessiliflora, Alectra orobanchoides, Alectra fluminensis, Cuscuta australis, Cuscuta campestris, Cuscuta chinensis, Cuscuta indecora, Cuscuta epithymum, Cuscutaepilinum, Cuscuta chinensisgronovii), Cuscuta plani flora, Cuscutamonogyna, Cuscuta pedicellata, Cuscuta palaesti na or Cuscuta rejlexa.

[0042] 6. The composition, wherein

[0043] In the component (A), Y is NH and R1 is methyl.

[0044] 7. The composition, wherein

[0045] The component (A) satisfies any one of the following conditions:

[0046] (1) X is an interatomic bond or an oxycarbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group;

[0047] (2) X is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group;

[0048] (3) X is an interatomic bond, and R2 is an amino acid bonded via a hydroxyl group;

[0049] (4) X is an interatomic bond, and R2 is an amino acid bonded via a thiol group;

[0050] (5) X is an interatomic bond, and R2 is an amino acid bonded via an amide group;

[0051] (6) X is an interatomic bond or an oxycarbonyl group, and R2 is a structure represented by formula (R2-1);

[0052] (7) X is an interatomic bond, and R2 is a structure represented by the formula (R2-2).

[0053] 8. The composition, wherein

[0054] The component (A) satisfies any one of the following conditions:

[0055] (1) X is an interatomic bond, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, guanidine bonded via an amino group, or a structure represented by formula (R2-1);

[0056] (2) X is an oxycarbonyl group, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via a carboxyl group or a structure represented by the formula (R2-2).

[0057] 9. The composition, wherein

[0058] In the component (B), Y is NH, bc is CH-CH2, and R1 is H.

[0059] 10. The composition, wherein

[0060] The component (B) satisfies any one of the following conditions:

[0061] (1) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group;

[0062] (2) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group;

[0063] (3) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an aliphatic alcohol;

[0064] (4) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a fatty acid;

[0065] (5) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is a structure represented by formula (R2-1);

[0066] (6) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a structure represented by formula (R2-2);

[0067] (7) X1 is an interatomic bond, X2 is an interatomic bond, and R2 is guanidine bonded via an amino group.

[0068] 11. The composition, wherein

[0069] The component (B) satisfies any one of the following conditions:

[0070] (1) X1 is an interatomic bond, X2 is a carbonyl group, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, guanidine bonded via an amino group, or a structure represented by formula (R2-1);

[0071] (2) X1 is a methyleneoxy group, X2 is an interatomic bond, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via a carboxyl group, a fatty acid having 2 to 18 carbon atoms, or a structure represented by formula (R2-2);

[0072] (3) X1 is an interatomic bond, X2 is an interatomic bond, Y is an oxygen atom (O), bc is C═CH, R1 is a methyl group, and R2 is a guanidine bonded via an amino group.

[0073] 12. The composition, wherein

[0074] Except for the case where the component (B) is a compound represented by the following formula (Compound 41), (Compound 50), (Compound 52), (Compound 54), (Compound 55) and (Compound 77).

[0075] 13. The composition, wherein

[0076] The component (A) or (B) is selected from compounds represented by the following formulas: (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 40), (Compound 42) to (Compound 49), (Compound 51), (Compound 53), (Compound 56) to (Compound 76), (Compound 78) to (Compound 80) and (Compound 82) to (Compound 90).

[0077] 14. The composition, wherein

[0078] The component (C) is a fermentation byproduct of lysine, tryptophan, threonine, valine, leucine or isoleucine.

[0079] 15. The composition is used in the form of a liquid containing the component (A), (B) or (C) at a concentration of 10 nM to 10 mM.

[0080] 16. A method for controlling parasitic plants, comprising:

[0081] Applying the following ingredients (A), (B) or (C) to the seeds of the parasitic plant:

[0082] (A) a compound represented by the following general formula (I);

[0083] (B) a compound represented by the following general formula (II);

[0084] (C) amino acid fermentation byproducts,

[0085] In formula (I),

[0086] X represents an interatomic bond or an oxycarbonyl group (OC(=O)),

[0087] Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (N Me),

[0088] R1 represents a hydrogen atom (H) or a methyl group,

[0089] R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2),

[0090] In formula (R2-1),

[0091] n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5,

[0092] In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group,

[0093] In formula (R2-2),

[0094] a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms,

[0095] R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms,

[0096] In formula (II),

[0097] X1 represents an interatomic bond or a methyleneoxy group (CH2O),

[0098] X2 represents an interatomic bond or a carbonyl group (C(=O)),

[0099] Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom,

[0100] R1 represents a hydrogen atom (H) or a methyl group,

[0101] R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2),

[0102] bc represents CH-CH2 or C=CH.

[0103] 17. A method for producing a plant body, comprising:

[0104] Applying the following component (A), (B) or (C) to the seeds of a parasitic plant to induce suicide germination of the parasitic plant;

[0105] cultivating a plant to be parasitized by the parasitic plant after the application; and

[0106] harvesting the plant body of the plant that is the target of parasitism of the parasitic plant,

[0107] (A) a compound represented by the following general formula (I);

[0108] (B) a compound represented by the following general formula (II);

[0109] (C) amino acid fermentation byproducts,

[0110] In formula (I),

[0111] X represents an interatomic bond or an oxycarbonyl group (OC(=O)),

[0112] Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (N Me),

[0113] R1 represents a hydrogen atom (H) or a methyl group,

[0114] R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2),

[0115] In formula (R2-1),

[0116] n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5,

[0117] In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group,

[0118] In formula (R2-2),

[0119] a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms,

[0120] R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms,

[0121] In formula (II),

[0122] X1 represents an interatomic bond or a methyleneoxy group (CH2O),

[0123] X2 represents an interatomic bond or a carbonyl group (C(=O)),

[0124] Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom,

[0125] R1 represents a hydrogen atom (H) or a methyl group,

[0126] R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2),

[0127] bc represents CH-CH2 or C=CH.

[0128] 18. A method for producing a plant body, comprising:

[0129] Cultivate plants that become targets of parasites;

[0130] Applying the following component (A), (B) or (C) to the seeds of the parasitic plant in the later stage of the cultivation to induce germination of the parasitic plant; and

[0131] harvesting the plant body of the plant that is the target of parasitism of the parasitic plant,

[0132] (A) a compound represented by the following general formula (I);

[0133] (B) a compound represented by the following general formula (II);

[0134] (C) amino acid fermentation byproducts,

[0135] In formula (I),

[0136] X represents an interatomic bond or an oxycarbonyl group (OC(=O)),

[0137] Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (N Me),

[0138] R1 represents a hydrogen atom (H) or a methyl group,

[0139] R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2),

[0140] In formula (R2-1),

[0141] n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5,

[0142] In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group,

[0143] In formula (R2-2),

[0144] a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms,

[0145] R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms,

[0146] In formula (II),

[0147] X1 represents an interatomic bond or a methyleneoxy group (CH2O),

[0148] X2 represents an interatomic bond or a carbonyl group (C(=O)),

[0149] Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom,

[0150] R1 represents a hydrogen atom (H) or a methyl group,

[0151] R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2),

[0152] bc represents CH-CH2 or C=CH.

[0153] 19. A method for producing a plant body, comprising:

[0154] Cultivate plants that become targets of parasites;

[0155] During the cultivation, the following component (A), (B) or (C) is applied to seeds of parasitic plants to inhibit germination of the parasitic plants; and

[0156] harvesting the plant body of the plant that is the target of parasitism of the parasitic plant,

[0157] (A) a compound represented by the following general formula (I);

[0158] (B) a compound represented by the following general formula (II);

[0159] (C) amino acid fermentation byproducts,

[0160] In formula (I),

[0161] X represents an interatomic bond or an oxycarbonyl group (OC(=O)),

[0162] Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (N Me),

[0163] R1 represents a hydrogen atom (H) or a methyl group,

[0164] R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2),

[0165] In formula (R2-1),

[0166] n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5,

[0167] In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group,

[0168] In formula (R2-2),

[0169] a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms,

[0170] R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms,

[0171] In formula (II),

[0172] X1 represents an interatomic bond or a methyleneoxy group (CH2O),

[0173] X2 represents an interatomic bond or a carbonyl group (C(=O)),

[0174] Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom,

[0175] R1 represents a hydrogen atom (H) or a methyl group,

[0176] R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2),

[0177] bc represents CH-CH2 or C=CH.

[0178] 20. The method for controlling a parasitic plant by inducing suicide germination of the parasitic plant or inhibiting germination of the parasitic plant.

[0179] 21. The method, which controls the parasitic plants by applying.

[0180] 22. The method, wherein:

[0181] The parasitic plant is a plant of the family Orobanchaceae, a plant of the family Scrophulariaceae or a plant of the family Convolvulaceae.

[0182] 23. The method, wherein:

[0183] The parasitic plant is a plant of the genus Striga, the genus Orobanche, the genus Phelipanche, the genus Alectra or the genus Cuscuta.

[0184] 24. The method, wherein:

[0185] The parasitic plants are Striga asiatica, Striga gesnerioides, Striga hermonthica, Striga aspera, Striga asiatica, Striga curviflora, Striga parviflora, Striga angustifolia, Striga latericea, Striga aequinoctialis, Striga angolensis, Striga bilabiate, Striga brachycalyx, Striga chrsantha, Striga dalzielii, Striga elegans, Striga forbesii, Striga gastonii, Striga gracillima, Striga hallaei, Striga hirsuta, Striga junodii, Striga klingii, Striga lepidagathidis, Striga lutea, Striga macrantha, Striga passargei, Striga pinnatifida, Striga primuloides, Striga yemenica, Striga pubiflora, Orobanche ramosa, Orobanche minor, Orobanche crenata, Orobanche cumana, Orobanche foetida, Orobanche aegyptiaca, Orobanche cernua, Phelipanche ramosa, Phelipanche aegyptiaca, Alectra voge lii, Alectra picta, Alectra sessiliflora, Alectra orobanchoides, Alectra fluminensis, Cuscuta australis, Cuscuta campestris, Cuscuta chinensis, Cuscuta indecora, Cuscuta epithymum, Cuscutaepilinum, Cuscuta chinensisgronovii), Cuscuta plani flora, Cuscutamonogyna, Cuscuta pedicellata, Cuscuta palaesti na or Cuscuta rejlexa.

[0186] 25. The method, wherein:

[0187] In the component (A), Y is NH and R1 is methyl.

[0188] 26. The method, wherein:

[0189] The component (A) satisfies any one of the following conditions:

[0190] (1) X is an interatomic bond or an oxycarbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group;

[0191] (2) X is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group;

[0192] (3) X is an interatomic bond, and R2 is an amino acid bonded via a hydroxyl group;

[0193] (4) X is an interatomic bond, and R2 is an amino acid bonded via a thiol group;

[0194] (5) X is an interatomic bond, and R2 is an amino acid bonded via an amide group;

[0195] (6) X is an interatomic bond or an oxycarbonyl group, and R2 is a structure represented by formula (R2-1);

[0196] (7) X is an interatomic bond, and R2 is a structure represented by the formula (R2-2).

[0197] 27. The method, wherein:

[0198] The component (A) satisfies any one of the following conditions:

[0199] (1) X is an interatomic bond, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, guanidine bonded via an amino group, or a structure represented by formula (R2-1);

[0200] (2) X is an oxycarbonyl group, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via a carboxyl group or a structure represented by the formula (R2-2).

[0201] 28. The composition, wherein

[0202] In the component (B), Y is NH, bc is CH-CH2, and R1 is H.

[0203] 29. The method, wherein:

[0204] The component (B) satisfies any one of the following conditions:

[0205] (1) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group;

[0206] (2) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group;

[0207] (3) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an aliphatic alcohol;

[0208] (4) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a fatty acid;

[0209] (5) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is a structure represented by formula (R2-1);

[0210] (6) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a structure represented by formula (R2-2);

[0211] (7) X1 is an interatomic bond, X2 is an interatomic bond, and R2 is guanidine bonded via an amino group.

[0212] 30. The method, wherein:

[0213] The component (B) satisfies any one of the following conditions:

[0214] (1) X1 is an interatomic bond, X2 is a carbonyl group, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or a structure represented by formula (R2-1);

[0215] (2) X1 is a methyleneoxy group, X2 is an interatomic bond, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via a carboxyl group, a fatty acid having 2 to 18 carbon atoms, or a structure represented by formula (R2-2);

[0216] (3) X1 is an interatomic bond, X2 is an interatomic bond, Y is an oxygen atom (O), bc is C═CH, R1 is a methyl group, and R2 is a guanidine bonded via an amino group.

[0217] 31. The method, wherein:

[0218] Except for the case where the component (B) is a compound represented by the following formula (Compound 41), (Compound 50), (Compound 52), (Compound 54), (Compound 55) and (Compound 77).

[0219] 32. The method, wherein:

[0220] The component (A) or (B) is selected from compounds represented by the following formulas: (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 40), (Compound 42) to (Compound 49), (Compound 51), (Compound 53), (Compound 56) to (Compound 76), (Compound 78) to (Compound 80) and (Compound 82) to (Compound 90).

[0221] 33. The method, wherein:

[0222] The component (C) is a fermentation byproduct of lysine, tryptophan, threonine, valine, leucine or isoleucine.

[0223] 34. The method, wherein:

[0224] The component (A), (B) or (C) is used in the form of a liquid containing the component (A), (B) or (C) at a concentration of 10 nM to 10 mM. BRIEF DESCRIPTION OF THE DRAWINGS

[0225] [ Figure 1 ] A graph showing the control effect of compound 5 or synthetic strigolactone GR24 on suicide sprout induction of Orobanche minor.

[0226] [ Figure 2 ] Figure (photo) showing the control effect of compound 5 or synthetic strigolactone GR24 on suicide sprout induction of Orobanche minor. DETAILED DESCRIPTION

[0227] Hereinafter, the present invention will be described in detail.

[0228] <1> Active ingredients

[0229] As the active ingredients used in the present invention, the following ingredients (A) to (C) can be mentioned:

[0230] (A) a compound represented by the following general formula (I);

[0231] (B) a compound represented by the following general formula (II);

[0232] (C) Amino acid fermentation byproducts.

[0233] Component (A) is a compound represented by the following general formula (I). n " and "Rn" (n is a positive integer) can be used in an interchangeable manner.

[0234] [Chemical formula 1]

[0235]

[0236] In formula (I), the cyclic structure located on the right side is also referred to as "D ring".

[0237] In formula (I), X represents an interatomic bond or an oxycarbonyl group (OC(=O)). It should be noted that "oxycarbonyl" as X means a group in which O is bonded to the D ring and C(=O) is bonded to R2.

[0238] In formula (I), Y represents an oxygen atom (O), a nitrogen atom (NH) bonded with a hydrogen atom, or a nitrogen atom (NMe) bonded with a methyl group.

[0239] In formula (I), R1 represents a hydrogen atom (H) or a methyl group.

[0240] In formula (I), R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2). In formula (I), R2 can particularly be an amino acid, agmatine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2).

[0241] [Chemical formula 2]

[0242]

[0243] In formula (R2-1), n ​​represents an integer of 2 to 5 (ie, 2, 3, 4, or 5).

[0244] In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group.

[0245] [Chemical formula 3]

[0246]

[0247] In the formula (R2-2), a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms.

[0248] In the formula (R2-2), R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms. In the formula (R2-2), R5 can particularly be an optionally substituted alkyl group having 1 to 4 carbon atoms.

[0249] Unless otherwise specified, for component (A), X, Y, n and R1 to R5 can be selected independently.

[0250] "Optionally substituted functional group" refers to the general term for substituted functional groups and unsubstituted functional groups. That is, for example, "optionally substituted alkyl" is a general term for substituted alkyl and unsubstituted alkyl. Substituted functional groups are also called "substituted functional groups," and unsubstituted functional groups are also called "unsubstituted functional groups." That is, for example, substituted alkyl groups are also called "substituted alkyl groups," and unsubstituted alkyl groups are called "unsubstituted alkyl groups." It should be noted that, unless otherwise specified, "functional groups" that do not mention substitution refer to unsubstituted functional groups. That is, for example, unless otherwise specified, "alkyl groups" that do not mention substitution refer to unsubstituted alkyl groups. Regarding the "number of carbon atoms" in the optionally substituted functional group, unless otherwise specified, regardless of whether there is substitution or not, it refers to the number of carbon atoms of the functional group in the unsubstituted state (i.e., the number of carbon atoms excluding the number of carbon atoms of the substituent). The description of the unsubstituted functional group can also be applied to the part other than the substituent in the substituted functional group. That is, for example, the description about the unsubstituted alkyl group can also be applied to the part other than the substituent in the substituted alkyl group (that is, the alkyl part).

[0251] "The functional group is substituted" means that one or more hydrogen atoms constituting the functional group are substituted by a substituent. "The functional group is substituted" is also referred to as "the functional group has a substituent." The number of hydrogen atoms substituted by substituents can be, for example, 1 to 5, 1 to 4, 1 to 3 or 1 to 2. Specifically, the number of hydrogen atoms substituted by substituents can be, for example, 1, 2, 3, 4 or 5. The number of hydrogen atoms substituted by substituents can be replaced by the number of substituents possessed by the functional group. When 2 or more hydrogen atoms are substituted by substituents, the substituents are selected independently for each hydrogen atom. As hydrogen atoms substituted by substituents, hydrogen atoms bonded to carbon atoms, hydrogen atoms bonded to nitrogen atoms, and hydrogen atoms bonded to oxygen atoms can be cited. The hydrogen atom bonded to the carbon atom can be, for example, a hydrogen atom bonded to a terminal carbon atom, or it may not be. "Terminal carbon atom" refers to the carbon atom at the end of the carbon chain. When the carbon chain is branched, the end can be the end of any branch.

[0252] As the substituents possessed by the substituted alkylene or substituted alkenylene of a, there can be mentioned: halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, mercapto groups, optionally substituted aryl groups, optionally substituted heteroaryl groups, optionally substituted alkoxy groups, optionally substituted alkylamino groups, optionally substituted alkoxycarbonylamino groups, optionally substituted alkoxycarbonyl groups, and optionally substituted alkylthio groups. As the substituents possessed by the substituted alkyl of R5, there can be mentioned: halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, mercapto groups, optionally substituted aryl groups, optionally substituted heteroaryl groups, optionally substituted alkoxy groups, optionally substituted alkylamino groups, optionally substituted alkoxycarbonylamino groups, optionally substituted alkoxycarbonyl groups, and optionally substituted alkylthio groups. The substituent possessed by the functional group constituting the acyl group as R3 or R4 (for example, a substituted alkyl group, a substituted cycloalkyl group, a substituted alkenyl group, a substituted aryl group, or a substituted alkoxy group) includes a halogen atom, a hydroxyl group, an amino group, a carboxyl group, an aminocarbonyl group, a mercapto group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an optionally substituted alkoxy group, an optionally substituted alkylamino group, an optionally substituted alkoxycarbonylamino group, an optionally substituted alkoxycarbonyl group, and an optionally substituted alkylthio group.

[0253] As the substituent possessed by the substituted aryl in the substituted alkylene or substituted alkenylene of A, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, and alkyl groups can be mentioned. As the substituent possessed by the substituted heteroaryl in the substituted alkylene or substituted alkenylene of A, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, and alkyl groups can be mentioned. As the substituent possessed by the substituted aryl in the substituted alkyl of R5, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, and alkyl groups can be mentioned. As the substituent possessed by the substituted heteroaryl in the substituted alkyl of R5, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, and alkyl groups can be mentioned. As the substituent possessed by the substituted aryl in the functional group constituting the acyl group as R3 or R4, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, and alkyl groups can be mentioned. As the substituent possessed by the substituted heteroaryl in the functional group constituting the acyl group as R3 or R4, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, and alkyl groups can be mentioned.

[0254] As the substituents possessed by the substituted alkoxy in the substituted alkylene or substituted alkenylene of a, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkoxycarbonyl in the substituted alkylene or substituted alkenylene of a, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkoxy in the substituted alkyl of R5, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkoxycarbonyl in the substituted alkyl of R5, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkoxy in the functional group constituting the acyl group as R3 or R4, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, aryl groups, and heteroaryl groups can be mentioned. Examples of the substituent that the substituted alkoxycarbonyl group has in the functional group constituting the acyl group as R3 or R4 include a halogen atom, a hydroxyl group, an amino group, a carboxyl group, an aminocarbonyl group, an aryl group, and a heteroaryl group.

[0255] As the substituents possessed by the substituted alkylamino in the substituted alkylene or substituted alkenylene of A, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, N-alkyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkoxycarbonylamino in the substituted alkylene or substituted alkenylene of A, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, N-alkyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkylamino in the substituted alkyl of R5, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, N-alkyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituents possessed by the substituted alkoxycarbonylamino in the substituted alkyl of R5, halogen atoms, hydroxyl groups, amino groups, carboxyl groups, aminocarbonyl groups, N-alkyl groups, aryl groups, and heteroaryl groups can be mentioned. As the substituent possessed by the substituted alkylamino group in the functional group constituting the acyl group as R3 or R4, a halogen atom, a hydroxyl group, an amino group, a carboxyl group, an aminocarbonyl group, an N-alkyl group, an aryl group, and a heteroaryl group can be mentioned. As the substituent possessed by the substituted alkoxycarbonylamino group in the functional group constituting the acyl group as R3 or R4, a halogen atom, a hydroxyl group, an amino group, a carboxyl group, an aminocarbonyl group, an N-alkyl group, an aryl group, and a heteroaryl group can be mentioned. "N-alkyl" refers to an alkyl group that replaces the hydrogen atom of an amino group.

[0256] Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.

[0257] Examples of the alkyl group include alkyl groups having 1 to 12 carbon atoms. Examples of the alkyl group include alkyl groups having 1 to 6 carbon atoms. Examples of the alkyl group include alkyl groups having 1 to 4 carbon atoms. The alkyl group may be linear or branched. Examples of the alkyl group having 1 to 6 carbon atoms include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, 2,3-dimethylpropyl, and hexyl. Examples of the alkyl group having 1 to 4 carbon atoms include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, and tert-butyl. The description of the alkyl group may also apply to the N-alkyl group.

[0258] The alkylene group may be linear or branched. Examples of the alkylene group having 1 to 4 carbon atoms include methylene, ethylene, propylene, isopropylene, butylene, isobutylene, secondary butylene, and tertiary butylene.

[0259] The alkenylene group may be linear or branched. Examples of the alkenylene group having 2 to 4 carbon atoms include vinylene, propenylene, isopropenylene, butenylene, isobutenylene and sec-butenylene.

[0260] Examples of the aryl group include aryl groups having 6 to 14 carbon atoms. Examples of the aryl group include aryl groups having 6 to 10 carbon atoms. Specific examples of the aryl group include phenyl, naphthyl, and fluorenyl.

[0261] "Heteroaryl" refers to an aryl group having at least one heteroatom selected from a nitrogen atom, an oxygen atom and a sulfur atom as an atom constituting a ring. Examples of heteroaryl groups include heteroaryl groups having 3 to 14 carbon atoms. Examples of heteroaryl groups include heteroaryl groups having 4 to 10 carbon atoms. Examples of heteroaryl groups include heteroaryl groups having 4 to 9 carbon atoms. Examples of heteroaryl groups include furanyl, pyrrolyl, oxazolyl, imidazolyl, pyrazolyl, pyranyl, indenyl, phenylthio, pyridyl, indolyl and quinolyl. Examples of heteroaryl groups include imidazolyl and indolyl.

[0262] As the alkoxy group, there can be mentioned an alkoxy group having 1 to 6 carbon atoms. As the alkoxy group, there can be mentioned particularly an alkoxy group having 1 to 4 carbon atoms. The alkoxy group can be straight-chain or branched. Specific examples of the alkoxy group include methoxy, ethoxy, 1-propoxy, 2-propoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, 1-pentoxy, 2-pentoxy, 3-pentoxy, 2-methyl-1-butoxy, 3-methyl-1-butoxy, 2-methyl-2-butoxy, 3-methyl-2-butoxy, 2,2-dimethyl-1-propoxy, 1-hexyloxy, 2-hexyloxy and 3-hexyloxy. As the alkoxy group, there can be mentioned particularly a tert-butoxy group.

[0263] The optionally substituted alkyl group is an alkyl group or a substituted alkyl group. The alkyl group is as described above. The descriptions of the alkyl group and its substituent group can be applied to the alkyl group and the substituent group constituting the substituted alkyl group. For example, as the optionally substituted alkyl group having 1 to 4 carbon atoms, methyl, ethyl, tert-butyl, and benzyl can be mentioned in particular.

[0264] The optionally substituted alkylene group is an alkylene group or a substituted alkylene group. The alkylene group is as described above. The descriptions of the alkylene group and the substituent group constituting the substituted alkylene group are respectively applicable.

[0265] The optionally substituted alkenylene group is an alkenylene group or a substituted alkenylene group. The alkenylene group is as described above. The alkenylene group and the substituent group constituting the substituted alkenylene group can be respectively applied to the description of the alkenylene group and the substituent group thereof.

[0266] The optionally substituted aryl group is an aryl group or a substituted aryl group. The aryl group is as described above. The description of the aryl group and the substituent group constituting the substituted aryl group can be applied respectively.

[0267] As the substituted aryl group, specifically, an alkyl aryl group optionally substituted (i.e., an alkyl aryl group, a substituted alkyl aryl group) can be mentioned. With respect to the alkyl group, the aryl group and the substituent group constituting the alkyl aryl group or the substituted alkyl aryl group, the descriptions of the alkyl group, the aryl group and the substituent groups thereof can be applied respectively. As the alkyl aryl group optionally substituted, specifically, a methylphenyl group (2-, 3- or 4-methylphenyl group, etc.) can be mentioned.

[0268] Specific examples of the substituted aryl group include hydroxyphenyl (2-, 3- or 4-hydroxyphenyl, etc.), chlorophenyl (2-, 3- or 4-chlorophenyl, etc.), dichlorophenyl (2,5-dichlorophenyl, etc.), fluorophenyl (2-, 3- or 4-fluorophenyl, etc.), and 2,3-dihydroxyindenyl.

[0269] The optionally substituted heteroaryl group is a heteroaryl group or a substituted heteroaryl group. The heteroaryl group is as described above. The heteroaryl group and the substituent group constituting the substituted heteroaryl group are respectively applicable to the description of the above-mentioned heteroaryl group and the substituent group.

[0270] The optionally substituted alkoxy group is an alkoxy group or a substituted alkoxy group. The alkoxy group is as described above. The description of the alkoxy group and the substituent group constituting the substituted alkoxy group can be applied respectively.

[0271] As the substituted alkoxy group, specifically, an optionally substituted arylalkoxy group (i.e., an arylalkoxy group, a substituted arylalkoxy group) can be mentioned. With regard to the aryl group, the alkoxy group and the substituent group constituting the arylalkoxy group or the substituted arylalkoxy group, the descriptions about the aryl group, the alkoxy group and the substituent groups thereof can be applied respectively. As the optionally substituted arylalkoxy group, specifically, a phenylmethoxy group can be mentioned.

[0272] Specific examples of the substituted alkoxy group include a hydroxyalkoxy group (such as a hydroxyethoxy group) and a trifluoromethoxy group.

[0273] The optionally substituted alkylamino group is an alkylamino group or a substituted alkylamino group. Regarding the alkyl group constituting the alkylamino group, the description regarding the alkyl group can be applied. Regarding the alkyl group and the substituent group constituting the substituted alkylamino group, the description regarding the alkyl group and its substituent group can be applied. For example, the number of carbon atoms of the alkyl group (for example, 1 to 12 or 1 to 6) can be replaced by the number of carbon atoms of the optionally substituted alkylamino group (excluding the number of carbon atoms of the substituent group). As the substituted alkylamino group, specifically, there can be mentioned an optionally substituted carboxyalkylamino group (i.e., carboxyalkylamino group, substituted carboxyalkylamino group). The number of carbon atoms of the optionally substituted carboxyalkylamino group (excluding the number of carbon atoms of the substituent group) can be, for example, 2 to 13 or 2 to 7. As the carboxyalkylamino group, specifically, there can be mentioned a carboxymethylamino group and a 1-methylcarboxymethylamino group. As the substituted carboxyalkylamino group, specifically, there can be mentioned a carboxyalkylamino group substituted with a hydroxyl group, an amino group, a carboxyl group, a phenyl group, an indolyl group, or an N-methyl group. More specifically, the substituted carboxyalkylamino group includes 1-(aminobutyl)carboxymethylamino, 1-methylcarboxymethylamino, 1-(indolylmethyl)carboxymethylamino, 1-(carboxymethyl)carboxymethylamino, 1-(1-hydroxyethyl)carboxymethylamino, 1-(hydroxymethyl)carboxymethylamino, 1-isobutylcarboxymethylamino, 1-benzylcarboxymethylamino and N-methylcarboxymethylamino.

[0274] The alkoxycarbonyl group optionally substituted is an alkoxycarbonyl group or a substituted alkoxycarbonyl group. Regarding the alkoxy group constituting the alkoxycarbonyl group, the description of the alkoxy group can be applied. Regarding the alkoxy group and the substituent constituting the substituted alkoxycarbonyl group, the description of the alkoxy group and its substituent can be applied. As the alkoxycarbonyl group optionally substituted, indolyl acetyl methoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl (also called Boc), phenyl methoxycarbonyl, 9-fluorenyl methoxycarbonyl (also called Fmoc), 3-methylphenoxyacetyl, 3-chlorophenyl methoxycarbonyl, trifluoromethoxycarbonyl, 2,5-dichlorobenzoyl, benzyloxycarbonyl (also called Cbz) can be specifically mentioned. As the alkoxycarbonyl group optionally substituted, tert-butoxycarbonyl, 9-fluorenyl methoxycarbonyl, benzyloxycarbonyl can be specifically mentioned.

[0275] The optionally substituted alkoxycarbonylamino group is an alkoxycarbonylamino group or a substituted alkoxycarbonylamino group. Regarding the alkoxy group (or alkoxycarbonyl) constituting the alkoxycarbonylamino group, the description of the alkoxy group (or alkoxycarbonyl) can be applied. Regarding the alkoxy group (or alkoxycarbonyl) and the substituent constituting the substituted alkoxycarbonylamino group, the description of the alkoxy group (or alkoxycarbonyl) and its substituent can be applied. As the optionally substituted alkoxycarbonylamino group, specifically tert-butoxycarbonylamino, 9-fluorenylmethyloxycarbonylamino, benzyloxycarbonylamino can be mentioned.

[0276] The optionally substituted alkylthio group is an alkylthio group or a substituted alkylthio group. Regarding the alkyl group constituting the alkylthio group, the description about the alkyl group can be applied. Regarding the alkyl group and the substituent group constituting the substituted alkylthio group, the description about the alkyl group and its substituent group can be applied. As the optionally substituted alkylthio group, a methylthio group can be specifically mentioned.

[0277] As the acyl group, there can be mentioned an optionally substituted alkylcarbonyl, an optionally substituted cycloalkylcarbonyl, an optionally substituted alkenylcarbonyl, an optionally substituted arylcarbonyl, and an optionally substituted alkoxycarbonyl. The optionally substituted alkylcarbonyl is an alkylcarbonyl or a substituted alkylcarbonyl. The optionally substituted cycloalkylcarbonyl is a cycloalkylcarbonyl or a substituted cycloalkylcarbonyl. The optionally substituted alkenylcarbonyl is an alkenylcarbonyl or a substituted alkenylcarbonyl. The optionally substituted arylcarbonyl is an arylcarbonyl or a substituted arylcarbonyl. The optionally substituted alkoxycarbonyl is an alkoxycarbonyl or a substituted alkoxycarbonyl. The substituents possessed by the functional group (e.g., substituted alkyl, substituted cycloalkyl, substituted alkenyl, substituted aryl, or substituted alkoxy) constituting the acyl group are as described above. Regarding the optionally substituted alkyl, optionally substituted aryl, and optionally substituted alkoxy constituting the acyl group, the descriptions of the optionally substituted alkyl, optionally substituted aryl, and optionally substituted alkoxy can be applied respectively. Examples of the cycloalkyl group include cyclic alkyl groups having 3 to 8 carbon atoms. Examples of the cycloalkyl group include cyclic alkyl groups having 4 to 6 carbon atoms. Examples of the cycloalkyl group include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Examples of the alkenyl group include alkenyl groups having 2 to 6 carbon atoms. The alkenyl group may be linear or branched. Examples of the alkenyl group include vinyl, allyl, propenyl, butenyl, butadienyl, pentenyl, pentadienyl, hexenyl, and hexadienyl. Examples of the acyl group include optionally substituted alkylcarbonyl and optionally substituted alkoxycarbonyl. As the acyl group, specifically, acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl, hexanoyl, acryloyl, methacryloyl, crotonyl, isocrotonyl, cyclopropanoyl, cyclobutanoyl, cyclopentanoyl, cyclohexanoyl, benzoyl, and the above-mentioned alkoxycarbonyl groups which may be substituted. As the acyl group, particularly, acetyl, tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl, and benzyloxycarbonyl can be mentioned.

[0278] The "amino acid" as R2 refers to an amino acid bonded to X via an appropriate bond. It should be noted that "the bond between the amino acid and X" in formula (I) is replaced by "the bond between the amino acid and the D ring" when X is an interatomic bond.

[0279] Examples of the amino acid of R2 include amino acids bonded via an amino group, amino acids bonded via a carboxyl group, amino acids bonded via a hydroxyl group, amino acids bonded via a thiol group, and amino acids bonded via an amide group.

[0280] "Amino acid bonded via an amino group" refers to an amino acid bonded to X via the nitrogen atom of the amino group. It should be noted that when the amino acid has two or more amino groups, any of these amino groups can be used for bonding to X. For example, the α amino group can be used for bonding to X, and the ε amino group can be used for bonding to X.

[0281] "Amino acid bonded via a carboxyl group" refers to an amino acid bonded to X via the oxygen atom of the OH of the carboxyl group. It should be noted that when an amino acid has two or more carboxyl groups, any of these carboxyl groups can be used for bonding to X. For example, the α carboxyl group can be used for bonding to X, and the other carboxyl groups can be used for bonding to X.

[0282] The "amino acid bonded via a hydroxyl group" refers to an amino acid bonded to X via the oxygen atom of the hydroxyl group.

[0283] The "amino acid bonded via a thiol group" refers to an amino acid bonded to X via the sulfur atom of the thiol group.

[0284] The "amino acid bonded via an amide group" refers to an amino acid bonded to X via the nitrogen atom of the amide group.

[0285] As amino acids, basic amino acids such as lysine, ornithine, arginine, histidine, citrulline, diaminobutyric acid, diaminopropionic acid, aliphatic amino acids such as isoleucine, alanine, valine, leucine, glycine, amino acids such as hydroxymonoaminocarboxylic acids, cyclic amino acids such as proline (also referred to as "imido acids"), aromatic amino acids such as phenylalanine, tyrosine, tryptophan, sulfur-containing amino acids such as cysteine, cystine, methionine, acidic amino acids such as glutamic acid, aspartic acid, glutamine, asparagine, etc., amino acids having amide groups in the side chains. As amino acids, valine, norleucine, α-aminobutyric acid, γ-aminobutyric acid, hydroxyproline, tert-leucine, sarcosine can also be mentioned. Amino acids may have substituents on their amino and / or carboxyl groups, or may not have substituents. That is, unless otherwise specified, "amino acids" include amino acids having substituents on their amino and / or carboxyl groups. That is, as amino acids, amino acids having substituents on the amino and / or carboxyl groups of the amino acids described above can also be mentioned. As the substituent possessed by the amino group in the amino acid, there can be mentioned an optionally substituted alkoxycarbonyl group and an optionally substituted alkyl group. That is, the amino group in the amino acid can constitute, for example, an optionally substituted alkoxycarbonylamino group or an optionally substituted alkylamino group. As the substituent possessed by the amino group in the amino acid, there can be mentioned, in particular, a tert-butoxycarbonyl group, a 9-fluorenylmethoxycarbonyl group, and a benzyloxycarbonyl group. As the substituent possessed by the carboxyl group in the amino acid, there can be mentioned an optionally substituted alkyl group and an amino group. That is, the carboxyl group in the amino acid can constitute, for example, an optionally substituted alkoxycarbonyl group or an aminocarbonyl group. As the substituent possessed by the carboxyl group in the amino acid, there can be mentioned, in particular, a methyl group, an ethyl group, a tert-butyl group, and a benzyl group.

[0286] "Agmatine" as R2 refers to agmatine bonded to X via an appropriate bond. It should be noted that "bond between agmatine and X" in formula (I) is replaced by "bond between agmatine and ring D" when X is an interatomic bond.

[0287] Examples of the agmatine for R2 include agmatine bonded via an amino group.

[0288] "Agmatine bonded via an amino group" refers to agmatine bonded to X via the nitrogen atom of the amino group. It should be noted that any of the amino groups of agmatine can be used for bonding to X. For example, the amino group at the guanidine site can be used for bonding to X, and the N-4-amino group can be used for bonding to X.

[0289] Agmatine may or may not have a substituent on its amino group. That is, unless otherwise specified, "agmatine" includes a group having a substituent on its amino group. Regarding the substituent on the amino group of agmatine, the description of the substituent on the amino group of the amino acid can be applied.

[0290] "Guanidine" as R2 refers to guanidine bonded to X via an appropriate bond. In formula (I), "a bond between guanidine and X" is replaced by "a bond between guanidine and ring D" when X is an interatomic bond.

[0291] Examples of the guanidine for R2 include guanidines bonded via an amino group.

[0292] The "guanidine bonded via the amino group" refers to guanidine bonded to X via the nitrogen atom of the amino group.

[0293] Guanidine may or may not have a substituent on its amino group. That is, unless otherwise specified, "guanidine" includes a case where its amino group has a substituent. Regarding the substituent in the amino group of guanidine, the description of the substituent in the amino group of the amino acid can be applied. In addition, as a substituent in the amino group of guanidine, an optionally substituted alkylcarbonyl group can be cited. Regarding the optionally substituted alkylcarbonyl group as a substituent in the amino group of guanidine, the description of the optionally substituted alkylcarbonyl group as the acyl group can be applied.

[0294] As the structure represented by formula (R2-1), specifically when R3 and R4 are H, ethylenediamine, propylenediamine, putrescine, and cadaverine can be mentioned. As the structure represented by formula (R2-1), specifically when R3 and / or R4 are not H, ethylenediamine, propylenediamine, putrescine, and cadaverine in which the hydrogen atom of the amino group is substituted by R3 and / or R4 can be mentioned.

[0295] Specific examples of the structure represented by formula (R2-2) include malonic acid, succinic acid, glutaric acid, adipic acid, fumaric acid, maleic acid, and citric acid in which the hydrogen atom of the carboxyl group is substituted with R5.

[0296] In one embodiment, Y may be NH, and R1 may be methyl.

[0297] In one embodiment, X may be an interatomic bond or an oxycarbonyl group, and R2 may be an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group. In one embodiment, in particular, X may be an interatomic bond or an oxycarbonyl group, and R2 may be an amino acid bonded via an amino group, or agmatine bonded via an amino group.

[0298] In one embodiment, X may be an interatomic bond, and R2 may be an amino acid bonded via a carboxyl group.

[0299] In one embodiment, X may be an interatomic bond, and R2 may be an amino acid bonded via a hydroxyl group.

[0300] In one embodiment, X may be an interatomic bond, and R2 may be an amino acid bonded via a thiol group.

[0301] In one embodiment, X may be an interatomic bond, and R2 may be an amino acid bonded via an amide group.

[0302] In one embodiment, X may be an interatomic bond or an oxycarbonyl group, and R2 may be a structure represented by formula (R2-1).

[0303] In one embodiment, X may be an interatomic bond, and R2 may be a structure represented by formula (R2-2).

[0304] In one embodiment, X may be an interatomic bond, R1 may be a methyl group, R2 may be an amino acid bonded through an amino group, agmatine bonded through an amino group, guanidine bonded through an amino group, or a structure represented by formula (R2-1). In one embodiment, in particular, X may be an interatomic bond, R1 may be a methyl group, R2 may be an amino acid bonded through an amino group, agmatine bonded through an amino group, or a structure represented by formula (R2-1).

[0305] In one embodiment, X may be an oxycarbonyl group, R1 may be a methyl group, and R2 may be an amino acid bonded via a carboxyl group or a structure represented by formula (R2-2).

[0306] In one embodiment, X may be an interatomic bond, Y may be NH, R1 may be a methyl group, R2 may be an amino acid bonded through an amino group, agmatine bonded through an amino group, guanidine bonded through an amino group, or a structure represented by formula (R2-1). In one embodiment, in particular, X may be an interatomic bond, Y may be NH, R1 may be a methyl group, R2 may be an amino acid bonded through an amino group, agmatine bonded through an amino group, or a structure represented by formula (R2-1).

[0307] In one embodiment, X may be an oxycarbonyl group, Y may be NH, R1 may be a methyl group, and R2 may be an amino acid bonded via a carboxyl group or a structure represented by formula (R2-2).

[0308] Component (B) is a compound represented by the following general formula (II). n " and "Rn" (n is a positive integer) can be used in an interchangeable manner. In addition, with respect to component (B), "X n " and "Xn" (n is a positive integer) can be used interchangeably.

[0309] [Chemical formula 4]

[0310]

[0311] In formula (II), the cyclic structure located on the right side is also referred to as "D ring."

[0312] In formula (II), X1 represents an interatomic bond or a methyleneoxy group (CH2O). It should be noted that "methyleneoxy" as X1 refers to a group in which CH2 is bonded to the D ring and O is bonded to X2. It should be noted that "the bond between O and X2" of the methyleneoxy group is replaced by "the bond between O and R2" when X2 is an interatomic bond.

[0313] In formula (II), X2 represents an interatomic bond or a carbonyl group (C(=O)).

[0314] In formula (II), Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom.

[0315] In formula (II), R1 represents a hydrogen atom (H) or a methyl group.

[0316] In formula (II), R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1), or the structure represented by the general formula (R2-2).

[0317] In the formula (II), bc represents CH-CH2 or C=CH.

[0318] Unless otherwise specified, for component (B), b to c, X1, X2, Y, n and R1 to R5 can be selected independently.

[0319] The structure represented by formula (R2-1) and the structure represented by formula (R2-2) are as described above.

[0320] The "amino acid" as R2 in formula (II) refers to an amino acid bonded to X2 via an appropriate bond. It should be noted that the "bonding of an amino acid to X2" in formula (II) is replaced by "bonding of an amino acid to X1" when X2 is an interatomic bond. In addition, the "bonding of an amino acid to X2" in formula (II) is replaced by "bonding of an amino acid to ring D" when X1 and X2 are interatomic bonds. Regarding the "amino acid" as R2 in formula (II), the description of the "amino acid" as R2 in formula (I) can be applied.

[0321] "Agmatine" as R2 in formula (II) refers to agmatine bonded to X2 via an appropriate bond. It should be noted that, when X2 is an interatomic bond, "bonding of agmatine to X2" in formula (II) is replaced by "bonding of agmatine to X1." In addition, when X1 and X2 are interatomic bonds, "bonding of agmatine to X2" in formula (II) is replaced by "bonding of agmatine to ring D." Regarding "agmatine" as R2 in formula (II), the description of "agmatine" as R2 in formula (I) can be applied.

[0322] "Guanidine" as R2 in formula (II) refers to guanidine bonded to X2 through an appropriate bond. It should be noted that "guanidine and X2 bonding" in formula (II) is replaced by "guanidine and X1 bonding" when X2 is an interatomic bonding. "In addition, "guanidine and X2 bonding" in formula (II) is replaced by "guanidine and D ring bonding" when X1 and X2 are interatomic bonding. "Regarding "guanidine" as R2 in formula (II), the description of "guanidine" as R2 in formula (I) can be applied.

[0323] The "aliphatic alcohol" as R2 in formula (II) refers to an aliphatic alcohol bonded to X2 via the oxygen atom of the hydroxyl group. It should be noted that "the bond between the aliphatic alcohol and X2" in formula (II) is replaced by "the bond between the aliphatic alcohol and X1" when X2 is an interatomic bond. In addition, "the bond between the aliphatic alcohol and X2" in formula (II) is replaced by "the bond between the aliphatic alcohol and the D ring" when X1 and X2 are interatomic bonds.

[0324] The aliphatic alcohol may be a saturated aliphatic alcohol or an unsaturated aliphatic alcohol. The aliphatic alcohol may be a straight chain or a branched chain. Examples of the aliphatic alcohol include aliphatic alcohols having 2 to 26, 2 to 22, or 2 to 18 carbon atoms. Examples of the aliphatic alcohol include aliphatic alcohols having 2 to 18 carbon atoms. Specific examples of the aliphatic alcohol include ethanol, propanol, isopropanol, butanol, isobutanol, sec-butanol, tert-butanol, pentanol, isopentanol, 2,3-dimethylpropanol, hexanol, heptanol, octanol, nonanol, decanol, undecanol, dodecanol, tridecanol, tetradecanol, pentadecanol, hexadecanol, cis-9-hexadecen-1-ol, heptadecanol, octadecanol, cis-9-octadecen-1-ol, cis, cis-9,12-octadecadien-1-ol, 9,12,15-octadecatriene-1-ol, 6,9,12-octadecatriene-1-ol, nonadecanol, eicosanol, heneicosanol, docosanol, tetracosanol and hexacosanol.

[0325] The "fatty acid" as R2 in formula (II) refers to a fatty acid bonded to X2 via the oxygen atom of the OH of the carboxyl group. It should be noted that the "bond between the fatty acid and X2" in formula (II) is replaced by "bond between the fatty acid and X1" when X2 is an interatomic bond. In addition, the "bond between the fatty acid and X2" in formula (II) is replaced by "bond between the fatty acid and the D ring" when X1 and X2 are interatomic bonds.

[0326] The fatty acid may be a saturated fatty acid or an unsaturated fatty acid. The fatty acid alcohol may be a straight chain or a branched chain. Examples of the fatty acid include fatty acids having 2 to 26, 2 to 22, or 2 to 18 carbon atoms. Examples of the fatty acid include fatty acids having 2 to 18 carbon atoms. Specific examples of the fatty acid include acetic acid, propionic acid, succinic acid, butyric acid, valeric acid, caproic acid, heptanoic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, eicosanoic acid, arachidonic acid, behenic acid, tetracosanoic acid, nervonic acid, cerotic acid, eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid.

[0327] In one embodiment, X1 may be an interatomic bond, and X2 may be a carbonyl group.

[0328] In one embodiment, X1 may be a methyleneoxy group, and X2 may be an interatomic bond.

[0329] In one embodiment, X1 may be an interatomic bond, and X2 may be an interatomic bond.

[0330] In one embodiment, X1 may be a methyleneoxy group, and X2 may be a carbonyl group.

[0331] In one embodiment, Y may be NH, bc may be CH-CH2, and R1 may be H.

[0332] In one embodiment, X1 may be an interatomic bond, X2 may be a carbonyl group, Y may be NH, bc may be CH-CH2, and R1 may be H.

[0333] In one embodiment, X1 may be a methyleneoxy group, X2 may be an interatomic bond, Y may be NH, bc may be CH-CH2, and R1 may be H.

[0334] In one embodiment, X1 may be an interatomic bond, X2 may be a carbonyl group, and R2 may be an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group. In one embodiment, in particular, X1 may be an interatomic bond, X2 may be a carbonyl group, and R2 may be an amino acid bonded via an amino group, or agmatine bonded via an amino group.

[0335] In one embodiment, X1 may be a methyleneoxy group, X2 may be an interatomic bond, and R2 may be an amino acid bonded via a carboxyl group.

[0336] In one embodiment, X1 may be an interatomic bond, X2 may be a carbonyl group, and R2 may be an aliphatic alcohol.

[0337] In one embodiment, X1 may be a methyleneoxy group, X2 may be an interatomic bond, and R2 may be a fatty acid.

[0338] In one embodiment, X1 may be an interatomic bond, X2 may be a carbonyl group, and R2 may be a structure represented by formula (R2-1).

[0339] In one embodiment, X1 may be a methyleneoxy group, X2 may be an interatomic bond, and R2 may be a structure represented by formula (R2-2).

[0340] In one embodiment, X1 may be an interatomic bond, X2 may be a carbonyl group, Y may be NH, bc may be CH-CH2, R1 may be H, R2 may be an amino acid bonded through an amino group, agmatine bonded through an amino group, guanidine bonded through an amino group, or a structure represented by formula (R2-1). In one embodiment, in particular, X1 may be an interatomic bond, X2 may be a carbonyl group, Y may be NH, bc may be CH-CH2, R1 may be H, R2 may be an amino acid bonded through an amino group, agmatine bonded through an amino group, or a structure represented by formula (R2-1).

[0341] In one embodiment, X1 can be a methyleneoxy group, X2 can be an interatomic bond, Y can be NH, bc can be CH-CH2, R1 can be H, and R2 can be an amino acid bonded via a carboxyl group, a fatty acid having 2 to 18 carbon atoms, or a structure represented by formula (R2-2).

[0342] In one embodiment, X1 may be an interatomic bond, X2 may be an interatomic bond, and R2 may be a guanidine bonded via an amino group.

[0343] In one embodiment, X1 may be an interatomic bond, X2 may be an interatomic bond, Y may be an oxygen atom (O), bc may be C═CH, R1 may be a methyl group, and R2 may be guanidine bonded via an amino group.

[0344] As X, Y, n and R1 to R5 of component (A), specifically, X, Y, n and R1 to R5 of compounds represented by formula (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 37), (Compound 80) and (Compound 82) to (Compound 85) described later can be mentioned. That is, X, Y, n and R1 to R5 of component (A) can be specifically selected from X, Y, n and R1 to R5 of compounds represented by formula (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 37), (Compound 80) and (Compound 82) to (Compound 85) described later.

[0345] Specifically, b to c, X1, X2, Y, n and R1 to R5 of component (B) include b to c, X1, X2, Y, n and R1 to R5 of compounds represented by formulas (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 80) and (Compound 82) to (Compound 90) described later. That is, b to c, X1, X2, Y, n and R1 to R5 of component (B) can be specifically selected from, for example, b to c, X1, X2, Y, n and R1 to R5 of compounds represented by formulas (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 80) and (Compound 82) to (Compound 90) described later.

[0346] Specific examples of the component (A) or (B) include compounds represented by the formulas (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 80), and (Compound 82) to (Compound 90) described below. Specific examples of the component (A) or (B) include compounds represented by the formulas (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 61), (Compound 65) to (Compound 80), and (Compound 83) to (Compound 90) described below. Specific examples of the component (A) or (B) include compounds represented by the formulas (Compound 1) to (Compound 8), (Compound 27) to (Compound 30), (Compound 38) to (Compound 56), and (Compound 66) to (Compound 77) described below. The compounds represented by formula (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 37), (Compound 80) and (Compound 82) to (Compound 85) can all be examples of component (A) or (B). The compounds represented by formula (Compound 38) to (Compound 79) and (Compound 86) to (Compound 90) can all be examples of component (B). In one embodiment, the compound represented by formula (Compound 85) can be excluded from component (A). In one embodiment, the compounds represented by formula (Compound 41), (Compound 50), (Compound 52), (Compound 54), (Compound 55), (Compound 58), (Compound 65), (Compound 77), (Compound 85), (Compound 86), (Compound 87) and (Compound 90) can be excluded from component (B). That is, in one embodiment, as component (A) or (B), specifically, compounds represented by formula (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 40), (Compound 42) to (Compound 49), (Compound 51), (Compound 53), (Compound 56), (Compound 57), (Compound 59) to (Compound 64), (Compound 66) to (Compound 76), (Compound 78) to (Compound 80), (Compound 82) to (Compound 84), (Compound 88), and (Compound 89) can be mentioned. In one embodiment, compounds represented by formula (Compound 41), (Compound 50), (Compound 52), (Compound 54), (Compound 55), and (Compound 77) can be excluded from component (B). That is, in one embodiment, as component (A) or (B), specific examples include compounds represented by formula (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 40), (Compound 42) to (Compound 49), (Compound 51), (Compound 53), (Compound 56) to (Compound 76), (Compound 78) to (Compound 80), and (Compound 82) to (Compound 90).

[0347] When component (A) or (B) can form a salt, component (A) or (B) can be used as a free body, can be used as a salt, or can be used as a combination thereof. That is, unless otherwise specified, the term "component (A)" can refer to the component (A) of the free body or its salt, or a combination thereof. In addition, unless otherwise specified, the term "component (B)" can refer to the component (B) of the free body, or its salt, or a combination thereof. Salts are not particularly limited as long as they do not damage the effect of the present invention. For example, as salts for acidic groups such as carboxyl groups, ammonium salts, salts with alkali metals such as sodium and potassium, salts with alkaline earth metals such as calcium and magnesium, aluminum salts, zinc salts, salts with organic amines such as triethylamine, ethanolamine, morpholine, pyrrolidine, piperidine, piperazine, dicyclohexylamine, and salts with basic amino acids such as arginine and lysine can be cited. In addition, as salts for basic groups such as amino groups, salts with inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, and hydrobromic acid, salts with organic carboxylic acids such as formic acid, acetic acid, citric acid, benzoic acid, maleic acid, fumaric acid, tartaric acid, succinic acid, tannic acid, butyric acid, sea benzoic acid (Hibenzoic acid), pamoic acid, enanthic acid, capric acid, theochloric acid, salicylic acid, lactic acid, oxalic acid, mandelic acid, malic acid, and their halides, and salts with organic sulfonic acids such as methanesulfonic acid, benzenesulfonic acid, and p-toluenesulfonic acid. As halides, heptafluorobutyric acid can be mentioned. As salts, one salt can be used, or two or more salts can be used in combination.

[0348] In addition, when component (A) or (B) can form a hydrate, component (A) or (B) can be used as a non-hydrate, can be used as a hydrate, or can be used as a combination thereof. That is, unless otherwise specified, the term "component (A)" (e.g., "free component (A)", "salt of component (A)") can include non-hydrates and hydrates. In addition, unless otherwise specified, the term "component (B)" (e.g., "free component (B)", "salt of component (B)") can include non-hydrates and hydrates.

[0349] Component (A) or (B) may be used in any form such as ions.

[0350] As component (A) or (B), one substance may be used, or two or more substances may be used in combination. When two or more components are selected as component (A) or (B), unless otherwise specified, the "amount" or "concentration" of component (A) or (B) may refer to the total amount or total concentration of the selected components.

[0351] As component (A) or (B), commercial products can be used, and substances obtained by appropriate manufacture can also be used. The manufacturing method of component (A) or (B) is not particularly limited. Component (A) or (B) can be manufactured, for example, by a known method. Component (A) or (B), specifically, for example, can be manufactured by chemical synthesis, enzyme reaction, fermentation method, extraction method, or a combination thereof. Component (A) or (B) can be purified to the desired degree, or not. That is, as component (A) or (B), a purified product can be used, or a raw material containing component (A) or (B) can be used. As a raw material containing component (A) or (B), specifically, for example, fermentation products such as culture solution, bacterial cells, and culture supernatant obtained by culturing a microorganism having the production capacity of the component (A) or (B), agricultural, aquatic, and livestock products containing the component (A) or (B), and their processed products can be cited. As a processed product, a product obtained by subjecting raw materials such as fermentation products as described above to treatments such as concentration, dilution, drying, classification, extraction, and purification can be cited. As component (A) or (B), for example, a raw material having a content of component (A) or (B) of 1% (w / w) or more, 5% (w / w) or more, 10% (w / w) or more, 30% (w / w) or more, 50% (w / w) or more, 70% (w / w) or more, 90% (w / w) or more, or 95% (w / w) or more can be used.

[0352] Ingredient (C) is an amino acid fermentation byproduct.

[0353] "Amino acid fermentation byproducts" refers to the general term for the liquid remaining after separating amino acids from the amino acid fermentation liquid (also referred to as "amino acid fermentation byproduct liquid"), its concentrate, and their fractions. The concentrate can be, for example, a liquid (i.e., a concentrated liquid) or a solid (i.e., a dried solid). There are no particular restrictions on the fraction as long as it contains a fraction having the function of an active ingredient as described later. It should be noted that the term "fractionated product of the concentrate" can be used instead of the term "concentrated product of the fraction".

[0354] "Amino acid fermentation broth" refers to a culture broth containing amino acids.

[0355] As amino acids in the amino acid fermentation byproducts and the amino acid fermentation broth, lysine, tryptophan, threonine, valine, leucine, and isoleucine can be mentioned. The amino acids in the amino acid fermentation byproducts and the amino acid fermentation broth can all be L-amino acids. The amino acids separated from the amino acid fermentation broth can all be free amino acids, salts thereof, or combinations thereof.

[0356] The amino acid fermentation broth is obtained by culturing microorganisms having the ability to produce amino acids.

[0357] "Microorganisms with amino acid production ability" can refer to microorganisms that, when cultured in a medium, have the ability to produce a target amino acid and accumulate it in the medium to a separable extent.

[0358] As the microorganism, bacteria can be cited. As the bacteria, bacteria belonging to the family Enterobacteriaceae and coryneform bacteria can be cited. As the bacteria belonging to the family Enterobacteriaceae, bacteria belonging to the genus Escherichia such as Escherichia coli, and bacteria belonging to the genus Pantoea such as Pantoea ananatis can be cited. As the coryneform bacteria, bacteria belonging to the genus Corynebacterium such as Corynebacterium glutamicum can be cited.

[0359] The microorganism with amino acid production ability can be a microorganism that originally has amino acid production ability, or a microorganism that is modified to have amino acid production ability. The microorganism with amino acid production ability can be obtained, for example, by endowing the microorganism with amino acid production ability or by enhancing the amino acid production ability of the microorganism. The endowment or enhancement of amino acid production ability (specifically L-amino acid production ability) can be carried out, for example, by the methods that have been conventionally used in the breeding of amino acid-producing bacteria (refer to Amino Acid Fermentation, Gakkai Shuppan Center, Ltd., first published on May 30, 1986, pages 77 to 100). In addition, the methods for endowing or enhancing amino acid production ability (specifically L-amino acid production ability) are disclosed, for example, in US2018-0282773 and WO2018 / 030507.

[0360] Hereinafter, specific examples of L-amino acid-producing bacteria and methods for endowing or enhancing L-amino acid production ability will be given. It should be noted that the properties of the L-amino acid-producing bacteria exemplified below and the modifications for endowing or enhancing L-amino acid production ability can be used alone or in appropriate combinations.

[0361] <L-Threonine-producing bacteria>

[0362] As a method for imparting or enhancing L-threonine production capacity, for example, a method for increasing the activity of one or more enzymes selected from the L-threonine biosynthesis enzyme by modifying bacteria can be enumerated. As such an enzyme, there is no particular limitation, and aspartate kinase III (lysC), aspartate semialdehyde dehydrogenase (asd), aspartate kinase I (thrA), homoserine kinase (homoserine kinase) (thrB), threonine synthase (threonine synthase) (thrC), aspartate aminotransferase (aspartate aminotransferase) (aspC) can be enumerated. Among these enzymes, it is preferred to enhance the activity of one or more enzymes selected from aspartate kinase III, aspartate semialdehyde dehydrogenase, aspartate kinase I, homoserine kinase, aspartate aminotransferase and threonine synthase. The L-threonine biosynthesis gene can be introduced into a strain that has suppressed the decomposition of threonine. Examples of strains in which threonine degradation is suppressed include E. coli TDH6 strain deficient in threonine dehydrogenase activity (Japanese Patent Application Laid-Open No. 2001-346578).

[0363] The activity of L-threonine biosynthetic enzymes is inhibited by the end product L-threonine. Therefore, in order to construct L-threonine producing bacteria, it is preferred to modify L-threonine biosynthetic genes so that they are not subject to feedback inhibition by L-threonine. The thrA, thrB, and thrC genes constitute the threonine operon, and the threonine operon forms an attenuator structure. The expression of the threonine operon is inhibited by isoleucine and threonine in the culture medium and is inhibited by attenuation. The enhancement of the expression of the threonine operon can be achieved by removing the leader sequence or attenuator in the attenuation region (Lynn, SP, Burton, WS, Donohue, TJ, Gould, RM, Gumport, RI, and Gardner, JFJ Mol. Biol. 194: 59-69 (1987); WO02 / 26993; WO2005 / 049808; WO2003 / 097839).

[0364] There is a native promoter upstream of the threonine operon, and the promoter can also be replaced with a non-natural promoter (WO98 / 04715). In addition, the threonine operon can also be constructed so that the genes involved in threonine biosynthesis are expressed under the control of the repressor and promoter of λ phage (EP0593792B). In addition, bacteria modified in a manner not to be feedback inhibited by L-threonine can also be obtained by selecting strains resistant to α-amino-β-hydroxyvaleric acid (AHV), which is an L-threonine analog.

[0365] Preferably, the expression level of the threonine operon in the host that is modified to the feedback inhibition of L-threonine is improved by increasing the copy number or by being connected to a powerful promotor. The increase of the copy number can be realized by importing the plasmid comprising the threonine operon into the host. In addition, the increase of the copy number can also be realized by utilizing transposon, Mu phage etc. to transfer the threonine operon to the genome of the host.

[0366] In addition, as a method for imparting or enhancing L-threonine production capacity, a method for imparting L-threonine tolerance to a host and a method for imparting L-homoserine tolerance can also be mentioned. Imparting tolerance can be achieved, for example, by strengthening the expression of a gene that imparts tolerance to L-threonine and a gene that imparts tolerance to L-homoserine. As a gene that imparts tolerance, rhtA gene (Res.Microbiol.154:123-135 (2003)), rhtB gene (EP0994190A), rhtC gene (EP1013765A), yfiK gene, yeaS gene (EP1016710A) can be mentioned. In addition, the method for imparting L-threonine tolerance to a host can refer to the method described in EP0994190A and WO90 / 04636.

[0367] Specific examples of L-threonine-producing bacteria or parent strains for inducing the same include E. coli TDH-6 / pVIC40 (VKPM B-3996; U.S. Patent No. 5,175,107, U.S. Patent No. 5,705,371), E. coli 472T23 / pYN7 (ATCC 98081; U.S. Patent No. 5,631,157), E. coli NRRL B-21593 (U.S. Patent No. 5,939,307), E. coli FERM BP-3756 (U.S. Patent No. 5,474,918), E. coli FERM BP-3519 and FERM BP-3520 (U.S. Patent No. 5,376,538), E. coli MG442 (Gusyatiner et al., Genetika (in Russian), 14, 947-956 (1978)), E. coli VL643 and VL2055 (EP1149911A) and E. coli VKPMB-5318 (EP0593792B).

[0368] The VKPM B-3996 strain is a strain in which the plasmid pVIC40 was introduced into the TDH-6 strain. The TDH-6 strain is a sucrose assimilator, lacks the thrC gene, and has a leaky mutation in the ilvA gene. In addition, the TDH-6 strain has a mutation in the rhtA gene that confers resistance to high concentrations of threonine or homoserine. Plasmid pVIC40 is a strain in which a mutant thrA gene encoding aspartate kinase homoserine dehydrogenase (aspartokinase-homoserine dehydrogenase) I resistant to feedback inhibition caused by threonine and a wild-type thrBC gene are inserted into the RSF1010-derived vector. * The mutant thrA gene encodes an aspartate kinase homoserine dehydrogenase I that is substantially free of feedback inhibition by threonine. The strain B-3996 was deposited on November 19, 1987 at the All-Union Scientific Center of Antibiotics (Nagatinskaya Street 3-A, 117105 Moscow, Russia) under the accession number RIA1867. In addition, the strain was deposited on April 7, 1987 at the Russian State Collection of Industrial Microorganisms (VK PM) (FGUP GosNII Genetika, 1 Dorozhny proezd., 1 Moscow 117545, Russia) under the accession number VKPM B-3996.

[0369] The strain VKPM B-5318 does not require isoleucine and maintains the plasmid pPRT614 in which the control region of the threonine operon in the plasmid pVIC40 was replaced with the temperature-sensitive lambda phage C1 repressor and PR promoter. VKPM B-5318 was internationally deposited on May 3, 1990 at the Russian State Collection of Industrial Microorganisms (VKPM) (FGUP GosNII Genetika, 1 Dorozhny proezd., 1 Moscow 117545, Russia) under the deposit number VKPM B-5318.

[0370] The thrA gene encoding the aspartate kinase homoserine dehydrogenase I of E. coli has been identified (nucleotide numbers 337 to 2799, GenBank accession NC_000913.2, gi: 49175990). The thrA gene is located between the thrL gene and the thrB gene in the chromosome of E. coli K-12. The thrB gene encoding the homoserine kinase of E. coli has been identified (nucleotide numbers 2801 to 3733, GenBank accession NC_000913.2, gi: 49175990). The thrB gene is located between the thrA gene and the thrC gene in the chromosome of E. coli K-12. The thrC gene encoding the threonine synthase of E. coli has been identified (nucleotide numbers 3734 to 5020, GenBank accession NC_000913.2, gi: 49175990). The thrC gene is located between the thrB gene and the yaaX open reading frame in the E. coli K-12 chromosome. In addition, the thrA gene includes a mutant thrA gene encoding aspartate kinase homoserine dehydrogenase I resistant to feedback inhibition by threonine and a wild-type thrBC gene. * The BC operon can be obtained from the known plasmid pVIC40 (U.S. Patent No. 5,705,371) present in the threonine-producing strain E. coli VKPM B-3996.

[0371] The rhtA gene of E. coli is present at 18 min of the E. coli chromosome near the glnHPQ operon encoding the elements of the glutamine transport system. The rhtA gene is identical to ORF1 (ybiF gene, nucleotide number 764-1651, GenBank accession number AAA218541, gi:440181) and is located between the pex B gene and the ompX gene. The unit expressing the protein encoded by ORF1 is called the rhtA gene (rht: resistant to homoserine and threonine). In addition, it was found that the rhtA23 mutation that confers resistance to high concentrations of threonine or homoserine is a G→A substitution at position -1 relative to the ATG start codon (ABSTRACTS of the 17th International Congress of Biochemistry and Molecular Biology in conjugation with Annual Meeting of the American Society for Biochemistry and Molecular Biology, San Francisco, California August 24-29, 1997, abstract No. 457, EP1013765A).

[0372] The asd gene of E. coli has been identified (nucleotide numbers 3572511 to 3571408, GenBank accession NC_000913.1, gi: 16131307), and can be obtained by PCR using primers prepared based on the base sequence of the gene (White, TJ et al., Trends Genet., 5, 185 (1989)). The asd genes of other microorganisms can also be obtained in the same manner.

[0373] In addition, the aspC gene of E. coli has also been identified (nucleotide numbers 983742 to 984932, GenBank accession NC_000913.1, gi: 16128895), and can be obtained by PCR using primers prepared based on the base sequence of the gene. The aspC genes of other microorganisms can also be obtained in the same manner.

[0374] In addition, as a coryneform bacterium having the ability to produce L-threonine, for example, Corynebacterium acetoacidophilum AJ12318 (FERM BP-1172; U.S. Patent No. 5,188,949) can be mentioned.

[0375] <L-lysine-producing bacterium>

[0376] Examples of methods for imparting or enhancing the ability to produce L-lysine include methods of modifying bacteria so that the activity of one or more enzymes selected from L-lysine biosynthetic enzymes is increased. Examples of such enzymes include, but are not limited to, dihydrodipicolinate synthase (dapA), aspartate kinase III (lysC), dihydrodipicolinate reductase (dapB), diamino pimerate decarboxylase (lysA), diaminopimerate dehydrogenase (ddh) (U.S. Pat. No. 6,040,160), phosphoenolpyruvate carboxylase (ppc), aspartate semialdehyde dehydrogenase (asd), aspartate aminotransferase (aspartate transaminase) (aspC), diaminopimerate epimerase (ddh) (U.S. Pat. No. 6,040,160), phosphoenolpyruvate carboxylase (ppc), aspartate semialdehyde dehydrogenase (asd), aspartate aminotransferase (aspartate transaminase) (aspC), diaminopimerate epimerase (ddh) (U.S. Pat. No. 6,040,160), epimerase) (dapF), tetrahydrodipicolinate succinylas (dapD), succinyl-diaminopimelate deacylase (succinyl-diaminopimelate deacylase) (dapE) and aspartase (aspA) (EP1253195 A). Among these enzymes, for example, it is preferred to enhance the activity of one or more enzymes selected from dihydrodipicolinate reductase, diaminopimelate decarboxylase, diaminopimelate dehydrogenase, phosphoenolpyruvate carboxylase, aspartate aminotransferase, diaminopimelate epimerase, aspartate semialdehyde dehydrogenase, tetrahydrodipicolinate succinylas (dapD), succinyl-diaminopimelate deacylase (succinyl-diaminopimelate deacylase) (dapE) and aspartase (aspA) (EP1253195 A). Among these enzymes, for example, it is preferred to enhance the activity of one or more enzymes selected from dihydrodipicolinate reductase, diaminopimelate decarboxylase, diaminopimelate dehydrogenase, phosphoenolpyruvate carboxylase, aspartate aminotransferase, diaminopimelate epimerase, aspartate semialdehyde dehydrogenase, tetrahydrodipicolinate succinylas and succinyl-diaminopimelate deacylase. In addition, in L-lysine producing bacteria or parent strains used to induce the same, genes related to energy efficiency (cyo) (EP1170376A), genes encoding nicotinamide nucleotide transhydrogenase (nicotinamide The expression level of the gene for nucleotide transhydrogenase (pnt AB) (U.S. Patent No. 5,830,716), the ybjE gene (WO2005 / 073390), or a combination thereof can be increased.Since aspartate kinase III (lysC) is subject to feedback inhibition by L-lysine, in order to enhance the activity of the enzyme, a mutant lysC gene encoding an aspartate kinase III having feedback inhibition by L-lysine removed can be used (U.S. Patent No. 5,932,453). As an aspartate kinase III having feedback inhibition by L-lysine removed, there can be enumerated aspartate kinase III from Escherichia coli having a mutation in which a methionine residue at position 318 is substituted with an isoleucine residue, a glycine residue at position 323 is substituted with an aspartate residue, and a threonine residue at position 352 is substituted with one or more mutations in a mutation in which an isoleucine residue is removed (U.S. Patent No. 5,661,012, U.S. Patent No. 6,040,160). In addition, dihydrodipicolinate synthetase (dapA) is subject to feedback inhibition by L-lysine, so in order to enhance the activity of the enzyme, a mutant dapA gene encoding a dihydrodipicolinate synthetase that is relieved of feedback inhibition by L-lysine can be used. As a dihydrodipicolinate synthetase that is relieved of feedback inhibition by L-lysine, there can be mentioned a dihydrodipicolinate synthetase from Escherichia coli having a mutation in which the histidine residue at position 118 is substituted with a tyrosine residue (U.S. Patent No. 6,040,160).

[0377] In addition, as a method for imparting or enhancing L-Lysine production capacity, for example, the following method can also be enumerated: modifying bacteria so that the activity of one or more enzymes selected from the enzyme of the reaction of generating compounds other than L-Lysine from the biosynthetic pathway branch of catalysis from L-Lysine is reduced. As such enzyme, there is no particular restriction, and homoserine dehydrogenase (homoserine dehydrogenase), lysine decarboxylase (lysine decarboxylase) (U.S. Patent No. 5,827,698), and malic enzyme (m alic enzyme) (WO2005 / 010175) can be enumerated.

[0378] In addition, as a method for imparting or enhancing L-lysine production ability to coryneform bacteria, for example, a method for modifying bacteria in a manner that increases the activity of the lysine excretion system (lysE) (WO97 / 23597) can be cited. The lysE gene of Corynebacterium glutamicum ATCC 13032 is equivalent to the complementary sequence of the sequence at positions 1329712 to 1330413 in the genome sequence registered as GenBank accession NC_006958 (VERSION NC_006958.1GI:62388892) in the NCBI database. The LysE protein of Corynebacterium glutamicum ATCC13032 is registered as GenBank accession YP_225551 (YP_225551.1GI:62390149).

[0379] In addition, as L-lysine producing bacteria or the parent strain for inducing it, a mutant strain having resistance to L-lysine analogs can be enumerated. L-lysine analogs inhibit the growth of bacteria such as bacteria of the Enterobacteriaceae family and coryneform bacteria, and the inhibition is completely or partially relieved when L-lysine coexists in the culture medium. As L-lysine analogs, there is no particular limitation, and oxaline, lysine hydroxamate (L ysine hydroxamate), S-(2-aminoethyl)-L-cysteine ​​(AEC), γ-methyllysine, α-chlorocaprolactam can be enumerated. Mutants having resistance to these lysine analogs can be obtained by carrying out common artificial mutation treatment on bacteria.

[0380] Specific examples of L-lysine-producing bacteria or parent strains for inducing the same include E. col iAJ11442 (FERM BP-1543, NRRL B-12185; US Pat. No. 4,346,170) and Ecoli VL611. In these strains, feedback inhibition of aspartate kinase by L-lysine is relieved.

[0381] As L-lysine producing bacteria or parent strains for inducing it, specifically, E. coli WC196 strain can also be cited. WC196 strain was bred by conferring AEC resistance to W3110 strain from E. coli K-12 (U.S. Patent No. 5,827,698). WC196 strain was named E. coli AJ13069, and on December 6, 1994, it was deposited at the Institute of Biotechnology, Institute of Industrial Technology, Institute of Biotechnology, Institute of Industrial Technology (currently the Patent Biological Depository of the Independent Administrative Institution Product Evaluation Technology Foundation, Postal Code: 292-0818, Address: Room 120, 2-5-8, Kazusa Kamata, Kisarazu City, Chiba Prefecture, Japan), and on September 29, 1995, it was transferred to the international deposit based on the Budapest Treaty and given the deposit number FERM BP-5252 (U.S. Patent No. 5,827,698).

[0382] Preferred L-lysine producing bacteria include E. coli WC196ΔcadAΔldc and E. coli WC196ΔcadAΔldc / pCABD2 (WO2010 / 061890). WC196ΔcadAΔldc is a strain constructed by destroying the cadA and ldcC genes encoding lysine decarboxylase from the WC196 strain. WC196ΔcadAΔldc / pCABD2 is a strain constructed by introducing the plasmid pCABD2 (U.S. Patent No. 6,040,160) containing lysine biosynthesis genes into WC196ΔcadAΔldc. WC196ΔcadAΔldc was named AJ110692 and was internationally deposited on October 7, 2008 with the deposit number FERM BP-11027 at the Patent Organism Depository of the National Institute of Advanced Industrial Science and Technology (now the Patent Organism Depository of the National Institute of Technology Evaluation and Research, postal code: 292-0818, address: Room 120, 2-5-8, Kazusa Kamata, Kisarazu-shi, Chiba Prefecture, Japan). pCABD2 contains a mutant dapA gene encoding a dihydrodipicolinate synthase (DDPS) from Escherichia coli having a mutation (H118Y) that releases feedback inhibition of L-lysine, a mutant lysC gene encoding an aspartate kinase III from Escherichia coli having a mutation (T352I) that releases feedback inhibition of L-lysine, a dapB gene encoding a dihydrodipicolinate reductase from Escherichia coli, and a ddh gene encoding a diaminopimelate dehydrogenase from Lactobacillus.

[0383] As a preferred L-lysine-producing bacterium, E. coli AJIK01 strain (NITE BP-01520) can also be cited. AJIK01 strain is named E. coli AJ111046, and was deposited in the Patent Microorganism Depository of the Independent Administrative Institution for Product Evaluation and Technology Foundation (zip code: 292-0818, address: Room 122, 2-5-8, Kazusa Kamata, Kisarazu City, Chiba Prefecture, Japan) on January 29, 2013, and was transferred to the international deposit based on the Budapest Treaty on May 15, 2014, and was given the deposit number NITE BP-01520.

[0384] In addition, as coryneform bacteria having the ability to produce L-lysine, examples include AEC-resistant mutant strains (such as Corynebacterium glutamicum (Brevibacterium lactofermentum) AJ11082 (NRRL B-11470) strain; Japanese Patent Publication No. 56-1914, Japanese Patent Publication No. 56-1915, Japanese Patent Publication No. 57-14157, Japanese Patent Publication No. 57-14158, Japanese Patent Publication No. 57-30474, Japanese Patent Publication No. 58-10075, Japanese Patent Publication No. 59-4993, Japanese Patent Publication No. 61-35840, Japanese Patent Publication No. 62-24074, Japanese Patent Publication No. 62-36673, Japanese Utility Model Publication No. 5-11958, Japanese Utility Model Publication No. 7-112437, Japanese Utility Model Publication No. 7-112438); mutant strains that require amino acids such as L-homoserine during growth (Japanese Patent Publication No. 48-28078, Japanese Patent Publication No. 56-6499); mutant strains that are resistant to AEC and require amino acids such as L-leucine, L-homoserine, L-proline, L-serine, L-arginine, L-alanine, L-valine (U.S. Patent No. 3,708,395, U.S. Patent No. 3,825,472); mutant strains that are resistant to DL-α-amino-ε-caprolactam, α-amino-lauryl lactam, aspartic acid analogs, sulfonamides, quinone type, N-lauroyl leucine; mutant strains that are resistant to oxaloacetate decarboxylase inhibitors or respiratory enzyme inhibitors (Japanese Unexamined Patent Publication No. 50-53588, Japanese Unexamined Patent Publication No. 50-31093, Japanese Unexamined Patent Publication No. 52-102498, Japanese Unexamined Patent Publication No. 53-9394, Japanese Unexamined Patent Publication No. 53-86089, Japanese Unexamined Patent Publication No. 55-9783, Japanese Unexamined Patent Publication No. 55-9759, Japanese Unexamined Patent Publication No. 56-32995, Japanese Unexamined Patent Publication No. 56-39778, Japanese Patent Publication No. 53-43591, Japanese Patent Publication No. 53-1833); mutant strains that require inositol or acetic acid (Japanese Unexamined Patent Publication No. 55-9784, Japanese Unexamined Patent Publication No. 56-8692); mutant strains that are sensitive to fluoropyruvate or temperatures above 34°C (Japanese Unexamined Patent Publication No. 55-9783, Japanese Unexamined Patent Publication No. 53-86090); mutant strains that are resistant to ethylene glycol (U.S. Patent No. 4,411,997).

[0385] <L-leucine-producing bacterium>

[0386] As a method for conferring or enhancing the L-leucine-producing ability, for example, a method of modifying a bacterium in such a way that the activity of one or more enzymes selected from L-leucine biosynthetic enzymes is increased can be mentioned. Such enzymes are not particularly limited, and examples include enzymes encoded by the genes of the leuABCD operon. In addition, in enhancing the enzyme activity, for example, a mutant leuA gene encoding isopropylmalate synthase whose feedback inhibition by L-leucine is released (U.S. Patent No. 6,403,342) can be preferably used.

[0387] As an L-leucine-producing bacterium or a parent strain for inducing the same, specifically, for example, a leucine-tolerant E. coli strain (e.g., strain 57 (VKPM B-7386; U.S. Patent No. 6,124,121)), an E. coli strain that is tolerant to leucine analogs such as β-2-thienylalanine, 3-hydroxy-leucine, 4-azaleucine, 5,5,5-trifluoroleucine (Japanese Patent Publication No. 62-34397 and Japanese Unexamined Patent Publication No. 8-70879), an E. coli strain obtained by the genetic engineering method described in WO96 / 06926, and strains belonging to the genus Escherichia such as E. coli H-9068 (Japanese Unexamined Patent Publication No. 8-70879) can be mentioned.

[0388] As a coryneform bacterium having the L-leucine-producing ability, for example, Corynebacterium glutamicum (Brevibacterium lactofermentum) AJ3718 (FERM P-2516), which is tolerant to 2-thiazolalanine and β-hydroxy-leucine and requires isoleucine and methionine, can be mentioned.

[0389] <L-isoleucine-producing bacterium>

[0390] As a method for conferring or enhancing the L-isoleucine-producing ability, for example, a method of modifying a bacterium in such a way that the activity of one or more enzymes selected from L-isoleucine biosynthetic enzymes is increased can be mentioned. Such enzymes are not particularly limited, and examples include threonine deaminase and acetohydroxy acid synthase (Japanese Unexamined Patent Publication No. 2-458, EP0356739A, U.S. Patent No. 5,998,178).

[0391] As an L-isoleucine-producing bacterium or a parental strain used for inducing it, specifically, for example, the following can be cited: a mutant strain resistant to 6-dimethylaminopurine (Japanese Patent Laid-Open No. 5-304969), a mutant strain resistant to isoleucine analogs such as thioisoleucine and isoleucine hydroxamate, a mutant strain resistant to DL-ethionine and / or arginine hydroxamate in addition to isoleucine analogs (Japanese Patent Laid-Open No. 5-130882), etc., which are Escherichia bacteria.

[0392] As coryneform bacteria having the ability to produce L-isoleucine, for example, the following can be cited: coryneform bacteria obtained by amplifying the brnE gene encoding a branched-chain amino acid excretion protein (Japanese Patent Laid-Open No. 2001-169788), coryneform bacteria having the ability to produce L-isoleucine conferred by protoplast fusion with an L-lysine-producing bacterium (Japanese Patent Laid-Open No. 62-74293), coryneform bacteria obtained by enhancing homoserine dehydrogenase (Japanese Patent Laid-Open No. 62-91193), a threonine hydroxamate-resistant strain (Japanese Patent Laid-Open No. 62-195293), an α-ketomalonic acid-resistant strain (Japanese Patent Laid-Open No. 61-15695), a methyllysine-resistant strain (Japanese Patent Laid-Open No. 61-15696), Corynebacterium glutamicum (Brevi bacterium flavum) AJ12149 (FERM BP-759; U.S. Patent No. 4,656,135).

[0393] <L-valine-producing bacterium>

[0394] As a method for imparting or enhancing the ability to produce L-valine, for example, a method of modifying bacteria in a manner that the activity of one or more enzymes selected from the L-valine biosynthetic enzymes is increased. Such enzymes are not particularly limited, and enzymes encoded by genes of the ilvGMEDA operon and the ilvBNC operon can be cited. ilvBN encodes acetohydroxyacid synthase, and ilvC encodes reductoisomerase (isomeror eductase) (WO00 / 50624). It should be noted that the ilvGMEDA operon and the ilvBNC operon are inhibited (attenuated) by the expression of L-valine, L-isoleucine and / or L-leucine. Therefore, in order to enhance the enzyme activity, it is preferred to remove or modify the region required for attenuation to release the expression inhibition of the generated L-valine. In addition, the threonine deaminase encoded by the ilvA gene is an enzyme that catalyzes the rate-limiting stage of the L-isoleucine biosynthesis system, i.e., the deamination reaction from L-threonine to 2-ketobutyrate. Therefore, in order to produce L-valine, it is preferred that the ilvA gene is disrupted to reduce the threonine deaminase activity.

[0395] In addition, as a method for imparting or enhancing the production capacity of L-valine, for example, the following method can also be enumerated: modifying bacteria so that the activity of one or more enzymes selected from the enzymes of the reaction of generating compounds other than L-valine by branching the biosynthetic pathway of L-valine is reduced. As such an enzyme, there is no particular restriction, and the threonine dehydratase participating in the synthesis of L-leucine and the enzyme participating in the synthesis of D-pantothenic acid (WO00 / 50624) can be enumerated.

[0396] Specific examples of L-valine-producing bacteria or parent strains for inducing L-valine-producing bacteria include E. coli strains modified to overexpress the ilvGMEDA operon (U.S. Patent No. 5,998,178).

[0397] In addition, as L-valine producing bacteria or parent strains for inducing L-valine producing bacteria, strains with mutations in aminoacyl t-RNA synthetase (U.S. Patent No. 5,658,766) can also be cited. As such a strain, for example, E. coli VL1970 having a mutation in the ileS gene encoding isoleucine tRNA synthetase can be cited. E. coli VL1970 was deposited in the Russian National Collection of Industrial Microorganisms (VKPM) (FGUP GosNII Geneti ka, 1Dorozhny proezd., 1Moscow 117545, Russia) on June 24, 1988 with the deposit number VKPM B-4411. In addition, as L-valine producing bacteria or parent strains for inducing thereof, strains requiring lipoic acid and / or lacking H for growth can also be cited. +A mutant strain of -ATPase (WO96 / 06926).

[0398] In addition, as an L-valine-producing bacterium or a parent strain for inducing the same, strains resistant to amino acid analogs and the like can also be cited. As such strains, for example, Corynebacterium-type bacterial strains (FERM P-1841, FERM P-29) (Japanese Patent Publication No. 53-025034) that require L-isoleucine and L-methionine, are resistant to D-ribose, purine ribonucleoside or pyrimidine ribonucleoside, and have the ability to produce L-valine; Corynebacterium-type bacterial strains (FERM P-1763, FERM P-1764) (Japanese Patent Publication No. 06-065314) that are resistant to polyketides; Corynebacterium-type bacterial strains (FERM BP-3006, FERM BP-3007) (Japanese Patent No. 3006929) that show L-valine resistance in a medium with acetic acid as the sole carbon source and are sensitive to pyruvic acid analogs (such as fluoropyruvic acid) in a medium with glucose as the sole carbon source.

[0399] <L-tryptophan-producing bacterium>

[0400] As a method for imparting or enhancing the L-tryptophan-producing ability, for example, a method of modifying a bacterium in such a way that the activity of one or more enzymes selected from L-tryptophan biosynthetic enzymes is increased can be cited.

[0401] There is no particular limitation on the L-tryptophan biosynthetic enzymes, and examples include 3-deoxy-D-arabino-heptulosonate-7-phosphate (aroG) synthase, 3-dehydroquinic acid synthase (aroB), shikimate dehydrogenase (aroE), shikimate kinase (aroL), 5-enolpyruvylshikimate-3-phosphate synthase (aroA), and chorismate synthase (aroC), which are common biosynthetic enzymes in aromatic amino acids (EP763127B). The expression of the genes encoding these enzymes is controlled by the tyrosine repressor (tyrR), and the activity of these enzymes can be enhanced by deleting the tyrR gene (EP763127B).

[0402] Examples of L-tryptophan biosynthetic enzymes include, but are not limited to, anthranilate synthase (trpE), tryptophan synthase (trpAB) and phosphoglycerate dehydrogenase (serA). For example, by introducing DNA comprising a tryptophan operon, L-tryptophan production capacity can be conferred or enhanced. Tryptophan synthase is composed of α and β subunits encoded by trpA and trpB genes, respectively. Since anthranilate synthase is subject to feedback inhibition by L-tryptophan, in order to enhance the activity of the enzyme, a gene encoding the enzyme into which a mutation that releases feedback inhibition can be introduced can also be used. Phosphoglycerate dehydrogenase is subject to feedback inhibition by L-serine, so in order to enhance the activity of the enzyme, a gene encoding the enzyme into which a mutation that releases feedback inhibition can be introduced can be used. Furthermore, L-tryptophan-producing ability can also be imparted or enhanced by increasing the expression of an operon (ace operon) comprising malate synthase (aceB), isocitrate lyase (aceA), and isocitrate dehydrogenase kinase / phosphatase (aceK) (WO2005 / 103275).

[0403] L-tryptophan producing bacteria can also be modified in a manner that the biosynthesis of aromatic amino acids other than L-tryptophan is reduced. In addition, L-tryptophan producing bacteria can also be modified in a manner that enhances the uptake system of byproducts. As byproducts, aromatic amino acids other than L-tryptophan can be mentioned. As genes encoding the uptake system of byproducts, for example, pheP, which is a gene encoding the uptake system of L-phenylalanine, and tyrP, which is a gene encoding the uptake system of L-tyrosine (EP1484410), can be mentioned.

[0404] Specific examples of L-tryptophan-producing bacteria or parent strains for inducing L-tryptophan-producing bacteria include: E. coli JP4735 / pMU3028 (DSM10122) and JP6015 / pMU91 (DSM10123) (U.S. Patent No. 5,756,345) that retain a mutant trpS gene encoding a partially inactivated tryptophanyl-tRNA synthetase; E. coli SV164 having a trpE allele encoding an anthranilate synthase that is not subject to feedback inhibition by tryptophan; and E. coli having a serA allele encoding a phosphoglycerate dehydrogenase that is not subject to feedback inhibition by serine and a trpE allele encoding an anthranilate synthase that is not subject to feedback inhibition by tryptophan. SV164 (pGH5) (U.S. Patent No. 6,180,373), a strain introduced with a tryptophan operon containing a trpE allele encoding an anthranilate synthase that is not feedback inhibited by tryptophan (Japanese Patent Application Laid-Open No. 57-71397, Japanese Patent Application Laid-Open No. 62-244382, U.S. Patent No. 4,371,614), tryptophanase-deficient E. coli AGX17 (pGX44) (NRRL B-12263) and AGX6 (pGX50) aroP (NRRL B-12264) (U.S. Patent No. 4,371,614), E. coli AGX17 / pGX50, pACKG4-pps with enhanced phosphoenolpyruvate production capacity (WO9708333, U.S. Patent No. 6,319,696), ye A strain belonging to the genus Escherichia in which the activity of the protein encoded by the dA gene or the yddG gene is increased (US2003-0148473A1 and US2003-0157667A1).

[0405] Examples of Corynebacterium-type bacteria capable of producing L-tryptophan include Corynebacterium glutamicum AJ12118 (FERM BP-478) resistant to sulfaguanidine (Japanese Patent No. 1681002), strains into which a tryptophan operon has been introduced (Japanese Patent Application Laid-Open No. 63-240794), and strains into which a gene encoding shikimate kinase from Corynebacterium-type bacteria has been introduced (Japanese Patent No. 1994749).

[0406] Regarding the culture conditions of the microorganism with amino acid production ability, as long as the microorganism with amino acid production ability can proliferate and produce the target amino acid, there is no particular restriction. Cultivation can be carried out under the usual conditions for the cultivation of microorganisms such as bacteria, for example. The culture conditions can be appropriately set according to various conditions such as the type of the microorganism used.

[0407] The culture medium used in the cultivation of a microorganism with amino acid production ability is not particularly limited as long as it can proliferate the microorganism with amino acid production ability and produce the target amino acid. As a culture medium, for example, a common culture medium used in the cultivation of microorganisms such as bacteria can be used. As a culture medium, for example, a culture medium containing a component selected from a carbon source, a nitrogen source, a phosphate source, a sulfur source, other various organic components, and an inorganic component as required can be used. The type and concentration of the culture medium components can be appropriately set according to various conditions such as the type of the microorganism used.

[0408] As the carbon source, specifically, sugars such as glucose, fructose, galactose, xylose, arabinose, sucrose, lactose, cellobiose, molasses, starch hydrolysate, biomass hydrolysate, organic acids such as acetic acid, fumaric acid, citric acid, succinic acid, alcohols such as glycerol, crude glycerol, ethanol, and fatty acids can be mentioned. As the carbon source, one carbon source can be used, or two or more carbon sources can be used in combination.

[0409] Specific examples of nitrogen sources include ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate, organic nitrogen sources such as peptone, casamino acid, yeast extract, malt extract, meat extract, corn steep liquor, and soybean protein decomposition products, ammonia, and urea. As the nitrogen source, one nitrogen source may be used, or two or more nitrogen sources may be used in combination.

[0410] Specific examples of the phosphoric acid source include phosphates such as potassium dihydrogen phosphate and dipotassium hydrogen phosphate, and phosphoric acid polymers such as pyrophosphoric acid. As the phosphoric acid source, one phosphoric acid source may be used alone, or two or more phosphoric acid sources may be used in combination.

[0411] Specific examples of the sulfur source include inorganic sulfur compounds such as sulfates, thiosulfates, and sulfites, and sulfur-containing amino acids such as cysteine, cystine, and glutathione. As the sulfur source, one sulfur source may be used alone, or two or more sulfur sources may be used in combination.

[0412] As other various organic components and inorganic components, specifically, for example, inorganic salts such as sodium chloride and potassium chloride; trace metals such as iron, manganese, magnesium, and calcium; vitamins such as vitamin B1, vitamin B2, vitamin B6, niacin, niacinamide, and vitamin B12; amino acids; nucleic acids; organic components such as peptone, casamino acid, yeast extract, malt extract, meat extract, corn steep liquor, and soy protein decomposition products containing them. As other various organic components and inorganic components, one component may be used, or two or more components may be used in combination.

[0413] Cultivation can be carried out by liquid culture (i.e., liquid culture medium). Cultivation can be carried out, for example, under aerobic conditions. "Aerobic conditions" means that in the case of liquid culture, the dissolved oxygen concentration in the liquid culture medium is above the detection limit of the oxygen membrane electrode of 0.33 ppm, preferably above 1.5 ppm. The oxygen concentration can be controlled, for example, to be 5 to 50% relative to the saturated oxygen concentration, preferably about 10%. Cultivation under aerobic conditions, specifically, can be carried out, for example, by aeration culture, shaking culture, stirring culture, or a combination thereof. The pH of the culture medium can be, for example, pH 3 to 10, preferably pH 4.0 to 9.5. During the culture, the pH of the culture medium can be adjusted as needed. The pH of the culture medium can be adjusted using various alkaline or acidic substances such as ammonia gas, ammonia water, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, magnesium carbonate, sodium hydroxide, calcium hydroxide, magnesium hydroxide, etc. The culture temperature can be, for example, 20°C to 40°C, preferably 25°C to 37°C. The culture period can be, for example, 10 hours to 120 hours. Cultivation can be carried out, for example, by batch culture, fed-batch culture, continuous culture, or a combination thereof. In addition, cultivation can also be carried out by pre-culture and main culture. For example, pre-culture can be carried out on a solid culture medium such as an agar medium, and main culture can be carried out in a liquid culture medium. Cultivation can be continued, for example, until the carbon source in the culture medium is consumed, or until the activity of the microorganism having the ability to produce amino acids disappears.

[0414] By culturing the microorganisms having the ability to produce amino acids in this manner, the amino acids are accumulated in the culture medium, thereby obtaining an amino acid fermentation liquid.

[0415] Amino acids can be separated from amino acid fermentation broth by known methods used in the separation and purification of compounds, for example. As such methods, ion exchange resin method (Nagai, H. et al., Sep aration Science and Technology, 39 (16), 3691-3710), precipitation method, membrane separation method (Japanese Patent Laid-Open No. 9-164323, Japanese Patent Laid-Open No. 9-173792), crystallization method (WO2008 / 078448, WO2008 / 078646) can be cited. These methods can be used alone or in appropriate combination. In addition, in the case where amino acids are precipitated in the culture medium, amino acids can be separated from amino acid fermentation broth by solid-liquid separation means such as centrifugation and filtration.

[0416] By separating the amino acids from the amino acid fermentation liquid in this manner, an amino acid fermentation by-product liquid is obtained as a by-product.

[0417] The concentration or fractionation of the amino acid fermentation byproduct liquid can be carried out, for example, by conventional methods. As the means of concentrating the amino acid fermentation byproduct liquid, reduced pressure concentration, freeze drying, and spray drying can be cited. As the means of fractionating the amino acid fermentation byproduct liquid, the method used in the separation and purification of the compound as exemplified above can be cited.

[0418] The active ingredient may have the same function as strigolactone. Therefore, by utilizing the active ingredient, for example, an effect based on the same function as strigolactone can be obtained. In other words, by utilizing the active ingredient, for example, the same effect as when strigolactone is utilized can be obtained.

[0419] As the same function as strigolactone, the function of inducing parasitic plant germination, the function of inhibiting plant branching, and the function of inducing mycelial branching of mycorrhizal fungi can be cited. The active ingredient can, for example, have one or more (for example, all) functions selected from the same functions as the strigolactone exemplified. The active ingredient can, for example, have at least the function of inducing parasitic plant germination. "Parasitic plant germination" and "parasitic plant seed germination" can be used alternatively. For example, the compounds represented by the formulas (Compound 1) to (Compound 3), (Compound 5) to (Compound 14), (Compound 16) to (Compound 20), (Compound 23), (Compound 26) to (Compound 35), (Compound 37), (Compound 38), (Compound 40), (Compound 53), (Compound 60), (Compound 72), (Compound 83), (Compound 88) and (Compound 89) described later can have the function of inducing parasitic plant germination. In addition, compounds represented by the formulas (Compound 1) to (Compound 3), (Compound 5) to (Compound 8), (Compound 27) to (Compound 30), (Compound 38), (Compound 40), (Compound 53) and (Compound 72) described later may have the function of inducing germination of parasitic plants.

[0420] In addition, the active ingredient is different from strigolactone, and for example, it can have the function of inhibiting the germination of parasitic plants. For example, the compounds represented by the formula (compound 4), (compound 15), (compound 36), (compound 39), (compound 42) to (compound 49), (compound 51), (compound 56), (compound 57), (compound 59), (compound 61), (compound 63), (compound 66) to (compound 71), (compound 73) to (compound 76), (compound 78) to (compound 80) and (compound 84) described later can have the function of inhibiting the germination of parasitic plants. In addition, for example, the compounds represented by the formula (compound 4), (compound 39), (compound 42) to (compound 49), (compound 51), (compound 56), (compound 66) to (compound 71), and (compound 73) to (compound 76) described later can have the function of inhibiting the germination of parasitic plants.

[0421] In one embodiment, by utilizing an active ingredient, specifically by applying the active ingredient to the seeds of a parasitic plant, the germination of the parasitic plant can be induced or inhibited, that is, the effect of inducing or inhibiting the germination of the parasitic plant can be obtained. The effect of inducing the germination of a parasitic plant is also referred to as a "germination induction effect." The effect of inhibiting the germination of a parasitic plant is also referred to as a "germination inhibition effect." As the germination of the induced parasitic plant, the suicide germination of the parasitic plant can be cited. "Suicide germination of a parasitic plant" can refer to the germination of a parasitic plant in an environment where there is no plant that is the parasitic object of the parasitic plant. The plant that is the parasitic object of the parasitic plant is also referred to as a "parasitic object plant." The parasitic plant after suicide germination cannot parasitize the parasitic object plant, so it can be exterminated. In addition, by inhibiting the germination of the parasitic plant, the growth of the parasitic plant and the parasitism of the parasitic object plant can be prevented. Therefore, by inducing the suicide germination of the parasitic plant or by inhibiting the germination of the parasitic plant, for example, the parasitic plant can be controlled, that is, the effect of controlling the parasitic plant can be obtained. The effect of controlling parasitic plants is also referred to as "parasitic plant control effect." The parasitic plant control effect may be an example of a germination induction effect or a germination inhibition effect. By inducing suicide germination of parasitic plants, inhibiting germination of parasitic plants, or controlling parasitic plants, for example, the cultivation performance of parasitic target plants can be improved, that is, the effect of improving the cultivation performance of parasitic target plants can be obtained. The effect of improving the cultivation performance of parasitic target plants is also referred to as "the effect of improving the cultivation performance of parasitic target plants." The effect of improving the cultivation performance of parasitic target plants may be an example of a germination induction effect, a germination inhibition effect, or a parasitic plant control effect. As an example of improving the cultivation performance of parasitic target plants, an increase in the yield of parasitic target plants, an increase in the growth of parasitic target plants, and an increase in the survival of parasitic target plants can be cited. As an example of improving the cultivation performance of parasitic target plants, an increase in the yield of parasitic target plants can be cited. As an example of improving the yield of plants, an increase in the yield of the entire plant body, an increase in the yield of a part of the plant body such as leaves, roots, fruits, and seeds can be cited.

[0422] As parasitic plants, root parasitic plants can be mentioned. In addition, as parasitic plants, plants induced to germinate by strigolactone can be mentioned. As parasitic plants, specifically, plants of the Orobanchaceae family, Scrophulariaceae family, and Convolvulaceae family can be mentioned. As Orobanchaceae plants, plants of the genus Striga, plants of the genus Orobanche, and plants of the genus Phelipanche can be mentioned. As Orobanchaceae plants, in particular, plants of the genus Striga and plants of the genus Orobanche can be mentioned. Examples of striga plants include: Striga asiatica, Striga gesnerioides, Striga hermonthica, Striga aspera, Striga asiatica, Striga curviflora, Striga parviflora, Striga angustifolia, Striga latericea, Striga aequinoctialis, Striga angolensis, Striga bilabiate, Striga bra chycalyx, Striga chrsantha, Striga dalzielii, Strigaelegans, Striga forbesii, S triga gastonii, Striga gracillima, Striga hallaei, Striga hirsuta, Striga junodii, Striga klingii, Striga lepidagathidis, Strigalutea, Striga macrantha, Striga p assargei, Striga pinnatifida, Strigaprimuloides, Striga Yemenica, Striga pubi flora. Examples of the Orobanche plant include Orobanche amosa, Orobanche minor, Orobanche crenata, Orobanche cumana, Orobanche foetida, Orobanche aegyptiaca, and Orobanche cernua. Examples of the Orobanche plant include Phelipancheramosa and Phelipanche aegyptiaca.Examples of the Scrophulariaceae include plants of the genus Alectra. Examples of the genus Alectra include Alectra vogelii, Alectra picta, Alectra sessiliflora, Alectraorobanchoides, and Alectra fluminensis. Examples of the Convolvulaceae include plants of the genus Cuscuta. Examples of the genus Cuscuta include plants of the genus Cuscuta. Examples of the genus Cuscuta include plants of the genus Cuscuta. It should be noted that, in the case where the classification of a parasitic plant is changed, the parasitic plant can be treated as a plant equivalent to one or both of the classifications before and after the change. However, in the case where the classification of a parasitic plant is changed, unless otherwise specified, the parasitic plant is deemed to conform to both of the classifications before and after the change. For example, Orobanche ramosa L. is now classified as Phelipanche ramosa (L.) Pomel, but unless otherwise specified, Orobanche ramosa L. is treated as equivalent to both Orobanche ramosa and Orobanche ramosa, and further, is treated as equivalent to both Orobanche ramosa and Phelipanc he ramosa. As a parasitic plant, one plant may be the object, or two or more plants may be the object.

[0423] The type of the parasitic plant is not particularly limited as long as it can be the parasite of the parasitic plant. The parasitic plant can be, for example, a woody plant or an herbaceous plant. Examples of the parasitic plant include Gramineae (rice, barley, wheat, corn, sorghum, millet, sugarcane, oats, Zoysia, pearl millet, finger millet, fonio millet, etc.), Solanaceae (tomato, bell pepper, eggplant, potato, tobacco, etc.), Cucurbitaceae (cucumber, melon, pumpkin, etc.), Leguminosae (peas, soybeans, beans, alfalfa, peanuts, broad beans, cowpeas, lentils, chickpeas, clover, peanuts, Bambara peanuts, etc.), Cruciferae (radish, cabbage, cabbage, komatsuna, cauliflower, green cabbage, Arabidopsis, etc.), Rosaceae (strawberry, apple, pear, peach, etc.), mulberry, etc. Plants of the family Apiaceae (mulberry, etc.), Malvaceae (cotton, etc.), Apiaceae (carrot, parsley, celery, etc.), Liliaceae (scallion, onion, asparagus, etc.), Asteraceae (burdock, sunflower, chrysanthemum, chamomile, safflower, lettuce, etc.), Amaranthaceae (beet, etc.), Ericaceae (blueberry, cranberry, etc.), Vitaceae (grape, etc.), Rutaceae (satsuma, lemon, grapefruit, etc.), Rubiaceae (coffee, etc.), Oleaceae (olive, etc.), Lauraceae (avocado, etc.), Anacardiaceae (mango, cashew, etc.), Sapindaceae (lychee, etc.), Lamiaceae (fire nettle, etc.). The parasitic plant may be one plant or two or more plants.

[0424] The germination inducing effect or the germination inhibiting effect can be confirmed, for example, by using the germination of the parasitic plant as an index. That is, when the germination of the parasitic plant is promoted when the active ingredient is used, compared with when the active ingredient is not used, it can be determined that the germination of the parasitic plant is induced by the active ingredient. The promotion of the germination of the parasitic plant can be measured, for example, as an increase in the germination rate of the parasitic plant or an increase in the germination speed of the parasitic plant. The germination rate of the parasitic plant can be measured, for example, by the steps described in the embodiments. In addition, when the germination of the parasitic plant is inhibited when the active ingredient is used, compared with when the active ingredient is not used, it can be determined that the germination of the parasitic plant is inhibited by the active ingredient. The inhibition of the germination of the parasitic plant can be measured, for example, as a decrease in the germination rate of the parasitic plant or a decrease in the germination speed of the parasitic plant. In addition, the inhibition of germination also includes the situation where germination is not seen at all.

[0425] In addition, the germination induction effect or the germination inhibition effect can also be confirmed by confirming the parasitic plant control effect, for example. The parasitic plant control effect can be confirmed by, for example, the growth, viability or parasitism of the parasitic plant as an index. That is, when the growth, viability or parasitism of the parasitic plant is reduced when the active ingredient is used compared to when the active ingredient is not used, it can be judged that the parasitic plant is controlled by the active ingredient.

[0426] In addition, the germination induction effect or the germination inhibition effect can also be confirmed by, for example, confirming the effect of improving the cultivation performance of the parasitic target plant. The effect of improving the cultivation performance of the parasitic target plant can be confirmed, for example, using the cultivation performance of the parasitic target plant as an indicator. That is, when the cultivation performance (e.g., yield, growth, or survival) of the parasitic target plant is improved when the active ingredient is used compared to when the active ingredient is not used, it can be determined that the cultivation performance of the parasitic target plant is improved due to the active ingredient.

[0427] In addition, in one embodiment, by utilizing an effective ingredient, specifically by applying the effective ingredient to a plant, the branching of the plant can be suppressed, that is, the effect of suppressing the branching of the plant can be obtained. The effect of suppressing the branching of the plant is also referred to as a "branching suppression effect." The plant whose branching is suppressed by the effective ingredient is also referred to as a "cultivated plant." Examples of the branching of the plant include the branching of the above-ground part of the plant. By suppressing the branching of the cultivated plant, for example, the cultivation performance of the cultivated plant can be improved, that is, the effect of improving the cultivation performance of the cultivated plant can be obtained. The effect of improving the cultivation performance of the cultivated plant is also referred to as a "cultivation performance improvement effect of the cultivated plant." The cultivation performance improvement effect of the cultivated plant can be an example of the branching suppression effect. Examples of the improvement of the cultivation performance of the cultivated plant include an increase in the yield of the cultivated plant, an increase in the growth of the cultivated plant, and an improvement in the viability of the cultivated plant. Examples of the improvement of the cultivation performance of the cultivated plant include an increase in the yield of the cultivated plant, an increase in the growth of the cultivated plant, and an improvement in the viability of the cultivated plant. As an improvement in the cultivation performance of the cultivated plant, an increase in the yield of the cultivated plant can be particularly mentioned.

[0428] The type of the cultivated plant is not particularly limited as long as it is a plant whose branching is inhibited by the active ingredient. Regarding the cultivated plant, for example, the description about the parasitic plant described above can be applied. That is, for example, as the cultivated plant, the plants exemplified as the parasitic plant can be cited.

[0429] The branching inhibition effect can be confirmed, for example, by using the branching of the cultivated plant as an index. That is, when the branching of the cultivated plant is inhibited when the active ingredient is used compared to when the active ingredient is not used, it can be determined that the branching of the cultivated plant is inhibited by the active ingredient. The inhibition of branching of the cultivated plant can be measured, for example, as a decrease in the number of branches per individual of the cultivated plant.

[0430] In addition, the branching inhibition effect can also be confirmed by, for example, confirming the effect of improving the cultivation performance of the cultivated plant. The effect of improving the cultivation performance of the cultivated plant can be confirmed, for example, by using the cultivation performance of the cultivated plant as an indicator. That is, when the cultivation performance (e.g., yield, growth, or viability) of the cultivated plant is improved when the active ingredient is used compared to when the active ingredient is not used, it can be judged that the cultivation performance of the cultivated plant is improved by the active ingredient.

[0431] In addition, in one embodiment, by utilizing an active ingredient, specifically by applying an active ingredient to mycorrhizal fungi, it is possible to induce mycorrhizal fungi hyphae branching, that is, the effect of inducing mycorrhizal fungi hyphae branching can be obtained. The effect of inducing mycorrhizal fungi hyphae branching is also referred to as a "hyphae branching inducing effect." Plants that are to be symbiotic objects of mycorrhizal fungi are also referred to as "symbiotic object plants." By inducing mycorrhizal fungi hyphae branching, for example, the cultivation performance of symbiotic object plants can be improved, that is, the effect of improving the cultivation performance of symbiotic object plants can be obtained. The effect of improving the cultivation performance of symbiotic object plants is also referred to as a "symbiotic object plant cultivation performance improvement effect." The cultivation performance improvement effect of symbiotic object plants can be an example of the hyphae branching inducing effect. Examples of the improvement of the cultivation performance of symbiotic object plants include an increase in the yield of symbiotic object plants, an increase in the growth of symbiotic object plants, and an increase in the viability of symbiotic object plants. Examples of the improvement of the cultivation performance of symbiotic object plants include an increase in the yield of symbiotic object plants, an increase in the growth of symbiotic object plants, and an increase in the viability of symbiotic object plants. As an improvement in the cultivation performance of symbiotic object plants, an increase in the yield of symbiotic object plants can be particularly cited.

[0432] Examples of mycorrhizal fungi include arbuscular mycorrhizal fungi and examples of arbuscular mycorrhizal fungi include Glomeromycota fungi.

[0433] The type of symbiotic object plant is not particularly limited as long as it can be a symbiotic object of mycorrhizal fungi. Regarding the symbiotic object plant, for example, the description about the parasitic object plant described above can be applied. That is, for example, as the symbiotic object plant, the plants exemplified as the parasitic object plants can be cited.

[0434] The hyphae branching induction effect can be confirmed, for example, by using the hyphae branching of mycorrhizal fungi as an indicator. That is, when the hyphae branching of mycorrhizal fungi is promoted when the active ingredient is used compared to when the active ingredient is not used, it can be determined that the hyphae branching of mycorrhizal fungi is induced by the active ingredient. The promotion of hyphae branching of mycorrhizal fungi can be measured, for example, as the generation of hyphae with a morphology of fine and pointed branches observed when the mycorrhizal fungi arrive near the roots of the symbiotic object plant.

[0435] In addition, the branching inhibition effect can also be confirmed by, for example, confirming the effect of improving the cultivation performance of the cultivated plant. The effect of improving the cultivation performance of the cultivated plant can be confirmed, for example, by using the cultivation performance of the cultivated plant as an indicator. That is, when the cultivation performance (e.g., yield, growth, or viability) of the cultivated plant is improved when the active ingredient is used compared to when the active ingredient is not used, it can be judged that the cultivation performance of the cultivated plant is improved by the active ingredient.

[0436] In addition, the same function as strigolactone can be measured by using the binding activity of the active ingredient to the strigolactone receptor as an index. As the strigolactone receptor, there can be cited: the strigolactone receptor D14 (DWARF14) protein of Arabidopsis thaliana, the strigolactone receptor D14 of rice, the strigolactone receptor HTL (HYPOSENSITIVE TO LIGHT) of Strigolactone, the strigolactone receptor D14 protein of Orobanche, the D14 of other parasitic plants, HTL / KAI2 (HYPOSENSITIVE TOLIGHT / KAR RIKIN INSENSITIVE2). That is, when the binding activity of the active ingredient to the strigolactone receptor is confirmed, it can be judged that the active ingredient has the same function as strigolactone (that is, by using the active ingredient, an effect based on the same function as strigolactone can be obtained). The binding activity of the active ingredient to the strigolactone receptor can be measured, for example, by measuring the inhibition of the binding of the active ingredient to Yoshimulactone Green (YLG) as a synthetic strigolactone labeled with a fluorescent probe and D14. The inhibition of the binding of the active ingredient to Yoshimulactone Green (YLG) and D14 can be measured, for example, by the steps described in the examples.

[0437] <2> Compositions of the present invention

[0438] The composition of the present invention is a composition containing an active ingredient (ie, the ingredient (A), (B) or (C)).

[0439] The composition of the present invention can be applied to objects such as seeds of parasitic plants, cultivated plants, mycorrhizal fungi, etc. The use of the composition of the present invention is described in detail in "the method of the present invention". The composition of the present invention can be used, for example, to obtain the effects exemplified above.

[0440] In one embodiment, by utilizing the composition of the present invention, specifically by applying the composition of the present invention to the seeds of parasitic plants, the germination of parasitic plants can be induced or inhibited. That is, the composition of the present invention can be, for example, a composition for germination induction of parasitic plants or a composition for germination inhibition of parasitic plants. The composition for germination induction of parasitic plants can be, for example, a composition for suicide germination induction of parasitic plants. By inducing suicide germination of parasitic plants or inhibiting germination of parasitic plants, for example, parasitic plants can be controlled. That is, the composition of the present invention can be, for example, a composition for control of parasitic plants. The composition for control of parasitic plants can be an example of a composition for germination induction of parasitic plants or a composition for germination inhibition of parasitic plants. By inducing suicide germination of parasitic plants, inhibiting germination of parasitic plants, or controlling parasitic plants, for example, the cultivation performance of parasitic target plants can be improved. Therefore, the composition of the present invention can be used for the cultivation of parasitic target plants, for example. That is, the composition of the present invention can be, for example, a composition for cultivation of parasitic target plants such as a composition for improving the cultivation performance of parasitic target plants. The cultivation performance-enhancing composition for parasitic plants such as the composition for improving the cultivation performance of parasitic plants may be an example of a germination-inducing composition for parasitic plants, a germination-inhibiting composition for parasitic plants, or a control composition for parasitic plants. The germination-inducing composition for parasitic plants, the germination-inhibiting composition for parasitic plants, the control composition for parasitic plants, and the cultivation performance-enhancing composition for parasitic plants are also referred to as "germination inducing agents for parasitic plants", "germination inhibitors for parasitic plants", "control agents for parasitic plants", and "agents for improving the cultivation performance of parasitic plants", respectively.

[0441] Furthermore, in one embodiment, by utilizing the composition of the present invention, specifically by applying the composition of the present invention to a cultivated plant, the branching of the plant can be suppressed. That is, the composition of the present invention can be, for example, a composition for suppressing branching of a cultivated plant. By suppressing the branching of a cultivated plant, for example, the cultivation performance of the cultivated plant can be improved. Therefore, the composition of the present invention can be used for the cultivation of cultivated plants, for example. That is, the composition of the present invention can be, for example, a composition for cultivating cultivated plants such as a composition for improving the cultivation performance of cultivated plants. A composition for cultivating cultivated plants such as a composition for improving the cultivation performance of cultivated plants can be an example of a composition for suppressing branching of cultivated plants. The composition for suppressing branching of cultivated plants and the composition for improving the cultivation performance of cultivated plants are also referred to as a "branching inhibitor of cultivated plants" and a "cultivation performance improver for cultivated plants," respectively.

[0442] Furthermore, in one embodiment, by utilizing the composition of the present invention, specifically by applying the composition of the present invention to mycorrhizal fungi, hyphal branching of mycorrhizal fungi can be induced. That is, the composition of the present invention can be, for example, a composition for inducing hyphal branching of mycorrhizal fungi. By inducing hyphal branching of mycorrhizal fungi, for example, the cultivation performance of symbiotic target plants can be improved. Therefore, the composition of the present invention can be used for the cultivation of symbiotic target plants, for example. That is, the composition of the present invention can be, for example, a composition for improving the cultivation performance of symbiotic target plants, such as a composition for cultivating symbiotic target plants. Compositions for cultivating symbiotic target plants, such as a composition for improving the cultivation performance of symbiotic target plants, can be an example of a composition for inducing hyphal branching of mycorrhizal fungi. The composition for inducing hyphal branching of mycorrhizal fungi and the composition for improving the cultivation performance of symbiotic target plants are also referred to as "mycorrhizal branching inducers of mycorrhizal fungi" and "agents for improving the cultivation performance of symbiotic target plants," respectively.

[0443] The use of the composition of the present invention exemplified above can be useful, for example, in the field of agronomy and horticulture. Therefore, the composition of the present invention can be utilized, for example, in the field of agronomy and horticulture. That is, the composition of the present invention can be, for example, an agronomy and horticulture composition. Specifically, the composition of the present invention can be, for example, an agronomy and horticulture composition used in the use of the composition of the present invention exemplified above.

[0444] The composition of the present invention can be provided, for example, in the form of a pesticide. In addition, the composition of the present invention can be provided, for example, in the form of a fertilizer.

[0445] There is no particular limitation on the composition of the composition of the present invention as long as the composition of the present invention contains active ingredients and can obtain the desired effect. The types and contents of the components contained in the composition of the present invention can be appropriately selected according to various conditions such as the type of the object, the cultivation method of the object, the growth stage of the object, the purpose of the composition of the present invention, and the mode of use of the composition of the present invention.

[0446] The composition of the present invention may be composed of active ingredients, or may contain ingredients other than active ingredients. As ingredients other than active ingredients, for example, ingredients commonly used for pesticides, fertilizers, medicines, etc. may be cited. As such ingredients, specifically, for example, additives such as excipients, binders, disintegrants, lubricants, stabilizers, diluents, surfactants, spreading agents, pH adjusters, water, alcohols, vitamins, and minerals may be cited. As spreading agents, specifically, for example, APPL AUCH BI TM (Kao Co., Ltd.), MIXPOWER TM (SYNGENTA JAPAN Co., Ltd.), SQUASH (スカッシュ) TM(Maruwa Biochemical Co., Ltd.). As ingredients other than the active ingredient, one ingredient may be used, or two or more ingredients may be used. The composition of the present invention may be formulated as appropriate. The dosage form of the composition of the present invention is not particularly limited. The dosage form of the composition of the present invention may be appropriately selected based on various conditions such as the method of use of the composition of the present invention. Examples of the dosage form include liquids, suspensions, powders, tablets, pills, capsules, and pastes.

[0447] The content of the active ingredient in the composition of the present invention is more than 0% (w / w) and is 100% (w / w) or less. The content of the active ingredient in the composition of the present invention may be, for example, 0.0005% (w / w) or more, 0.001% (w / w) or more, 0.002% (w / w) or more, 0.005% (w / w) or more, 0.01% (w / w) or more, 0.02% (w / w) or more, 0.05% (w / w) or more, 0.1% (w / w) or more, 0.2% (w / w) or more, 0.5% (w / w) or more, 1% (w / w) or more, 2% (w / w) or more, 5% (w / w) or more, or 10% (w / w) or more, and may be It may be 100% (w / w) or less, 99.9% (w / w) or less, 70% (w / w) or less, 50% (w / w) or less, 30% (w / w) or less, 20% (w / w) or less, 15% (w / w) or less, 10% (w / w) or less, 5% (w / w) or less, 2% (w / w) or less, 1% (w / w) or less, 0.5% (w / w) or less, 0.2% (w / w) or less, 0.1% (w / w) or less, 0.05% (w / w) or less, or 0.02% (w / w) or less, and may be a non-contradictory combination thereof. In addition, the content of the active ingredient in the composition of the present invention can be, for example, 10nM or more, 20nM or more, 50nM or more, 100nM or more, 200nM or more, 500nM or more, 1μM or more, 2μM or more, 5μM or more, 10μM or more, 20μM or more, 50μM or more, 100μM or more, or 200μM or more, and can be 1M or less, 500mM or less, 200mM or less, 100mM or less, 50mM or less, 20mM or less, 10mM or less, 5mM or less, 2mM or less, or 1mM or less, or a combination thereof that is not contradictory. In the case where the composition of the present invention contains two or more active ingredients, the content of these two or more active ingredients in the composition of the present invention can be set to the range of the content of the active ingredient in the composition of the present invention as exemplified, respectively, independently or in total (wherein the total content of these two or more active ingredients in the composition of the present invention is 100% (w / w) or less). It should be noted that when the composition of the present invention contains two or more active ingredients, unless otherwise specified, "the content of the active ingredients in the composition of the present invention" refers to the total content of these two or more active ingredients in the composition of the present invention.

[0448] In addition, the content of the active ingredient in the composition of the present invention can be set, for example, in such a way that the concentration of the active ingredient becomes a predetermined range when the composition of the present invention is used. The concentration of the active ingredient when the composition of the present invention is used is also referred to as "the use concentration of the active ingredient" or "the application concentration of the active ingredient." The use concentration of the active ingredient can be particularly the concentration when the composition of the present invention is used in the form of a liquid.

[0449] The concentration of the active ingredient used may be, for example, 1 nM or more, 2 nM or more, 5 nM or more, 10 nM or more, 20 nM or more, 50 nM or more, 100 nM or more, 200 nM or more, 500 nM or more, 1 μM or more, 2 μM or more, 5 μM or more, 10 μM or more, 20 μM or more, 50 μM or more, 100 μM or more, 200 μM or more, 500 μM or more, or 1 mM or more; it may be 10 mM or less, 5 mM or less, 2 mM or less, 1 mM or less, 500 μM or less, 200 μM or less, 100 μM or less, 50 μM or less, 20 μM or less, 10 μM or less, 5 μM or less, 2 μM or less, 1 μM or less, 500 nM or less, 200 nM or less, or a non-contradictory combination thereof. The concentration of the active ingredient used may specifically be, for example, 1 nM to 10 nM, 10 nM to 100 nM, 100 nM to 1 μM, 1 μM to 10 μM, 10 μM to 100 μM, 100 μM to 1 mM, or 1 mM to 10 mM. The concentration of the active ingredient used may specifically be, for example, 1 nM to 1 mM, 10 nM to 10 mM, 10 nM to 1 mM, 10 nM to 100 μM, 100 nM to 10 mM, 100 nM to 1 mM, 100 nM to 100 μM, 1 μM to 10 mM, 1 μM to 1 mM, 1 μM to 100 μM, 10 μM to 10 mM, 10 μM to 1 mM, 10 μM to 100 μM, 100 μM to 10 mM, or 100 μM to 1 mM. When two or more active ingredients are used, the concentrations of these two or more active ingredients can be set to the range of the concentrations of the active ingredients exemplified above, either independently or in total. It should be noted that when two or more active ingredients are used, "the concentration of the active ingredient" refers to the total concentration of these two or more active ingredients unless otherwise specified.

[0450] It should be noted that the amount of the active ingredient (e.g., content (concentration), usage amount) is calculated based on the amount of the active ingredient itself in the raw material when a raw material containing the active ingredient is used. In addition, when the active ingredient forms a salt or a hydrate, the amount of the active ingredient (e.g., content (concentration), usage amount) is calculated based on the value obtained by converting the mass of the salt or hydrate into the mass of an equimolar free body. In addition, when the active ingredient is component (C), the amount of the active ingredient (e.g., content (concentration), usage amount) is calculated based on the dry weight of component (C).

[0451] The active ingredient and other ingredients may be contained in the composition of the present invention as a mixture, or may be contained in the composition of the present invention separately, or may be contained in the composition of the present invention in any combination.

[0452] <3> Method of the present invention

[0453] The method of the present invention is a method comprising applying an active ingredient (i.e., the ingredient (A), (B) or (C)) to a target object such as seeds of a parasitic plant, a plant to be cultivated, or a mycorrhizal fungus. The method of the present invention can be carried out, for example, to obtain the effects exemplified above.

[0454] In one embodiment, by implementing the method of the present invention, specifically, by applying the active ingredient to the seeds of the parasitic plant, the germination of the parasitic plant can be induced or inhibited. That is, the method of the present invention can be, for example, a method for inducing or inhibiting the germination of the parasitic plant. The method for inducing the germination of the parasitic plant can be, for example, a method for inducing suicide germination of the parasitic plant. By inducing or inhibiting the suicide germination of the parasitic plant, for example, the parasitic plant can be controlled. That is, the method of the present invention can be, for example, a method for controlling parasitic plants. The method for controlling parasitic plants can be an example of a method for inducing or inhibiting the germination of parasitic plants. By inducing suicide germination of parasitic plants, inhibiting the germination of parasitic plants, or controlling parasitic plants, for example, the cultivation results of the parasitic target plant can be improved. Therefore, the method of the present invention can be used for the cultivation of parasitic target plants, for example. That is, the method of the present invention can be, for example, a method for cultivating parasitic target plants, such as a method for improving the cultivation results of parasitic target plants. The method of cultivating a parasitic plant, such as the method of improving the cultivation results of a parasitic plant, may be an example of a method of inducing germination of a parasitic plant, a method of inhibiting germination of a parasitic plant, or a method of controlling a parasitic plant.

[0455] In addition, in one embodiment, by implementing the method of the present invention, specifically by applying an active ingredient to the plant to be cultivated, the branching of the plant to be cultivated can be suppressed. That is, the method of the present invention can be, for example, a method for suppressing the branching of the plant to be cultivated. By suppressing the branching of the plant to be cultivated, for example, the cultivation results of the plant to be cultivated can be improved. Therefore, the method of the present invention can be used for the cultivation of the plant to be cultivated, for example. That is, the method of the present invention can be, for example, a method for cultivating the plant to be cultivated, such as a method for improving the cultivation results of the plant to be cultivated. The method for cultivating the plant to be cultivated, such as a method for improving the cultivation results of the plant to be cultivated, can be an example of a method for suppressing the branching of the plant to be cultivated.

[0456] In addition, in one embodiment, by implementing the method of the present invention, specifically by applying an active ingredient to mycorrhizal fungi, hyphal branching of mycorrhizal fungi can be induced. That is, the method of the present invention can be, for example, a method for inducing hyphal branching of mycorrhizal fungi. By inducing hyphal branching of mycorrhizal fungi, for example, the symbiotic object plant can be improved. Therefore, the method of the present invention can be used, for example, for the cultivation of symbiotic object plants. That is, the method of the present invention can be, for example, a method for cultivating symbiotic object plants, such as a method for improving the cultivation results of symbiotic object plants. A method for cultivating symbiotic object plants, such as a method for improving the cultivation results of symbiotic object plants, can be an example of a method for inducing hyphal branching of mycorrhizal fungi.

[0457] The active ingredient can be applied to plants, for example, using the composition of the present invention (i.e., by applying the composition of the present invention). That is, one embodiment of the method of the present invention may be, for example, a method comprising applying the composition of the present invention to plants. "Applying the active ingredient to plants" also includes applying the composition of the present invention to plants. The composition of the present invention can be applied directly to plants, for example, or appropriately diluted, dispersed or dissolved with liquids such as water, saline, buffer, alcohol, DMSO, and applied to plants. That is, the composition of the present invention can, for example, be appropriately adjusted in concentration to obtain the use concentration of the active ingredient as exemplified above, and applied to plants. The composition of the present invention can particularly be applied to plants in the form of a liquid. The composition of the present invention can be used alone or in combination with other ingredients. With regard to other ingredients, the description of ingredients other than the active ingredient in the description of the composition of the present invention can be applied. That is, the composition of the present invention can, for example, be used in combination with additives such as a spreading agent.

[0458] The application method of the composition of the present invention is not particularly limited as long as the desired effect can be obtained. The application method of the composition of the present invention can be appropriately selected according to various conditions such as the type of object, the growth method of the object, the growth stage of the object, and the purpose of the use of the composition of the present invention. The composition of the present invention can be applied to the object by applying pesticides or fertilizers to the seeds of plants, plants or mycorrhizal fungi in the usual way. The composition of the present invention can be applied to the object itself, such as seeds of parasitic plants, cultivated object plants, mycorrhizal fungi, etc., or it can be applied to the medium for implementing the growth of the object, and it can also be applied to their combination. The medium for implementing the growth of the object is also referred to as "growth medium" or "growth system." The growth medium can be appropriately selected according to various conditions such as the type of object and the growth method of the object. As the growth of the object, the germination of parasitic plants, the cultivation of cultivated object plants, and the growth of mycorrhizal fungi can be cited. The growth method of the object is not particularly limited. In addition to applying the composition of the present invention, the growth of the object can be implemented by the same method as the usual method for growing the object. As the cultivation method of plants such as the cultivated object plants, soil cultivation, nutrient solution cultivation, and nutrient solution soil cultivation can be cited. As nutrient solution cultivation, hydroponic cultivation and solid culture medium cultivation can be cited. As hydroponic cultivation, thin film hydroponics (Nutrient Film Technique; NFT) and deep flow hydroponics (Deep Flow Technique; DFT) can be cited. That is, as the growth medium for implementing the cultivation of plants such as the cultivated object plants, soil, hydroponic culture solution, and solid culture medium can be cited. It should be noted that the growth of other objects such as the germination of parasitic plants and the growth of mycorrhizal fungi can also be implemented by, for example, implementing the medium for the cultivation of plants such as the cultivated object plants. Therefore, regarding the medium for implementing the growth of other objects such as the germination of parasitic plants and the growth of mycorrhizal fungi, the record of the medium for implementing the cultivation of plants such as the cultivated object plants can be applied. That is, as a medium for implementing the germination of parasitic plants and the growth of other objects such as mycorrhizal fungi, the medium exemplified as the medium for implementing the cultivation of plants can be cited. It should be noted that the medium for implementing the germination of parasitic plants can also be a medium for implementing the cultivation of parasitic object plants. In addition, the medium for implementing the growth of mycorrhizal fungi can also be a medium for implementing the cultivation of symbiotic object plants. As the application to the object itself, the scattering or coating of the object and the immersion of the object can be cited. The composition of the present invention can be applied to the whole of the object or to a part of the object. For example, when the object is a plant, the composition of the present invention can be applied to the whole of the plant body or to a part of the plant body. The composition of the present invention can be applied to the aboveground part of the plant body as a whole. As a part of the plant body, leaves, stems, trunks, roots, and fruits can be cited.When the composition of the present invention is applied to leaves, the composition of the present invention may be applied only to one of the surface and the back of the leaves, or may be applied to both. As the application to the plant body, specifically, for example, leaf surface spreading and root immersion can be mentioned. As the application to the growth medium, spreading, pouring, and mixing of the growth medium can be mentioned. Specifically, for example, the composition of the present invention can be applied (for example, spread) to the growth medium through an irrigation pipe. The application to the growth medium can be implemented in a manner that the active ingredient reaches a position where it can act on the object. For example, the application to the medium for implementing plant cultivation can be implemented in a manner that the active ingredient reaches the rhizosphere of the plant.

[0459] The application period of the composition of the present invention is not particularly limited as long as the desired effect can be obtained. The application period of the composition of the present invention can be appropriately selected according to various conditions such as the type of object, the growth method of the object, the growth stage of the object and the purpose of use of the composition of the present invention. In the case of applying the composition of the present invention to the growth medium, the object may already exist in the growth medium, or the object may not exist. By applying the composition of the present invention to the object itself, or by applying the composition of the present invention to the growth medium where the object already exists, the desired effect can be obtained in the object. In addition, by applying the composition of the present invention to the growth medium where the object does not exist, the desired effect can be obtained in the object that may exist in the growth medium in the future. As the object that may exist in the growth medium in the future, the object that will be transferred to the growth medium from the outside in the future and the object that will be generated in the growth medium in the future can be cited. The composition of the present invention can be applied only once, or it can be applied twice or more than twice. The composition of the present invention can be applied intermittently or continuously.

[0460] For example, when the composition of the present invention is used to induce or inhibit the germination of parasitic plants, the composition of the present invention can be applied before the parasitic plants germinate.

[0461] Specifically, for example, when the composition of the present invention is used to induce suicide germination of parasitic plants (for example, parasitic plants are controlled by inducing suicide germination), the composition of the present invention can be applied before the germination of the parasitic plants so as to induce the germination of the parasitic plants during the period when the parasitic target plants are not present in the growth medium. That is, for example, when the composition of the present invention is used to induce suicide germination of parasitic plants (for example, parasitic plants are controlled by inducing suicide germination), the composition of the present invention can be applied before the germination of the parasitic plants and at a time point when the parasitic target plants are not present in the growth medium. As the period or time point when the parasitic target plants are not present in the growth medium, the period or time point before the seeds or seedlings of the parasitic target plants are planted in the growth medium can be cited. In the case of implementing the cultivation of the parasitic target plants after the induction of suicide germination of the parasitic plants or after the control of the parasitic plants, for example, the planting of seeds or seedlings of the parasitic target plants, the germination of the parasitic target plants and / or the growth of the parasitic target plants can be implemented after the induction of suicide germination of the parasitic plants or after the control of the parasitic plants.

[0462] In addition, specifically, for example, when the composition of the present invention is used to induce the germination of a parasitic plant (for example, to control a parasitic plant by inducing germination), the composition of the present invention can be applied before the germination of the parasitic plant to induce the germination of the parasitic plant during a period when the productivity of the parasitic plant is not affected by the parasitism of the parasitic plant. By inducing the germination of the parasitic plant during a period when the productivity of the parasitic plant is not affected by the parasitism of the parasitic plant, the parasitic plant can parasitize the parasitic plant during this period. As a period when the productivity of the parasitic plant is not affected by the parasitism of the parasitic plant, the late stage of the cultivation of the parasitic plant, that is, the late stage of the cultivation season of the parasitic plant can be cited. "The late stage of the growth of the parasitic plant" can refer to, for example, a period after the parasitic plant has fully grown. In addition, "the late stage of the growth of the parasitic plant" can refer to, for example, a period after more than 50%, more than 60%, more than 70%, more than 80%, more than 90% or more than 95% of the entire period of the cultivation of the parasitic plant has passed. "The entire period of cultivation of the parasitic object plant" may refer to the period from the planting of the seeds or seedlings of the parasitic object plant to the completion of the cultivation of the parasitic object plant (e.g., the harvest of the plant body). At this time, for example, the composition of the present invention can be applied (e.g., spread) to the growth medium through an irrigation pipe. After the germination and parasitism of the parasitic plant, and before the parasitic plant matures and forms seeds, the parasitic plant can be removed from the growth medium. The parasitic plant, for example, can also be recovered (e.g., harvested) from the growth medium together with the parasitic object plant.

[0463] In addition, specifically, for example, in the case where the composition of the present invention is used to inhibit the germination of parasitic plants (for example, by inhibiting germination to control parasitic plants), the composition of the present invention can be applied before the germination of parasitic plants so as to inhibit the germination of parasitic plants during the period when the parasitic target plant is present in the growth medium. That is, for example, in the case where the composition of the present invention is used to inhibit the germination of parasitic plants (for example, by inhibiting germination to control parasitic plants), the composition of the present invention can be applied before the germination of parasitic plants and at a time point when the parasitic target plant is not present in the growth medium or at a time point when it is present in the growth medium. That is, by pre-applying the composition of the present invention at a time point when the parasitic target plant is not present in the growth medium, the germination of the parasitic plant can be inhibited during the period when the parasitic target plant is present in the growth medium. In addition, by applying the composition of the present invention at a time point when the parasitic target plant is present in the growth medium, the germination of the parasitic plant can be inhibited during the period when the parasitic target plant is present in the growth medium. In the case where the composition of the present invention is used to inhibit the germination of parasitic plants (for example, by inhibiting germination to control parasitic plants), for example, the composition of the present invention can be applied at a time point when the parasitic target plant is present in the growth medium. Examples of the period or time point during which the target plant is present in the growth medium include the period or time point after germination of the target plant and the period or time point after seedlings of the target plant are planted in the growth medium.

[0464] By applying the composition of the present invention to the seeds of parasitic plants, or by applying the composition of the present invention to the growth medium where the seeds of parasitic plants already exist, it is possible to induce the germination (e.g., suicide germination) of the parasitic plants, inhibit the germination of the parasitic plants, control the parasitic plants generated from the seeds, and / or improve the cultivation performance of plants that become the parasitic objects of the parasitic plants generated from the seeds. In addition, by applying the composition of the present invention to the growth medium where the seeds of parasitic plants do not exist, it is possible to induce the germination (e.g., suicide germination) of parasitic plants that may exist in the growth medium in the future, inhibit the germination of parasitic plants that may exist in the growth medium in the future, control the parasitic plants generated from the seeds, and / or improve the cultivation performance of plants that become the parasitic objects of the parasitic plants generated from the seeds. That is, the composition of the present invention can be used, for example, for the control of parasitic plants in the growth medium that has been contaminated by the seeds of parasitic plants, and can also be used preventively for the control of parasitic plants in the growth medium that may be contaminated by the seeds of parasitic plants in the future.

[0465] For example, when the composition of the present invention is used to inhibit the branching of the cultivated plant, the composition of the present invention can be applied before the branching of the cultivated plant proceeds. Specifically, for example, when the branching of the cultivated plant is limited to a desired degree using the composition of the present invention, the composition of the present invention can be applied before the branching of the cultivated plant proceeds to the desired degree.

[0466] For example, when the composition of the present invention is used for the induction of hyphal branching of mycorrhizal fungi, the composition of the present invention can be applied before the hyphal branching of mycorrhizal fungi is completed. In addition, for example, the composition of the present invention can be applied after the hyphal branching of mycorrhizal fungi is completed to further promote the hyphal branching.

[0467] The application amount of the composition of the present invention is not particularly limited as long as the desired effect can be obtained. The application amount of the composition of the present invention can be appropriately selected according to the type of the object, the growth method of the object, the growth stage of the object, the purpose of the composition of the present invention, the application method of the composition of the present invention, the application period and other conditions.

[0468] The application rate of the composition of the present invention, for example, in terms of the application rate of the composition of the present invention in liquid form (for example, the composition of the present invention in liquid form containing the active ingredient at the above-exemplified usage concentration), can be 100 L / hectare or more, 200 L / hectare or more, 500 L / hectare or more, 1000 L / hectare or more, 1500 L / hectare or more, 2000 L / hectare or more, 3000 L / hectare or more, 4000 L / hectare or more, 5000 L / hectare or more, 7000 L / hectare or more, 10,000 L / hectare or more, 30,000 L / hectare or more, 50,000 hectare or more, 70,000 hectare or more, 100,000 L / hectare or more, 150,000 L / hectare or more, 200,000 L / hectare or more, 300,000 L / hectare or more, 500,000 L / hectare or more, The amount of alcohol in the aqueous phase may be greater than 10 L / ha or greater than 750,000 L / ha; it may be less than 1,000,000 L / ha, less than 750,000 L / ha, less than 500,000 L / ha, less than 300,000 L / ha, less than 200,000 L / ha, less than 150,000 L / ha, less than 100,000 L / ha, less than 70,000 L / ha, less than 50,000 L / ha, less than 30,000 L / ha, less than 10,000 L / ha, less than 9000 L / ha, less than 8000 L / ha, less than 7000 L / ha, less than 6000 L / ha, less than 5000 L / ha, less than 4000 L / ha, less than 3000 L / ha, less than 2000 L / ha or less than 1500 L / ha, and may be a non-contradictory combination thereof. Regarding the application rate of the composition of the present invention, specifically, for example, the application rate of the composition of the present invention in liquid form (for example, the composition of the present invention in liquid form containing the active ingredient at the usage concentration as exemplified above) can be 100 L / hectare to 1500 L / hectare, 1500 L / hectare to 5000 L / hectare, 5000 L / hectare to 10,000 L / hectare, 10,000 L / hectare to 30,000 L / hectare, 30,000 L / hectare to 50,000 L / hectare, 50,000 L / hectare to 100,000 L / hectare, 100,000 L / hectare to 150,000 L / hectare, 150,000 L / hectare to 200,000 L / hectare, 200,000 L / hectare to 500,000 L / hectare or 500,000 L / hectare to 10,000,000 L / hectare.Regarding the application amount of the composition of the present invention, specifically, for example, the application amount of the composition of the present invention in liquid form (for example, the composition of the present invention in liquid form containing the active ingredient at the exemplified use concentration) can be 100L / hectare to 1,000,000L / hectare, 200L / hectare to 1,000,000L / hectare, 500L / hectare to 1,000,000L / hectare, 1000L / hectare to 750,000L / hectare, 10,000L / hectare to 750,000L / hectare or 100,000L / hectare to 750,000L / hectare. In addition, the application amount of the composition of the present invention can be set not only in consideration of the application area (two-dimensional element), but also in consideration of the three-dimensional element. That is, the application amount of the composition of the present invention can be set, for example, according to the height of the plant to which the composition of the present invention is applied (for example, spread). Regarding the application amount of the composition of the present invention, specifically, for example, the application amount of the composition of the present invention in a liquid form (e.g., the composition of the present invention in a liquid form containing the active ingredient at the above-exemplified concentration for use) can be 1000 L / ha to 750,000 L / ha, 1000 L / ha to 30,000 L / ha, 1000 L / ha to 5000 L / ha, or 1000 L / ha to 1500 L / ha for plants from ground level to knee height. Regarding the application amount of the composition of the present invention, specifically, for example, the application amount of the composition of the present invention in a liquid form (e.g., the composition of the present invention in a liquid form containing the active ingredient at the above-exemplified concentration for use) can be 1500 L / ha to 750,000 L / ha, 1500 L / ha to 70,000 L / ha, 1500 L / ha to 10,000 L / ha, or 1500 L / ha to 3000 L / ha for plants from knee height to human height. Regarding the application amount of the composition of the present invention, specifically, for example, the application amount of the composition of the present invention in a liquid form (for example, the composition of the present invention in a liquid form containing the active ingredient at the above-exemplified usage concentration) can be 3000 L / ha to 750,000 L / ha, 3000 L / ha to 100,000 L / ha, 3000 L / ha to 30,000 L / ha, or 3000 L / ha to 5000 L / ha for plants with a height of human to 2 meters. Regarding the application amount of the composition of the present invention, specifically, for example, the application amount of the composition of the present invention in a liquid form (for example, the composition of the present invention in a liquid form containing the active ingredient at the above-exemplified usage concentration) can be 5000 L / ha to 750,000 L / ha, 5000 L / ha to 150,000 L / ha, 5000 L / ha to 30,000 L / ha, or 5000 L / ha to 7000 L / ha for plants with a height of 2 meters or more.When the composition of the present invention is applied to a growth medium (for example, by pouring it onto the ground surface), the application amount of the composition of the present invention, specifically, for example, the application amount of the composition of the present invention in liquid form (for example, the composition of the present invention in liquid form containing the active ingredient at the above-exemplified usage concentration), can be 250,000 L / hectare to 750,000 L / hectare. The composition of the present invention can be applied only once or in multiple applications. The composition of the present invention can be applied, for example, in 2 or more times, 3 or more times, 5 or more times, or 10 or more times. When the composition of the present invention is applied in multiple applications, the "application amount of the composition of the present invention" refers to the total application amount of the composition of the present invention obtained by multiple applications.

[0469] Furthermore, the dosage of the composition of the present invention can be set, for example, so that the dosage of the active ingredient falls within a predetermined range.

[0470] The amount of the active ingredient applied may be, for example, 1 μmol / hectare or more, 10 μmol / hectare or more, 20 μmol / hectare or more, 50 μmol / hectare or more, 100 μmol / hectare or more, 200 μmol / hectare or more, 500 μmol / hectare or more, 1 mmol / hectare or more, 2 mmol / hectare or more, 5 mmol / hectare or more, 10 mmol / hectare or more, 20 mmol / hectare or more, 50 mmol / hectare or more, 100 mmol / hectare or more, 200 mmol / hectare or more, 500 mmol / hectare or more, 1 mol / hectare or more, 2 mol / hectare or more, 5 mol / hectare or more, 10 mol / hectare or more, 20 mol / hectare or more, 50 mol / hectare or more, 100 mol / hectare or more, 100 mol / hectare or more, The amount of iodine per hectare may be more than 300 mol / hectare, more than 500 mol / hectare, more than 1000 mol / hectare or more than 1500 mol / hectare, less than 2500 mol / hectare, less than 1500 mol / hectare, less than 1000 mol / hectare, less than 500 mol / hectare, less than 200 mol / hectare, less than 100 mol / hectare, less than 50 mol / hectare, less than 20 mol / hectare, less than 10 mol / hectare, less than 5 mol / hectare, less than 2 mol / hectare, less than 10 mol / hectare, less than 5 mol / hectare, less than 2 mol / hectare, less than 1 mol / hectare, less than 500 mmol / hectare, less than 200 mmol / hectare, less than 100 mmol / hectare, less than 50 mmol / hectare, less than 20 mmol / hectare, less than 10 mmol / hectare, less than 5 mmole / hectare, less than 2 mmol / hectare, less than 1 mmol / hectare, less than 500 μmol / hectare, less than 200 μmol / hectare or less than 100 μmol / hectare, or a non-contradictory combination thereof. Regarding the application amount of the active ingredient, specifically, for example, it can be 1 μmol / hectare to 100 μmol / hectare, 10 μmol / hectare to 1 mmol / hectare, 1 mmol / hectare to 10 mmol / hectare, 10 mmol / hectare to 100 mmol / hectare, 100 mmol / hectare to 1 mol / hectare, 1 mol / hectare to 10 mol / hectare, 10 mol / hectare to 100 mol / hectare, 100 mol / hectare to 500 mol / hectare, 500 mol / hectare to 1000 mol / hectare, 1000 mol / hectare to 1500 mol / hectare, or 1500 mol / hectare to 2500 mol / hectare. When the composition of the present invention is applied in multiple times, the "application amount of the active ingredient" refers to the total application amount of the active ingredient applied in multiple times.

[0471] The description of the application method of the composition of the present invention as described above can also be applied to any other case of applying the active ingredient to plants. That is, the active ingredient can be applied to plants, for example, at the exemplified usage concentration. In addition, the active ingredient can be applied to plants, for example, at the exemplified application amount of the active ingredient. In addition, the active ingredient can be prepared into a composition such as a liquid composition containing the active ingredient and applied to plants. Regarding the composition containing the active ingredient, the description of the composition of the present invention can be applied. The active ingredient can especially be applied to plants in the form of a liquid. That is, the active ingredient can specifically be prepared into a liquid composition containing the active ingredient at the exemplified usage concentration and applied to plants. In addition, the active ingredient can be used in combination with other ingredients such as a spreading agent.

[0472] It should be noted that by cultivating plants using the method of the present invention, plants (specifically, plant bodies) can be obtained. Therefore, one embodiment of the method of the present invention can be a method for manufacturing plants (specifically, plant bodies). More specifically, one embodiment of the method of the present invention can be a method for manufacturing plants (specifically, plant bodies), which includes applying an active ingredient (i.e., the component (A), (B) or (C)) to an object such as a seed of a parasitic plant, a cultivated object plant, or mycorrhizal fungi to cultivate the plant. The combination of the object and the plant to be manufactured can be appropriately selected. As a combination of an object and a plant to be manufactured, a combination of seeds of a parasitic plant and a parasitic object plant, a combination of a cultivated object plant and a cultivated object plant (this means that the cultivated object plant to which the active ingredient is applied is cultivated), and a combination of mycorrhizal fungi and a symbiotic object plant can be cited. The cultivation method of the plant to be manufactured is not particularly limited. The cultivation of the plant to be manufactured can be implemented, for example, by the same method as the usual method of cultivating plants, except for applying the active ingredient to the object. As for the cultivation method of the plant, it is as described above. The application of the active ingredient and the cultivation of the plant to be produced can be implemented, for example, in a manner that the desired effect is obtained by applying the active ingredient. For example, the application of the active ingredient can be implemented during the cultivation of the plant to be produced, or the cultivation of the plant to be produced can be implemented after the application of the active ingredient is implemented. Specifically, for example, the cultivation of the parasitic object plant can be implemented after inducing the suicide germination of the parasitic plant, inhibiting the germination of the parasitic plant, or controlling the parasitic plant. That is, one mode of the method of the present invention can be, for example, a method for producing a parasitic object plant (specifically, a plant body of a parasitic object plant), and the method for producing a parasitic object plant includes: inducing the suicide germination of the parasitic plant, inhibiting the germination of the parasitic plant, or controlling the parasitic plant by applying the active ingredient (i.e., the ingredient (A), (B) or (C)) to the seeds of the parasitic plant; and cultivating the parasitic object plant after the application (specifically, after inducing the suicide germination of the parasitic plant, inhibiting the germination of the parasitic plant, or controlling the parasitic plant). In addition, one embodiment of the method of the present invention may be, for example, a method for producing a parasitic plant (specifically, a plant body of a parasitic plant), which comprises: cultivating the parasitic plant; and applying an active ingredient (i.e., the ingredient (A), (B) or (C)) to the seeds of the parasitic plant during the cultivation, thereby inhibiting the germination of the parasitic plant. The plant (specifically, the plant body) may be harvested appropriately. That is, the method of the present invention may also include harvesting the plant (specifically, the plant body). "Harvesting" may be used instead of "recovering". "Harvesting or recycling of the plant" may be used instead of "harvesting or recycling of the plant body". The harvested plant (specifically, the plant body) may be the whole plant body or a part of the plant body. As a part of the plant body, leaves, stems, trunks, roots, and fruits may be cited.

[0473] <4> Uses of active ingredients

[0474] In addition, the present invention discloses the use of the active ingredient in the above-exemplified uses. That is, the present invention discloses the use of the active ingredient for inducing the germination of parasitic plants (e.g., suicide germination), inhibiting the germination of parasitic plants, controlling parasitic plants, inhibiting the branching of cultivated plants, inducing the hyphae branching of mycorrhizal fungi, or improving the cultivation performance of plants (e.g., parasitic plants, cultivated plants, or symbiotic plants), and the use of the active ingredient in the manufacture of a composition for inducing the germination of parasitic plants (e.g., suicide germination), inhibiting the germination of parasitic plants, controlling parasitic plants, inhibiting the branching of cultivated plants, inducing the hyphae branching of mycorrhizal fungi, or improving the cultivation performance of plants (e.g., parasitic plants, cultivated plants, or symbiotic plants).

[0475] In addition, the present invention discloses active ingredients for the above-exemplified uses. That is, the present invention discloses, for example, active ingredients for inducing germination (e.g., suicide germination) of parasitic plants, inhibiting germination of parasitic plants, controlling parasitic plants, inhibiting branching of cultivated plants, inducing hyphae branching of mycorrhizal fungi, or improving the cultivation performance of plants (e.g., parasitic plants, cultivated plants, or symbiotic plants), and active ingredients for the manufacture of compositions for inducing germination (e.g., suicide germination) of parasitic plants, inhibiting germination of parasitic plants, controlling parasitic plants, inhibiting branching of cultivated plants, inducing hyphae branching of mycorrhizal fungi, or improving the cultivation performance of plants (e.g., parasitic plants, cultivated plants, or symbiotic plants).

[0476] Example

[0477] The present invention will be described in more detail below by way of non-limiting examples.

[0478] (synthesis example)

[0479] Compounds 1 to 90 were obtained by the following method. The structures of Compounds 1 to 90 are shown in the following formulas (Compound 1) to (Compound 90), respectively.

[0480] Synthesis example 1

[0481] In N αPyridine (0.2 mL) was added to a chloroform solution (5 mL) of -Boc-Lys-OMe·AcOH·nH2O(0·AcOH) (296 mg, 0.87 mmol, as a monohydrate), and the mixture was stirred at 0°C for 5 minutes. Then, a chloroform solution (5 mL) of triphosgene (266 mg, 0.99 mmol) was added, and the mixture was further stirred for 2 hours. After adding 0.1N hydrochloric acid to the reaction solution, the mixture was partitioned and extracted with chloroform. The organic layer was dried over anhydrous sodium sulfate and then concentrated under reduced pressure to dryness. The obtained residue was dissolved in chloroform (2 mL) without purification, and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one (115 mg, 1.01 mmol) and triethylamine (0.15 mL, 1.08 mmol) were added, and the mixture was stirred at room temperature for 5 hours. Chloroform was added to the reaction solution, and the mixture was partitioned and washed with 0.1N hydrochloric acid, and the organic layer was dehydrated and dried over anhydrous sodium sulfate. The organic layer was concentrated under reduced pressure to dryness to obtain a residue which was purified by reverse phase HPLC (linear gradient based on water-acetonitrile) to obtain Compound 1.

[0482] Yield 13%; ESIMS m / z 423.1 (M+Na) + ; 1 H NMR(400MHz,CD3OD)δ7.09(1H,t,J=1.6Hz),6.85(1H,t,J=1.6Hz),4.11(1H,dd,J=4.8,8.8Hz),3.73(3 H,s),3.16(2H,t,J=6.8Hz),1.94(3H,s),1.79(1H,m),1.67(1H,m),1.58-1.52(2H,m),1.46(11H,brs).

[0483] [Chemical formula 5]

[0484]

[0485] Synthesis example 2

[0486] Compound 1 (23 mg, 0.057 mmol) was dissolved in formic acid (0.1 mL), and the mixture was stirred at room temperature for 18 hours. The reaction mixture was concentrated to dryness under reduced pressure to obtain Compound 2 as a formate salt.

[0487] Yield 99%; ESIMS m / z 301.0 (M+H) + ; 1H NMR(400MHz,CD3OD)δ9.26(1H,s),7.09(1H,t,J=1.6Hz),6.85(1H,t,J=1.6Hz),4.06( 1H,t,J=6.4Hz),3.86(3H,s),3.25-3.12(2H,m),1.99-1.89(5H,m),1.62-1.43(4H,m).

[0488] [Chemical formula 6]

[0489]

[0490] Synthesis example 3

[0491] N ε -Boc-lysine tert-butyl ester and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one were used as raw materials and compound 3 was obtained in the same manner as compound 1.

[0492] Yield 20%; 1 H NMR (400MHz, CD3OD) δ7.11(1H,m),6.85(1H,m),4.06(1H,m),3.07-3.03(2H,m),1.95(3H,d,J=0.8Hz),1.81(1H,m),1.69(1H,m),1.49-1.44(22H,m)

[0493] [Chemical formula 7]

[0494]

[0495] Synthesis example 4

[0496] Using compound 3 as a starting material, compound 4 was obtained by the same method as compound 2.

[0497] Yield 99%; ESIMS m / z 287.0 (M+H) + ; 1 H NMR(400MHz,D2O)δ7.08(0.5H,d,J=1.6Hz),7.05(0.5H,d,J=2.0Hz),6.76(0.5H,t,J=1.6Hz),6.74(0.5H,t,J =1.6Hz),3.95(1H,m),2.91(2H,t,J=7.6Hz),1.85(3H,s),1.76(1H,m),1.68-1.58(3H,m),1.39-1.33(2H,m).

[0498] [Chemical formula 8]

[0499]

[0500] Synthesis example 5

[0501] CDI (N, N'-Carbonyldiimidazole; 1,1'-Carbonyldiimidazole) (80 mg, 0.49 mmol) was dissolved in THF (3 mL), 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one (59 mg, 0.52 mmol) was added, and the mixture was stirred at room temperature for 5 hours. After adding tert-butyl phenylalanine hydrochloride (125 mg, 0.49 mmol) to the reaction solution, triethylamine (0.08 mL, 0.57 mmol) was added under ice cooling, and the mixture was further stirred at room temperature for 1 hour. After adding ethyl acetate to the reaction solution, it was washed with 0.1N hydrochloric acid. The organic layer was dehydrated and dried over anhydrous sodium sulfate, and then dried and solidified by concentrating under reduced pressure. The residue was purified by reverse phase HPLC (water-acetonitrile containing 0.1% formic acid) to obtain compound 5.

[0502] Yield 35%; ESIMS m / z 384.1 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ7.33-7.22(5H,m),7.09(0.5H,s),7.05(0.5H,s),6.81(0.5H,brs),6.78( 0.5H,brs),4.34(1H,m),2.96(1H,m),2.11(1H,m),1.44(4H,s),1.41(5H,m).

[0503] [Chemical formula 9]

[0504]

[0505] Synthesis example 6

[0506] Compound 6 was obtained by using tert-butyl leucine hydrochloride and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials in the same manner as compound 5.

[0507] Yield 21%; ESIMS m / z 350.0 (M+Na) + ; 1 H NMR (400MHz, CD3O D) δ7.11(1H,m),6.85(1H,m),4.12(1H,m),1.95(3H,s),1.73(1H,m),1.60-1.56(2H,m),1.49(9H,s),0.99-0.94(6H,m).

[0508] [Chemical formula 10]

[0509]

[0510] Synthesis Example 7

[0511] Using mono-N-Boc-propylenediamine as a raw material, compound 7 was obtained by the same method as compound 1.

[0512] Yield 40%; ESIMS m / z 337.1 (M+Na) + ; 1 H NMR(400MHz,CD3OD)δ7.09(1H,t,J=1.6Hz),6.85(1H,t,J=1.6Hz),3.19(2H,t, J=6.8Hz),3.10(2H,t,J=6.8Hz),1.94(3H,s),1.71-1.64(2H,m),1.45(9H,s).

[0513] [Chemical formula 11]

[0514]

[0515] Synthesis example 8

[0516] Using compound 7 as a starting material, compound 8 was obtained in the form of formate by the same method as compound 2.

[0517] Yield 99%; ESIMS m / z 215.0 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ8.34(1H,s),7.10(1H,t,J=1.6Hz),6.85(1H,t,J=1.6Hz ),3.30-3.23(2H,m),3.00(2H,t,J=7.6Hz),1.949(3H,s),1.945-1.88(2H,m).

[0518] [Chemical formula 12]

[0519]

[0520] Synthesis example 9

[0521] Compound 9 was obtained using the same method as compound 5, using mono-N-Boc-cadaverine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0522] Yield 19%; ESIMS m / z 365.1 (M+Na) + ; 1H NMR(400MHz, CDCl3)δ6.87(2H,m),5.06(1H,brs),4.57(1H,brs),3.25-3.20(2H,m) ,3.14-3.09(2H,m),1.97(3H,s),1.58-1.48(4H,m),1.43(9H,s),1.39-1.33(2H,m).

[0523] [Chemical formula 13]

[0524]

[0525] Synthesis example 10

[0526] Compound 10 was obtained as a formate salt using compound 9 as a raw material in the same manner as compound 2.

[0527] Yield 99%; ESIMS m / z 243.0 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ8.51 (1H, s), 7.09 (1H, d, J = 1.6Hz), 6.84 (1H, t, J = 1.6Hz), 3.23-3.14 (2H, m),2.94(2H,t,J=7.6Hz),1.94(3H,s),1.72-1.68(2H,m),1.61-1.55(2H,m),1.48-1.42(2H,m).

[0528] [Chemical formula 14]

[0529]

[0530] Synthesis Example 11

[0531] Compound 9 (2.5 mg, 0.0073 mmol) was dissolved in heptafluorobutyric acid (0.1 mL), and the mixture was stirred at room temperature for 18 hours, and then concentrated under reduced pressure to dryness to obtain Compound 10 as a heptafluorobutyric acid salt.

[0532] Yield 99%; 1 H NMR (400MHz, CD3OD) δ7.09 (1H, d, J = 1.6Hz), 6.85 (1H, t, J = 1.6Hz), 3.25-3.13 (2H, m), 2.9 4(2H,t,J=7.6Hz),1.94(3H,s),1.72-1.68(2H,m),1.61-1.56(2H,m),1.48-1.42(2H,m).

[0533] Synthesis example 12

[0534] Triethylamine (0.15 mL) was added to a THF solution (15 mL) of compound 10 (formate) (264 mg), and the mixture was stirred at room temperature for 5 minutes. N,N',N"-tri-Boc-guanidine (327 mg) was added to the reaction solution, and the mixture was further stirred at room temperature for 2 days. After the reaction solution was concentrated by reduced pressure, ethyl acetate was added, and the mixture was washed with 1N hydrochloric acid. The organic layer was dehydrated and dried over anhydrous sodium sulfate, and then concentrated under reduced pressure to dryness. The residue was purified by silica gel column chromatography (n-hexane / ethyl acetate) to obtain compound 11.

[0535] Yield 35%; ESIMS m / z 485.3 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ7.08(1H,t,J=1.6Hz), 6.85(1H,t,J=1.6Hz), 3.39-3.36(2H,m), 3.20-3.16(2H,m), 1.94(3H,s), 1.66-1.38(24H,m).

[0536] [Chemical formula 15]

[0537]

[0538] Synthesis example 13

[0539] Compound 12 was obtained as a formate salt using compound 11 as a raw material in the same manner as compound 2.

[0540] Yield 99%; ESIMS m / z 285 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ8.38(1H,s),7.10(1H,t,J=1.6Hz),6.84(1H,t,J=1.6 Hz),3.21-3.15(4H,m),1.94(3H,s),1.65-1.56(4H,m),1.46-1.40(4H,m).

[0541] [Chemical formula 16]

[0542]

[0543] Synthesis example 14

[0544] Compound 12 was obtained as a heptafluorobutyrate salt using compound 11 as a raw material in the same manner as compound 9.

[0545] Yield 99%; 1H NMR (400MHz, CD3OD) δ7.09 (1H, s), 6.84 (1H, d, J = 1.6Hz), 3.24-3.13 (4H, m), 1.94 (3H, s), 1.66-1.55 (4H, m), 1.45-1.40 (2H, m).

[0546] Synthesis Example 15

[0547] Compound 13 was obtained using the same method as compound 5 using GABA ethyl ester and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0548] Yield 14%; ESIMS m / z 272.0 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ7.09(1H,t,J=1.6Hz), 6.85(1H,t,J=1.6Hz), 4.14(2H,q,J=7.2Hz), 3.20 (2H,t,J=7.2Hz),2.38(2H,t,J=7.2Hz),1.94(3H,s),1.86-1.79(2H,m),1.27(3H,t,J=7.2Hz).

[0549] [Chemical formula 17]

[0550]

[0551] Synthesis example 16

[0552] Compound 14 was synthesized using GABA tert-butyl ester and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials in the same manner as compound 5.

[0553] Yield 20%; ESIMS 322.0 (M+Na) + ; 1 H NMR(400MHz,CD3OD)δ7.09(1H,t,J=1.6Hz),6.85(1H,t,J=1.6Hz),3.20-3.1 7(2H,m),2.29(2H,t,J=7.6Hz),1.94(3H,s),1.82-1.75(2H,m),1.47(9H,s).

[0554] [Chemical formula 18]

[0555]

[0556] Synthesis Example 17

[0557] Compound 15 was obtained by using compound 14 as a raw material in the same manner as compound 2.

[0558] Yield 73%; ESIMS 244.0 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ7.09(1H,t,J=1.6Hz), 6.85(1H,t,J=1.6Hz), 3.23-3.19(2H,m), 2.36(2H,t,J=7.6Hz), 1.94(3H,s), 1.86-1.79(2H,m).

[0559] [Chemical formula 19]

[0560]

[0561] Synthesis Example 18

[0562] Compound 16 was obtained using the same method as compound 5 using L-homoserine lactone hydrochloride and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0563] Yield 7%; ESIMS m / z 263.9 (M+Na) + ; 1 H NMR (400MHz, CD3OD) δ7.12(1H,m),6.87(1H,m),4.52(0.5H,m),4.33(1.5H,m),4.29(1H,m),2.60(1H,m),2.33(1H,m),1.95(3H,s).

[0564] [Chemical formula 20]

[0565]

[0566] Synthesis example 19

[0567] Compound 17 was obtained using the same method as compound 5 using D-homoserine lactone hydrochloride and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0568] Yield 19%; ESIMS m / z 263.9 (M+Na) + ; 1 H NMR (400MHz, CD3O D) δ7.11(1H,m),6.87(1H,m),4.61-4.56(1.5H,m),4.51-4.42(1.5H,m),4.32(1H,m),2.59(1H,m),2.33(1H,m),1.95(3H,s).

[0569] [Chemical formula 21]

[0570]

[0571] Synthesis example 20

[0572] Compound 18 was obtained by using proline benzyl ester hydrochloride and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials in the same manner as compound 5.

[0573] Yield 16%; ESIMS m / z 368.0 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ7.42-7.34(4H,m),7.12(0.7H,t,J=1.6Hz),7.05(0.3H,t,J=1.6Hz),6.84(1H,m),6.70(0.7H,t,J=1.6Hz),6.48(0.3H,t ,J=1.6Hz),5.27-5.02(1.7H,m),5.03(0.3H,d,J=11.6Hz),4.42(1H,m),3.61-3.49(2H,m),2.32(1H,m),2.07-1.86(6H,m).

[0574] [Chemical formula 22]

[0575]

[0576] Synthesis Example 21

[0577] Compound 19 was obtained using the same method as compound 5, using phenylalanine methyl ester hydrochloride and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0578] Yield 22%; ESIMS m / z 342.0 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ7.32-7.22(5H,m),7.08(0.5H,s),7.03(0.5H,t,J=1.6Hz),6.79(0.5H,s),6.76(0.5H,s),4.4 8(1H,m),3.74(1.5H,s),3.72(1.5H,s),3.18(1H,m),2.97(1H,m),1.94(1.5H,s),1.93(1.5H,s).

[0579] [Chemical formula 23]

[0580]

[0581] Synthesis example 22

[0582] Using phenylalanine ethyl ester hydrochloride and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials, compound 20 was obtained by the same method as compound 5.

[0583] Yield 15%; ESIMS m / z 356.0 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ7.32-7.22(5H,m),7.08(0.5H,s),7.04(0.5H,t,J=1.6Hz),6.78(0.5H,d,J=1.2Hz),6.76(0.5H,d,J=1.6Hz ),4.45(1H,m),4.21-4.13(2H,m),3.17(1H,m),2.98(1H,m),1.94(1.5H,s),1.93(1.5H,s),1.26-1.20(3H,m).

[0584] [Chemical formula 24]

[0585]

[0586] Synthesis example 23

[0587] (Step 1) Synthesis of Compound 21

[0588] HOAt (132 mg, 0.97 mmol) and WSC·HCl (190 mg, 0.99 mmol) were added to an acetonitrile solution (10 mL) of N-Cbz-leucine (259 mg, 0.95 mmol), and the mixture was stirred at room temperature for 1 hour. Leucine tert-butyl ester hydrochloride (235 mg, 1.05 mmol) and triethylamine (0.16 mL, 1.15 mmol) were added to the reaction solution, and the mixture was further stirred at room temperature for 3 hours. The reaction solution was concentrated by reducing pressure, ethyl acetate was added, and then washed with 10% citric acid aqueous solution and saturated sodium bicarbonate aqueous solution in sequence. The organic layer was dehydrated and dried over anhydrous sodium sulfate, and then concentrated and dried to solidify by reducing pressure to obtain compound 21.

[0589] Yield 93%; ESIMS m / z 457.2 (M+Na) + ; 1H NMR(400MHz,CD3OD)δ7.39-7.30(5H,m),5.12(1H,d,J=12.0Hz),5.09(1H,d,J=12.0Hz),4.35(1H, dd,J=6.0,8.8Hz),4.22(1H,m),1.73(4H,m),1.62-1.54(4H,m),1.47(9H,s),0.99-0.91(12H,m).

[0590] [Chemical formula 25]

[0591]

[0592] (Step 2) Synthesis of Compound 22

[0593] 5% palladium carbon (54 mg) was added to an ethanol solution (10 mL) of compound 21 (370 mg, 0.85 mmol), and the mixture was stirred at room temperature for 18 hours under a hydrogen atmosphere. The reaction mixture was filtered, and the filtrate was concentrated to dryness under reduced pressure to obtain compound 22.

[0594] Yield 88%; ESIMS m / z 301.2 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ4.37(1H,t,J=6.8Hz),3.40(1H,dd,J=6.0,8.0Hz),1.79- 1.71(2H,m),1.63-1.56(3H,m),1.48(9H,s),1.39(1H,m),1.00-0.94(12H,m).

[0595] [Chemical formula 26]

[0596]

[0597] (Step 3) Synthesis of Compound 23

[0598] Compound 23 was obtained by the same method as compound 5 using compound 22 and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0599] Yield 17%; ESIMS m / z 463.2 (M+Na) + ; 1H NMR (400MHz, CD3O D) δ7.10(1H,m),6.84(1H,m),4.34(1H,m),4.25(1H,m),1.95(3H,s),1.76-1.71(2H,m),1.64-1.58(4H,m),1.47(9H,s),1.00-0.93(12H,m).

[0600] [Chemical formula 27]

[0601]

[0602] Synthesis example 24

[0603] (Step 1) Synthesis of Compound 24

[0604] Compound 24 was obtained by the same method as compound 21 using phenylalanine methyl ester hydrochloride and N-Cbz-proline as raw materials.

[0605] Yield 94%; ESIMS m / z 411.1 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ7.39-7.15(10H,m),5.14(2H,brs),5.06(1H,d,J=12.4Hz),4.99(1H,d,J=12.4Hz),4.68(1H,m),4.29(1H,m),3. 69(1.5H,s),3.65(1.5H,s),3.53-3.45(2H,m),3.16-3.07(1.5H,m),2.92(0.5H,dd,J=4.8,14.0Hz),2.18(1H,m),1.85-1.80(3H,m).

[0606] [Chemical formula 28]

[0607]

[0608] (Step 2) Synthesis of Compound 25

[0609] Compound 25 was obtained using compound 24 as a starting material in the same manner as compound 22.

[0610] Yield 95%; ESIMS m / z 277.0 (M+H) + ; 1H NMR (400MHz, CD3OD) δ7.31-7.18(5H,m),4.72(1H,dd,J=5.2,8.8Hz), 3.74(3H,s),3.63(1H,dd,J=5.2,9.2Hz), 3.21(1H,dd,J=5.2,14.0Hz),3.02(1H,dd,J=8.8,14.0Hz),2.90-2.84(2H,m),2.06(1H,m),1.69-1.57(3H,m).

[0611] [Chemical formula 29]

[0612]

[0613] (Step 3) Synthesis of Compound 26

[0614] Compound 26 was obtained by the same method as compound 5 using compound 25 and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0615] Yield 20%; ESIMS m / z 417.1 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ7.33-7.06(6H,m),7.06-6.77(1H,m),4.82(0.5H,m),4.71(0.5H,m),4.35(0.5H,m),4.25 (0.5H,m),3.74(1.5H,s),3.70(1.5H,s),3.58-3.45(2H,m),3.24-2.99(2H,m),2.17(1H,m),1.97-1.72(6H,m).

[0616] [Chemical formula 30]

[0617]

[0618] Synthesis example 25

[0619] Compound 27 was obtained using the same method as compound 21 using N-Boc-phenylalanine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials.

[0620] Yield 88%; ESIMS m / z 384.1 (M+Na) + ; 1H NMR(400MHz,CD3O D) δ7.19-7.10(4H,m),7.03-6.95(1H,m),6.83-6.72(2H,m),4.29(1H,m ),3.00(1H,m),2.86(1H,m),1.82(0.6H,s),1.81(0.4H,s),1.28(9H,s).

[0621] [Chemical formula 31]

[0622]

[0623] Synthesis Example 26

[0624] Using N-Boc-leucine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials, compound 28 was obtained by the same method as compound 21.

[0625] Yield 91%; ESIMS m / z 350.1 (M+Na) + ; 1 H NMR (400MHz, CD3O D) δ7.03 (0.5H, t, J = 1.6Hz), 7.00 (0.5H, t, J = 1.6Hz), 6.82 (1H, t, J = 1.6H z),6.79(0.5H,d,J=1.6Hz),4.09(1H,m),1.84(3H,d,J=1.6Hz),1.62(1H,m),1.52-1.43(2H,m),1.34(9H,s),0.86-0.81(6H,m).

[0626] [Chemical formula 32]

[0627]

[0628] Synthesis Example 27

[0629] N α -,N ε Compound 29 was obtained by using -diBoc-lysine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials and the same method as compound 21.

[0630] Yield 92%; ESIMS m / z 465.2 (M+Na) + ; 1 H NMR (400MHz, CD3O D) δ4.01(1H,m),2.95-2.92(2H,m),1.95(3H,d,J=0.8Hz).1.87(1H,m),1.71(1H,m),1.49-1.44(22H,m).

[0631] [Chemical formula 33]

[0632]

[0633] Synthesis example 28

[0634] Compound 30 was obtained by using mono-tert-butyl succinate and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials in the same manner as compound 21.

[0635] Yield 87%; ESIMS m / z 293.1 (M+Na) + ; 1 H NMR (400MHz, CD3OD) δ7.12(1H,t,J=1.6Hz), 6.92(1H,t,J=1.6Hz), 2.67-2.65(2H,m), 2.59-2.56(2H,m), 1.86(3H,s), 1.46(9H,s).

[0636] [Chemical formula 34]

[0637]

[0638] Synthesis Example 29

[0639] Using N-Boc-tryptophan and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials, compound 31 was obtained by the same method as compound 21.

[0640] Yield 95%; ESIMS m / z 423.1 (M+Na) + ; 1 H NMR (400MHz, CD3OD) δ7.41(1H,m),7.24(1H,m),7.02-6.90(3H,m),6.82(0.33H,t,J=1.6Hz),6.73(0.67H,m),6.56(0.67H, t,J=1.6Hz),6.32(0.33H,d,J=2.4Hz),4.36(1H,m),3.18-3.02(2H,m),1.79(1H,s),1.72(2H,s),1.30(3H,s),1.28(6H,s).

[0641] [Chemical formula 35]

[0642]

[0643] Synthesis example 30

[0644] Using N-Boc-methionine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials, compound 32 was obtained by the same method as compound 21.

[0645] Yield 99%; ESIMS m / z 377.0 (M+MeOH) + ; 1 H NMR (400MHz, CD3OD) δ7.02(1H,m),6.82(1H,t,J=1.6Hz),4.24(0.5H,m),4.04(0.5H,m),2.53-2.39(2H,m),2.08-1.74(8H,m),1.34(9H,s).

[0646] [Chemical formula 36]

[0647]

[0648] Synthesis Example 31

[0649] Using N-Boc-aspartic acid β-methyl ester and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials, compound 33 was obtained by the same method as compound 21.

[0650] Yield 87%; ESIMS m / z 366.0 (M+Na) + ; 1 H NMR (400MHz, CD3OD) δ7.00(1H,m),6.80(1H,t,J=1.6Hz),4.47(1H,m),3.59(3H,s),2.84-2.67(2H,m),1.84(3H,s),1.34(9H,s).

[0651] [Chemical formula 37]

[0652]

[0653] Synthesis example 32

[0654] τ-Benzyl-N α Compound 34 was obtained by using -Boc-histidine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials and the same method as compound 21.

[0655] Yield 21%; ESIMS m / z 442.2 (M+H) + ; 1H NMR (400MHz, CD3OD) δ7.57(0.5H,m),7.54(0.5H,s),7.27-7.20(3H,m),7.15-7.13(2H,m),6.96(0.5H,d,J=1.6Hz),6.84-6.69( 3H,m),5.06(1H,s),5.05(1H,s),4.30(1H,m),2.91-2.81(2H,m),1.83(1.5H,s),1.81(1.5H,s),1.292(4.5H,s)1.288(4.5H,s).

[0656] [Chemical formula 38]

[0657]

[0658] Synthesis example 33

[0659] τ-Cbz-N α Compound 35 was obtained by using -Boc-histidine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials and the same method as compound 21.

[0660] Yield 68%; ESIMS m / z 486.2 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ8.08(1H,m),7.38(1H,m),7.30-7.22(5H,m),6.96(1H,m),6.77(1H,t,J=1.6Hz),5. 33(1.2H,s),5.05(0.8H,s),4.36(1H,m),2.97-2.80(2H,m),1.81(3H,s),1.28(5.4H,s),1.27(3.6H,s).

[0661] [Chemical formula 39]

[0662]

[0663] Synthesis example 34

[0664] 5-Hydroxy-3-methyl-2,5-dihydrofuran-2-one (114 mg, 1.00 mmol) and glutaric anhydride (114 mg, 1.00 mmol) were dissolved in acetonitrile (2 mL), and triethylamine (0.15 mL, 1,08 mmol) was added, and stirred at room temperature for 2 hours. The solvent and excess reagent were dried and solidified by reducing pressure to obtain compound 36 as a triethylamine salt.

[0665] Yield 99%; ESIMS m / z 250.9 (M+Na) + ; 1 H NMR (400MHz, CDCl3) δ11.36(1H,br),6.94(1H,d,J=1.6Hz),6.88(1H,t,J=1.6Hz),3.11(2H,q,J =7.2Hz), 2.48(2H,t,J=7.2Hz), 2.38(2H,t,J=7.2Hz), 2.05-1.91(5H,m), 1.27(3H,t,J=7.2Hz).

[0666] [Chemical formula 40]

[0667]

[0668] Synthesis Example 35

[0669] Using N-Boc-phenylalanine and 5-hydroxy-2,5-dihydrofuran-2-one as raw materials, compound 37 was obtained by the same method as compound 21.

[0670] Yield 40%; ESIMS m / z 370.0 (M+Na) + ; 1 H NMR (400MHz, CD3OD) δ7.53 (0.5H, dd, J = 1.2, 5.6Hz), 7.37-7.23 (4.5H, m), 7.05 (0.5H, s), 6.99 (0.5H,t,J=1.2Hz),6.38(1H,t,J=1.2Hz),4.42(1H,m),3.13(1H,m),2.98(1H,m),1.40(9H,s).

[0671] [Chemical formula 41]

[0672]

[0673] Synthesis Example 36

[0674] L-pyroglutamic acid and N ε -Boc-lysine tert-butyl ester hydrochloride was used as the raw material and the same method as compound 21 was used to obtain compound 38.

[0675] Yield 85%; ESIMS m / z 414.2 (M+H) + ; 1H NMR (400MHz, CD3OD) δ4.28-4.24(2H,m),3.05(2H,t,J=6.8Hz),2.54-2.27(5H,m ),2.15(1H,m),1.86-1.83(2H,m),1.76-1.68(2H,m),1.49(9H,s),1.45(9H,s).

[0676] [Chemical formula 42]

[0677]

[0678] Synthesis Example 37

[0679] Compound 38 (150 mg, 0.36 mmol) was dissolved in 4N hydrochloric acid dioxane solution (2 mL), and the mixture was stirred at room temperature for 18 hours, and then concentrated under reduced pressure to dryness to obtain Compound 39 as a hydrochloride.

[0680] Yield 99%; 1 H NMR(400MHz,D2O)δ4.30-4.26(2H,m),2.88(2H,t,J=8.0Hz),2.43(1H,m),2.33-2.28 (2H,m),1.97(1H,m),1.83(1H,m),1.70(1H,m),1.61-1.54(2H,m),1.39-1.30(2H,m).

[0681] [Chemical formula 43]

[0682]

[0683] Synthesis example 38

[0684] N α -Cbz-lysine benzyl ester and L-pyroglutamic acid were used as raw materials and compound 40 was obtained in the same manner as compound 21.

[0685] Yield 96%; ESIMS m / z 482.2 (M+H) + ; 1H NMR (400MHz, CD3OD) δ7.37-7.30(10H,m),5.21-5.06(4H,m),4.23(1H,dd,J=4.8,8.8Hz),4.12(1H,dd,J=4.8,8.8Hz),3.19 -3.16(2H,m),2.46-2.34(2H,m),2.27(1H,m),2.01(1H,m),1.84(1H,m),1.70(1H,m),1.57-1.47(2H,m),1.43-1.36(2H,m).

[0686] [Chemical formula 44]

[0687]

[0688] Synthesis Example 39

[0689] Compound 41 was obtained using compound 40 as a starting material in the same manner as compound 22.

[0690] Yield: 92%; 1 H NMR(400MHz,D2O)δ4.19(1H,dd,J=5.2,8.8Hz),3.60(1H,t,J=6.0Hz),3.17-3.12(2H,m), 2.49-2.30(3H,m),1.96(1H,m),1.77-1.73(2H,m),1.49-1.45(2H,m),1.32-1.28(2H,m).

[0691] [Chemical formula 45]

[0692]

[0693] Synthesis Example 40

[0694] N α -Cbz-lysine benzyl ester and D-pyroglutamic acid were used as raw materials and compound 42 was obtained in the same manner as compound 21.

[0695] Yield 72%; ESIMS m / z 482.2 (M+H) + ; 1H NMR (400MHz, CD3OD) δ7.36-7.29 (10H, m), 5.20-5.06 (4H, m), 4.25 (1H, t, J = 4.4Hz), 4.12 (1H, dd, J = 4.8, 8.8Hz), 3.19-3. 15(2H,m),2.41-2.34(2H,m),2.26(1H,m),2.01(1H,m),1.83(1H,m),1.70(1H,m),1.56-1.44(2H,m),1.42-1.34(2H,m).

[0696] [Chemical formula 46]

[0697]

[0698] Synthesis Example 41

[0699] Compound 43 was obtained using compound 42 as a starting material in the same manner as compound 41.

[0700] Yield 86%; ESIMS m / z 258.1 (M+H) + ; 1 H NMR(400MHz,D2O)δ4.19(1H,dd,J=5.2,8.8Hz),3.63(1H,dd,J=6.0,6.4Hz),3.17-3.13(2H, m),2.47-2.30(3H,m),1.96(1H,m),1.84-1.70(2H,m),1.51-1.44(2H,m),1.38-1.23(2H,m).

[0701] [Chemical formula 47]

[0702]

[0703] Synthesis Example 42

[0704] Compound 44 was obtained by the same method as compound 21 using tert-butyl leucine hydrochloride and D-pyroglutamic acid as starting materials.

[0705] Yield 74%; ESIMS m / z 299.1 (M+H) + ; 1H NMR (400MHz, CD3OD) δ4.35 (1H, dd, J = 6.4, 8.8 Hz), 4.24 (1H, dd, J = 4.8, 8.4 Hz), 2. 54-2.28(3H,m),2.09(1H,m),1.70(1H,m),1.66-1.61(2H,m),0.99(3H,d,J=6.4H z),0.94(3H,d,J=6.4Hz).

[0706] [Chemical formula 48]

[0707]

[0708] Synthesis Example 43

[0709] Compound 45 was obtained by the same method as compound 21 using tert-butyl phenylalanine hydrochloride and D-pyroglutamic acid as raw materials.

[0710] Yield 89%; ESIMS m / z 377.1 (M+HCO2) - ; 1 H NMR(400MHz,CD3OD)δ7.33-7.22(5H,m),4.64(1H,dd,J=6.0,9.2Hz),4.16(1H,dd,J=4.8,8.4Hz),3.1 8(1h,dd,J=6.0,13.6Hz),2.97(1H,dd,J=9.2,13.6Hz),2.34-2.21(3H,m),1.77(1H,m),1.44(9H,s).

[0711] [Chemical formula 49]

[0712]

[0713] Synthesis Example 44

[0714] N α -Cbz-lysine benzyl ester benzenesulfonate and (R)-(-)-5-oxotetrahydrofuran-2-carboxylic acid were used as raw materials and compound 46 was obtained in the same manner as compound 21.

[0715] Yield 91%; ESIMS m / z 483.2 (M+H) + ; 1H NMR (400MHz, CD3OD) δ7.38-7.30(10H,m),5.20(1H,d,J=13.4Hz),5.15(1H,d,J=13.4Hz),5.10(2H,s),3.21(2H,t ,J=6.8Hz),2.57-2.54(3H,m),2.23-2.14(2H,m),1.85(1H,m),1.71(1H,m),1.59-1.47(2H,m),1.43-1.35(2H,m).

[0716] [Chemical formula 50]

[0717]

[0718] Synthesis Example 45

[0719] N ε Compound 47 was obtained by the same method as compound 21 using -Cbz-lysine benzyl ester hydrochloride and D-pyroglutamic acid as raw materials.

[0720] Yield 64%; ESIMS m / z 482.2 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ7.41-7.30(10H,m),5.19(1H,d,J=12.0Hz),5.16(1H,d,J=12.0Hz),5.07(2H,s),4.45(1H,dd,J=4.8,9.2Hz),4.22( 1H,d,J=4.8,8.8Hz),3.12-3.08(2H,m),2.47-2.20(4H,m),2.02(1H,m),1.89(1H,m),1.76(1H,m),1.52-1.46(2H,m),1.42-1.36(2H,m).

[0721] [Chemical formula 51]

[0722]

[0723] Synthesis Example 46

[0724] Compound 48 was obtained using compound 44 as a starting material in the same manner as compound 39.

[0725] Yield 99%; ESIMS m / z 243.1 (M+H) + ; 1H NMR(400MHz,CD3OD)δ6.34(1H,d,J=8.0Hz),4.48(1H,m),4.25(1H,dd,J=4.8,8.8Hz),2.53-2.40( 2H,m),2.31(1H,m),2.10(1H,m),1.71-1.67(3H,m),1.00(3H,d,J=6.0Hz),0.96(3H,d,J=6.0Hz).

[0726] [Chemical formula 52]

[0727]

[0728] Synthesis Example 47

[0729] Compound 49 was obtained using compound 45 as a starting material in the same manner as compound 39.

[0730] Yield 99%; ESIMS m / z 277.1 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ7.32-7.21(5H,m),4.76(1H,dd,J=4.8,9.6Hz),4.15(1H,dd,J=4.8,8.4H z),3.30(1H,dd,J=4.4,10.0Hz),2.97(1H,dd,J=9.6,10.0Hz),3.32-2.19(3H,m),1.71(1H,m).

[0731] [Chemical formula 53]

[0732]

[0733] Synthesis Example 48

[0734] Compound 50 was obtained by the same method as compound 21 using D-phenylalanine tert-butyl ester hydrochloride and D-pyroglutamic acid as raw materials.

[0735] Yield 85%; ESIMS m / z 377.1 (M+HCO2) - ; 1H NMR(400MHz,CD3OD)δ7.32-7.24(5H,m),4.61(1H,dd,J=6.0,8.8Hz),4.17(1H,dd,J=4.4,8.8Hz),3.17(1H, dd,J=6.0,12.0Hz),3.00(1H,dd,J=8.8,12.0Hz),2.42(1H,m),2.30-2.24(2H,m),1.96(1H,m),1.44(9H,s).

[0736] [Chemical formula 54]

[0737]

[0738] Synthesis Example 49

[0739] Compound 51 was obtained by the same method as compound 21 using tert-butyl phenylalanine hydrochloride and L-pyroglutamic acid as raw materials.

[0740] Yield 80%; ESIMS m / z 377.1 (M+HCO2) - ; 1 H NMR(400MHz,CD3OD)δ7.32-7.24(5H,m),4.61(1H,dd,J=6.0,8.8Hz),4.17(1H,dd,J=4.4,8.4Hz),3.17(1H, dd,J=6.0,14.0Hz),3.00(1H,dd,J=8.8,14.0Hz),2.42(1H,m),2.30-2.24(2H,m),1.97(1H,m),1.44(9H,s).

[0741] [Chemical formula 55]

[0742]

[0743] Synthesis Example 50

[0744] Compound 52 was obtained by the same method as compound 21 using D-phenylalanine tert-butyl ester hydrochloride and L-pyroglutamic acid as raw materials.

[0745] Yield 89%; ESIMS m / z 377.0 (M+HCO2) - ; 1H NMR(400MHz,CD3OD)δ7.33-7.22(5H,m),4.64(1H,dd,J=6.0,9.2Hz),4.16(1H,dd,J=4.8,8.4Hz),3.1 8(1H,dd,J=6.0,14.0Hz),2.97(1H,dd,J=9.2,14.0Hz),2.34-2.21(3H,m),1.76(1H,m),1.44(9H,s).

[0746] [Chemical formula 56]

[0747]

[0748] Synthesis Example 51

[0749] Compound 53 was obtained using the same method as compound 21, using leucine tert-butyl ester hydrochloride and D-pyroglutamic acid as raw materials.

[0750] Yield 70%; ESIMS m / z 456.2 (M+HCO2) - ; 1 H NMR(400MHz,CD3OD)δ4.48(1H,dd,J=6.8,8.0Hz),4.33(1H,dd,J=6.8,8.4Hz),4.24(1H,dd,J=4.8,8.8Hz),2.52-2.28(3H,m),2.06(1H,m),1 .78-1.67(2H,m),1.65-1.58(4H,m),1.48(9H,s),1.00(3H,d,J=6.8Hz),0.98(3H,d,J=6.8Hz),0.97(3H,d,J=6.4Hz),0.92(3H,d,J=6.4Hz).

[0751] [Chemical formula 57]

[0752]

[0753] Synthesis example 52

[0754] Compound 54 was obtained by the same method as compound 21 using tert-butyl sarcosine and D-pyroglutamic acid as raw materials.

[0755] Yield 17%; ESIMS m / z 513.3 (2M+H) + ; 1H NMR(400MHz,CD3O D) δ4.77(0.7H,dd,J=4.0,8.8Hz), 4.59(0.3H,dd,J=4.4,8.4Hz), 4.27(0.3H,d,J=18.4Hz), 4.19(0.7H,d,J=16.8Hz), 4.12(0.7H,d,J=18. 4Hz),3.90(0.3H,d,J=16.8Hz),3.14(2.1H,s),2.97(0.9H,s),2.57(1H,m),2.44-2.30(2H,m),2.09(1H,m),1.52(2.7H,s),1.49(6.3H,s).

[0756] [Chemical formula 58]

[0757]

[0758] Synthesis example 53

[0759] Compound 55 was obtained by the same method as compound 21 using proline tert-butyl ester and D-pyroglutamic acid as raw materials.

[0760] Yield 12%; ESIMS m / z 565.3 (2M+H) + ; 1 H NMR(400MHz,CD3O D) δ4.67(0.25H,dd,J=2.4,8.8Hz),4.60(0.75H,dd,J=4.4,8.8Hz),4.40(0.25H,t,J=4.0Hz),4.34(0.75H,dd,J =4.4,8.8Hz),3.76(1H,m),3.60(1H,m),2.57-2.21(4H,m),2.12-1.93(4H,m),1.52(2.25H,s),1.48(6.75H,s).

[0761] [Chemical formula 59]

[0762]

[0763] Synthesis example 54

[0764] Compound 56 was obtained using compound 53 as a starting material in the same manner as compound 39.

[0765] Yield 99%; ESIMS m / z 356.1 (M+H) + ; 1H NMR(400MHz,CD3OD)δ4.50-4.43(2H,m),4.25(1H,dd,J=4.4,8.4Hz),2.52-2.28 (3H,m),2.06(1H,m),1.80-1.70(2H,m),1.68-1.62(4H,m),1.00-0.93(12H,m).

[0766] [Chemical formula 60]

[0767]

[0768] Synthesis Example 55

[0769] Compound 57 was obtained using mono-N-Boc-cadaverine and D-pyroglutamic acid as starting materials in the same manner as compound 21.

[0770] Yield 27%; ESIMS m / z 314.1 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.17(1H,m),3.24-3.20(2H,m),3.06(2H,t,J=6.8Hz),2.50-2.28(3H,m),2.07(1H,m),1.58-1.34(15H,m).

[0771] [Chemical formula 61]

[0772]

[0773] Synthesis example 56

[0774] Compound 58 was obtained using compound 39 and the same method as compound 57.

[0775] Yield 99%; ESIMS m / z 214.0 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.27 (1H, dd, J = 4.8, 8.4Hz), 3.25 (2H, t, J = 6.8Hz), 2.98-2.94 (2H, m) ,2.53-2.32(3H,m),2.08(1H,m),1.74-1.70(2H,m),1.62-1.58(2H,m),1.48-1.42(2H,m).

[0776] [Chemical formula 62]

[0777]

[0778] Synthesis Example 57

[0779] Compound 59 was obtained by the same method as compound 21 using GABA ethyl ester hydrochloride and D-pyroglutamic acid as raw materials.

[0780] Yield 33%; ESIMS m / z 243.0 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.05-4.00(3H,m),3.21-3.12(2H,m),2.40-2.16(5H,m),1.94(1H,m),1,75-1.68(2H,m),1.15(3H,t,J=6.8Hz).

[0781] [Chemical formula 63]

[0782]

[0783] Synthesis example 58

[0784] Compound 59 (75 mg, 0.31 mmol) was dissolved in ethanol (2 mL), and 1N sodium hydroxide aqueous solution (0.5 mL) was added, and the mixture was stirred at room temperature for 2 hours. After adding the reaction solution water (3 mL), Amberlite FPC3500 (H + ) column and eluted with water. The obtained non-adsorbed fraction was concentrated and dried to obtain compound 60.

[0785] Yield 90%; 1 H NMR (400MHz, D2O) δ4.20 (1H, dd, J = 5.2, 9.2Hz), 3.20-3.16 (2H, m), 2.47-2.28 (3H, m), 1.97 (1H, m), 1.76-1.69 (2H, m).

[0786] [Chemical formula 64]

[0787]

[0788] Synthesis Example 59

[0789] Compound 61 was obtained by the same method as compound 21 using serine methyl ester hydrochloride and D-pyroglutamic acid as raw materials.

[0790] Yield 57%; ESIMS m / z 231.0 (M+H) + ; 1H NMR (400MHz, CD3OD) δ4.56 (1H, dd, J = 4.0, 9.2 Hz), 4.36 (1H, dd, J = 4.8, 8.8 Hz), 3.94 (1H, dd, J = 5.2,11.2Hz),3.85(1H,dd,J=4.0,11.2Hz),3.77(3H,s),2.54-2.36(4H,m),2.24-2.13(2H,m).

[0791] [Chemical formula 65]

[0792]

[0793] Synthesis Example 60

[0794] Compound 62 was obtained by the same method as compound 21 using L-homoserine lactone hydrochloride and N-Boc-L-pyroglutamic acid as raw materials.

[0795] Yield 26%; ESIMS m / z 357.0 (M+HCO2 - ) - ; 1 H NMR(400MHz,CD Cl3)δ7.54(1H,d,J=8.0Hz),4.62(1H,dd,J=4.4,9.2Hz),4.41(1H,m),4.25(1H,m),2.75-2.60(2H,m),2.50-2.35(3H,m),2.17(1H,m).

[0796] [Chemical formula 66]

[0797]

[0798] Synthesis Example 61

[0799] Compound 63 was obtained using compound 62 as the starting material by the same method as compound 39.

[0800] Yield 99%; ESIMS m / z 213.0 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.67(1H,dd,J=8.8,11.2Hz), 4.49(1H,dd,J=2.0,8.8Hz), 4.45-4.25(2H,m), 2.60-2.30(5H,m), 2.16(1H,m).

[0801] [Chemical formula 67]

[0802]

[0803] Synthesis example 62

[0804] Compound 64 was obtained by the same method as compound 21 using D-homoserine lactone hydrochloride and N-Boc-L-pyroglutamic acid as raw materials.

[0805] Yield 20%; ESIMS m / z 357.0 (M+HCO2 - ) - ; 1 H NMR (400MHz, CD3OD) δ4.66-4.58(2H,m),4.48(1H,m),4.33(1H,m),2.67-2.56(2H,m),2.52-2.31(3H,m),2.00(1H,m),1.52(9H,s).

[0806] [Chemical formula 68]

[0807]

[0808] Synthesis example 63

[0809] Compound 65 was obtained using compound 64 as a starting material in the same manner as compound 39.

[0810] Yield 99%; ESIMS m / z 212.9 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.55 (1H, dd, J = 8.8, 10.8 Hz), 4.38 (1H, dd, J = 1.6, 9.2 Hz), 4.34-4.12 (2H, m), 2.45-2.21 (5H, m), 2.01 (1H, m).

[0811] [Chemical formula 69]

[0812]

[0813] Synthesis example 64

[0814] To D-pyroglutamic acid (30 mg, 0.023 mmol) were added n-butanol (0.5 mL) and 4N hydrochloric acid in dioxane (0.5 mL), and the mixture was stirred at room temperature for 4 days. The solvent and excess reagent were removed under reduced pressure to obtain Compound 66 as a colorless oily substance.

[0815] Yield 99%; ESIMS m / z 186.1 (M+H) + ; 1H NMR(400MHz, CDCl3)δ6.70(1H,brs),4.25(1H,m),4.16(2H,m),2.52-2.34(3H ,m),2.20(1H,m),1.66-1.60(2H,m),1.41-1.35(2H,m),0.94(3H,t,J=7.2Hz).

[0816] [Chemical formula 70]

[0817]

[0818] Synthesis Example 65

[0819] Compound 67 was obtained as a colorless oily substance by using D-pyroglutamic acid and n-hexanol as starting materials in the same manner as for Compound 66.

[0820] ESIMS m / z 214.1(M+H) + ; 1 H NMR(400MHz, CDCl3)δ4.26(1H,m),4.16-4.15(2H,m),2.49(1H,m),2.42-2.36(2 H,m),2.23(1H,m),1.68-1.62(2H,m),1.37-1.29(6H,m),0.90(3H,t,J=6.8Hz).

[0821] [Chemical formula 71]

[0822]

[0823] Synthesis Example 66

[0824] Compound 68 was obtained using the same method as compound 66 using D-pyroglutamic acid and n-dodecanol as raw materials.

[0825] ESIMS m / z 595.5(2M+H) + ; 1 H NMR (400MHz, CDCl3) δ4.30 (1H, dd, J = 4.4, 8.4Hz), 4.18 (2H, t, J = 6.4Hz), 2.57-2.29 (3H, m ),2.16(1H,m),1.71-1.65(2H,m),1.52(1H,m),1.37-1.22(17H,m),0.92(3H,t,J=6.8Hz).

[0826] [Chemical formula 72]

[0827]

[0828] Synthesis example 67

[0829] Compound 69 was obtained using the same method as compound 21 using D-pyroglutamic acid and geraniol as starting materials.

[0830] Yield 78%; ESIMS m / z 266.1 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ5.39(1H,m),5.11(1H,m),4.71(2H,d,J=6.8Hz),4.29(1H,dd,J=4.8,8.8Hz),2.50(1H, m),2.42-2.28(2H,m),2.19-2.06(5H,m),1.75(3H,d,J=1.6Hz),1.69(3H,d,J=1.6Hz),1.63(3H,d,J=1.6Hz).

[0831] [Chemical formula 73]

[0832]

[0833] Synthesis example 68

[0834] Compound 70 was obtained using the same method as compound 21 using nerol and D-pyroglutamic acid as raw materials.

[0835] Yield 95%; ESIMS m / z 266.1 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ5.39(1H,m),5.14(1H,m),4.68(2H,dd,J=0.8,6.8Hz),4.29(1H,dd,J=4.8,8.8Hz),2.50(1 H,m),2.42-2.28(2H,m),2.20-2.10(5H,m),1.79(3H,d,J=1.2Hz),1.70(3H,d,J=1.2Hz),1.64(3H,d,J=1.2Hz).

[0836] [Chemical formula 74]

[0837]

[0838] Synthesis example 69

[0839] Compound 71 was obtained using the same method as compound 21 using phenylethanol and D-pyroglutamic acid as raw materials.

[0840] Yield 54%; m / z 234.1 (M+H)+ ; 1 H NMR(400MHz,CD3OD)δ7.33-7.21(5H,m),4.45-4.37(2H,m),4.25(1H,dd,J=4.0,8.8Hz ),3.01-2.97(2H,m),2.55(1H,m),2.43(1H,m),2.28-2.24(2H,m),2.05-1.99(2H,m).

[0841] [Chemical formula 75]

[0842]

[0843] Synthesis Example 70

[0844] Compound 72 was obtained using the same method as compound 21 using indoleacetic acid and (S)-pyroglutamate as starting materials.

[0845] Yield: 72%; ESIMS m / z 273.1 (M+H) + ; 1 H NMR(400MHz,CD3O D) δ7.42(1H,d,J=7.6Hz),7.24(1H,d,J=8.4Hz),7.05(1H,s),7.00(1H,m),6.92(1H,m),4.03(1H,dd,J =4.0,11.6Hz),3.89(1H,dd,J=2.0,11.6Hz),3.72(1H,m),3.69(2H,s),2.07-1.98(3H,m),1.60(1H,m).

[0846] [Chemical formula 76]

[0847]

[0848] Synthesis Example 71

[0849] Compound 73 was obtained using the same method as compound 21 using indoleacetic acid and (R)-pyroglutamate as starting materials.

[0850] Yield: 65%; ESIMS m / z 273.1 (M+H) + ; 1H NMR(400MHz,CD3O D) δ7.54(1H,dd,J=1.2,8.0Hz),7.36(1H,d,J=8.0Hz),7.18(1H,s),7.12(1H,m),7.04(1H,m),4.16(1H,dd ,J=4.0,11.6Hz),4.02(1H,dd,J=5.2,11.6Hz),3.86(1H,m),3.85(2H,s),2.20-2.11(3H,m),1.73(1H,m).

[0851] [Chemical formula 77]

[0852]

[0853] Synthesis Example 72

[0854] Compound 74 was obtained using the same method as compound 21 using n-octanoic acid and (R)-pyroglutamate as raw materials.

[0855] Yield 89%; ESIMS m / z 242.1 (M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.19 (1H, dd, J = 4.0, 11.2Hz), 4.03-3.92 (2H, m), 2.45-2.26 (5H,m),1.91(1H,m),1.65-1.62(2H,m),1.37-1.31(8H,m),0.92(3H,t,J=6.8Hz).

[0856] [Chemical formula 78]

[0857]

[0858] Synthesis Example 73

[0859] Compound 75 was obtained using the same method as compound 21 using lauric acid and (R)-pyroglutamate as starting materials.

[0860] Yield 95%; m / z 595.5 (2M+H) + ; 1 H NMR (400MHz, CD3OD) δ4.19 (1H, dd, J = 4.0, 11.2Hz), 4.03-3.94 (2H, m), 2.40-2.27 ( 5H,m),1.91(1H,m),1.65-1.62(2H,m),1.37-1.31(16H,m),0.92(3H,t,J=6.8Hz).

[0861] [Chemical formula 79]

[0862]

[0863] Synthesis Example 74

[0864] Compound 76 was obtained using the same method as compound 21 using N-Boc-phenylalanine and (R)-pyroglutamate as raw materials.

[0865] Yield: 87%; ESIMS m / z 385.2 (M+Na) + ; 1 H NMR(400MHz,CD3OD)δ7.33-7.22(5H,m),4.38(1H,dd,J=6.0,8.8Hz),4.10-4.08(2H,m),3.88(1H,m),3 .12(1H,dd,J=6.0,13.6Hz),2.95(1H,dd,J=8.8,13.6Hz),2.45-2.18(3H,m),1.84(1H,m),1.41(9H,s).

[0866] [Chemical formula 80]

[0867]

[0868] Synthesis Example 75

[0869] Compound 77 (hydrochloride) was obtained by using compound 42 as a starting material in the same manner as compound 39.

[0870] Yield: 99%; ESIMS m / z 263.1 (M+H) + ; 1 H NMR (400MHz, CD3O D) δ7.37-7.19(5H,m),4.43(1H,t,J=6.8Hz),4.26(1H,dd,J=3.6,11.2H z),4.06(1H,dd,J=6.0,11.2Hz),3.90(1H,m),3.26-3.16(2H,m),2.33-2.28(2H,m),2.24-1.76(2H,m),.

[0871] [Chemical formula 81]

[0872]

[0873] Synthesis Example 76

[0874] Compound 78 was obtained by the same method as compound 21 using hemi-tert-butyl succinate and (R)-pyroglutamate as raw materials.

[0875] Yield 78%; ESIMS m / z 294.1 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ4.17(1H,dd,J=4.0,11.2Hz),4.06(1H,dd,J=6.0,11.2Hz),3.95(1H,m),2.64-2.54(4H,m),2.46-2.26(3H,m),1.91(1H,m),1.46(9H,s).

[0876] [Chemical formula 82]

[0877]

[0878] Synthesis Example 77

[0879] Compound 79 was obtained by the same method as compound 21 using N-Boc-GABA and (R)-pyroglutamate as raw materials.

[0880] Yield 57%; ESIMS m / z 301.0 (M+H) + ; 1 H NMR(400MHz,CD3OD)δ4.18(1H,dd,J=3.6,10.8Hz),4.05-3.94(2H,m),3.11- 3.08(2H,m),2.43-2.29(5H,m),1.90(1H,m),1.82-1.75(2H,m),1.45(9H,s).

[0881] [Chemical formula 83]

[0882]

[0883] Synthesis Example 78

[0884] Concentrated sulfuric acid (0.05 mL) was added to a THF solution (2 mL) of 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one (35 mg, 0.31 mmol) and N-Boc-glutamine methyl ester (77 mg, 0.30 mmol), and stirred at room temperature for 2 days. Ethyl acetate was added to the reaction solution and washed with water. The organic layer was dried over anhydrous sodium sulfate and then concentrated under reduced pressure to dryness. The obtained residue was purified by reverse phase HPLC (water / acetonitrile) to obtain compound 80.

[0885] Yield 4%; ESIMS m / z 379.0 (M+Na) + ; 1H NMR(400MHz,CD3OD)δ7.04(1H,t,J=1.6Hz),6.55(1H,dd,J=1.6Hz),4.15(1H,m),3.74(3H, s), 2.37 (2H, t, J = 7.2Hz), 2.16 (1H, m), 1.94-1.91 (4H, m), 1.459 (4.5H, s), 1.457 (4.5H, s).

[0886] [Chemical formula 84]

[0887]

[0888] Synthesis Example 79

[0889] (Step 1) Synthesis of Compound 81

[0890] Compound 81 was obtained by the same method as compound 21 using octanoic acid and N,N'-di-Boc-guanidine as raw materials.

[0891] Yield 66%; ESIMS m / z 386.2 (M+H) + ; 1 H NMR (400MHz, CDCl3) δ2.51(1H,br),2.32(1H,t,J=7.2Hz),1.69-1.61(2H,m),1.50(9H,s),1.49(9H,s),1.34-1.26(8H,m),0.90-0.86(3H,m).

[0892] [Chemical formula 85]

[0893]

[0894] (Step 2) Synthesis of Compound 82

[0895] 60% mineral oil-dispersed sodium hydride (26 mg, 1.08 mmol) was dispersed in DMF (1 mL), stirred at room temperature for 5 minutes, and then a DMF solution (1 mL) of compound 81 (240 mg, 0.62 mmol) was added, and stirred at room temperature for 5 minutes. A DMF solution (1 mL) of 5-bromo-3-methyl-2,5-dihydrofuran-2-one (110 mg, 0.62 mmol) was added to the reaction solution and stirred at room temperature for 4 hours. After ethyl acetate was added to the reaction solution, it was washed with 0.1N hydrochloric acid. After the organic layer was concentrated and dried by decompression and solidified, it was purified with Sep-Pak silica (n-hexane / ethyl acetate) to obtain compound 82.

[0896] Yield 16%; ESIMS m / z 482.3 (M+H)+ ; 1 H NMR (400MHz, CDCl3) δ6.19(1H,d,J=7.6Hz),5.12(1H,dd,J=7.6,11.2Hz Hz),3.08-2.94(2H,m),1.70-1.61(2H,m),1.54(9H,s),1.52(9H,s),1.50(3H,s),1.33-1.27(8H,m),0.89(3H,t,J=6.8Hz).

[0897] [Chemical formula 86]

[0898]

[0899] (Step 3) Synthesis of Compound 83

[0900] Compound 83 was obtained using compound 82 as a starting material in the same manner as compound 2.

[0901] Yield 99%; ESIMS m / z 282.0 (M+H) + ; 1 H NMR(400MHz, CDCl3)δ5.38(1H,brs),4.67(1H,brs),2.82(1H,m),2.64(1H,m),2. 49(1H,m),2.30(1H,m),1.66-1.61(3H,m),1.30-1.26(8H,m),0.89-0.86(3H,m).

[0902] [Chemical formula 87]

[0903]

[0904] Synthesis example 80

[0905] Compound 84 was obtained by using N,N',N"-tri-Boc-guanidine and 5-hydroxy-3-methyl-2,5-dihydrofuran-2-one as raw materials in the same manner as compound 80.

[0906] Yield: 87%; 1 H NMR (400MHz, CD3OD) δ6.99(1H,t,J=1.6Hz), 6.05(1H,brs), 1.91(3H,t,J=1.6Hz), 1.54(18H,s), 1.46(9H,s).

[0907] [Chemical formula 88]

[0908]

[0909] Synthesis example 81

[0910] Using compound 84 as the starting material, compound 85 (formate) was obtained by the same method as compound 2.

[0911] Yield 99%; 1 H NMR (400MHz, CD3OD) δ8.53(1H,s),7.03(1H,t,J=1.6Hz), 6.46(1H,t,J=1.6Hz), 1.93(3H,t,J=1.6Hz).

[0912] [Chemical formula 89]

[0913]

[0914] Synthesis example 82

[0915] Compound 86 was obtained by using N-Boc-glutamic acid-γ-tert-butyl ester and L-homoserine lactone hydrochloride as raw materials in the same manner as compound 21.

[0916] Yield 83%; ESIMS m / z 409.1 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ4.63(1H,dd,J=9.2,11.2Hz),4.45(1H,dd,J=5.6,8.8Hz),4.33(1H,m),3.99(1H,m ),2.57(1H,m),2.38-2.23(3H,m),2.11(1H,m),1.89(1H,m),1.49(9H,s),1.46(9H,s).

[0917] [Chemical formula 90]

[0918]

[0919] Synthesis example 83

[0920] Compound 87 was obtained using compound 86 as a starting material in the same manner as compound 39 as a hydrochloride salt.

[0921] Yield 99%; ESIMS m / z 230.9 (M+H) + ; 1 H NMR (400MHz, D2O) δ4.62(1H,dd,J=9.2,10.8Hz),4.51(1H,m),4.34(1H,m),4.05(1H,t,J=6.4Hz),2.61-2.50(3H,m),2.35-2.16(3H,m).

[0922] [Chemical formula 91]

[0923]

[0924] Synthesis example 84

[0925] Using N-Boc-glutamic acid-γ-tert-butyl ester and D-homoserine lactone hydrochloride as raw materials, compound 88 was obtained in the same manner as compound 21.

[0926] Yield 89%; ESIMS m / z 409.1 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ4.60(1H,dd,J=9.6,11.2Hz),4.47(1H,m),4.32(1H,m),4.00(1H,m),2.56( 1H,m),2.38-2.27(3H,m),2.11(1H,m),1.91(1H,m),1.49(9H,s),1.46(9H,s).

[0927] [Chemical formula 92]

[0928]

[0929] Synthesis example 85

[0930] Compound 89 was obtained in the form of hydrochloride by the same method as compound 39 using compound 88 as a starting material.

[0931] Yield 99%; ESIMS m / z 231.0 (M+H) + ;

[0932] 1 H NMR (400MHz, D2O) δ4.58(1H,dd,J=9.2,11.2Hz),4.47(1H,m),4.30(1H,m),3.98(1H,t,J=6.4Hz),2.54-2.45(3H,m),2.29-2.10(3H,m).

[0933] [Chemical formula 93]

[0934]

[0935] Synthesis example 86

[0936] Compound 90 was obtained using compound 5 as a starting material in the same manner as compound 22.

[0937] Yield 68%; ESIMS m / z 386.1 (M+Na) + ; 1 H NMR(400MHz,CD3O D) δ7.32-7.23(5H,m),6.45(1H,m),4.33(1H,m),3.14-2.92(2H,m),2.80-2.72(2H,m),1.90(1H,m),1.48(2H ,s),1.43(3.5H,s),1.41(3.5H,s),1.34(2H,d,J=6.8Hz),1.13(0.4H,d,J=7.2Hz),0.93(0.6H,d,J=7.2Hz).

[0938] [Chemical formula 94]

[0939]

[0940] [Example 1] Binding activity of various compounds to Arabidopsis thaliana strigolactone receptor D14 protein

[0941] In this example, the binding activity of compounds 1 to 20, 23, 26 to 61, 65 to 80 and 83 to 90 to the Arabidopsis thaliana yoshimulactone receptor D14 protein was analyzed by measuring the degree of inhibition of the binding of the fluorescent probe-labeled synthetic yoshimulactone eGreen (YLG) to D14. YLG is a compound that emits green fluorescence when bound to the yoshimulactone receptor. D14 has the activity of hydrolyzing yoshimulactone. If YLG is bound instead of yoshimulactone, the D-ring site of YLG is separated from the fluorescent probe and exhibits fluorescence. If a compound with yoshimulactone activity coexists therein, the binding of YLG to D14 is hindered and the fluorescence value is reduced. By measuring the degree of inhibition, the degree of binding of a compound having strigolactone activity to the receptor can be determined (Reference 1: Tsuchiya et al., (2015) Science, 349, 864-868. PARASITIC PLANTS. Probing strigolactone receptors in Striga hermonthica with fluorescence.).

[0942] The in vitro assay of D14 receptor YLG was carried out with reference to reference 1. 1 μg of D14 protein expressed and purified by Escherichia coli was added to a buffer solution (100 mM HEPES, 150 mM NaCl, pH 7.0), and the assay was carried out using a COSTAR black 96-well plate with a total volume of 100 μL using a spectraMax M2 (Molecular Devices). The fluorescence of YLG was excited at 480 nm and measured at 520 nm. Various compounds to be tested were added to the reaction solution in such a way that the final concentration became 100 μM to 1000 μM, and YLG was added to the reaction solution in such a way that the final concentration became 1 μM. The values ​​of the degree of inhibition obtained using the various compounds to be tested were calculated as relative values ​​when the values ​​of the degree of inhibition obtained using the same concentration of the synthetic monocotyledon GR24 were set to 100%.

[0943] The results are shown in Tables 1 to 6.

[0944] In the table, "D14 inhibition" indicates the binding activity of each compound to D14, and compounds with a relative value of the inhibition degree of 80% or less are set as (+), and the others are set as (-). Some compounds inhibit the binding of YLG and D14, that is, the binding activity to D14. The "D14 inhibition" of both the formate salt and the heptafluorobutyrate salt of compound 10 is (+). The "D14 inhibition" of both the formate salt and the heptafluorobutyrate salt of compound 12 is (+).

[0945] [Example 2] Germination inducing activity of various compounds on Orobanche minor

[0946] In this example, the germination inducing activity of Orobanche minor caused by compounds 1 to 20, 23, 26 to 61, 65 to 80, and 83 to 90 was analyzed by measuring the germination rate. Seeds of white clover (Trifolium repens) parasitizing on the natural growth of Japan were used for Orobanche minor. The experiment was carried out by slightly changing the method described in reference 2 (Uraguchi et al., (2018) Science, 362, 1301-1305. A femtomolar-range suicide germination stimulant for the parasitic plant Striga hermonthica.). A volume of 50 μL of dried seeds of Orobanche minor was added to a 1.5 mL tube, and 100 μL of chloroform was added and stirred to remove the wax layer of the seed coat. Then, the chloroform was removed by evaporation in a fume hood for more than 3 hours. Then, 1 mL of about 1% sodium hypochlorite was added to sterilize the seeds, washed three times with sterile water, transferred to a culture dish, and incubated at 22°C for 7 to 10 days in the dark for conditioning. Then, the liquid containing the seeds was dispensed into a 96-well plate in units of 30 μL, and an equal amount of compound solution was added. The various compounds tested were added in a manner such that the final concentration became 100 nM to 10 μM. After adding the treatment solution, the germination rate was evaluated by counting the number of germinated seeds under a stereomicroscope after incubation at 22°C for 1 week. The germination rate obtained using various compounds was calculated as a relative value when the germination rate obtained using the same concentration of synthetic monocotyledon GR24 was set to 100%.

[0947] The results are shown in Tables 1 to 6.

[0948] In the table, "Germination" indicates the germination inducing activity of each compound, and the compounds with a relative value of germination rate of 5% or more are set as (+), and the others are set as (-). Some compounds showed germination inducing activity of Orobancheminor. The "Germination" of both the formate and heptafluorobutyrate of compound 10 was (+). The "Germination" of both the formate and heptafluorobutyrate of compound 12 was (+).

[0949] In the table, "Function" indicates the predicted function of each compound. Compounds judged as "germination" (+) have germination induction function. In addition, compounds judged as "D14 inhibition" and "germination" (+) and (-) respectively have germination inhibition function.

[0950] In the table, "D ring" in the column "D ring part" indicates a structure represented by the following formula (ID).

[0951] [Chemical formula 95]

[0952]

[0953] [Table 1]

[0954] Table 1

[0955]

[0956] [Table 2]

[0957] Table 2

[0958]

[0959] [Table 3]

[0960] Table 3

[0961]

[0962] [Table 4]

[0963] Table 4

[0964]

[0965] [Table 5]

[0966] Table 5

[0967]

[0968] [Table 6]

[0969] Table 6

[0970]

[0971] [Example 3] Control effect of compound 5 or synthetic strigolactone GR24 on suicide germination induction of Orobanche minor

[0972] In this example, the parasitic plant control activity of Compound 5 was analyzed by measuring the suicide sprouting activity of Orobanche minor as a parasitic plant.

[0973] The suicide germination test of Orobanche minor was carried out with reference to reference 2 (Uraguchi et al., (2018) Science, 362, 1301-1305.). In a plastic pot (diameter of the upper surface 52.5 mm, diameter of the bottom surface 35 mm, depth 85 mm, with a hole in the bottom surface), 0.52 L of dry soil (mixed with equal amounts of combined culture soil and vermiculite) was filled from the upper surface to below 2 cm, and soil mixed with 5 mg of Orobanche minor was added thereon to form a 2 cm layer. The pot was supplied with water from the bottom and regulated at 21°C for 14 days. Then, 120 mL of 1 nM or 10 nM compound 5 (DMSO concentration 0.0001%), 10 nM GR24 (DMSO concentration 0.0001%), or 0.0001% DMSO was applied to each pot from the surface of the soil and incubated for a further 14 days. Then, 10 seeds of white clover were sown per pot, and the number of plants was finally thinned to 3. During cultivation, water was applied from the bottom every 2 to 3 days, and 0.1% Hyponex fertilizer was applied from the bottom once a week. R (NPK = 6-10-5%), and cultivated at 21°C for about 3 months under long-day conditions. The number of Orobanche minor that emerged was measured on the 98th day. The pots were then dismantled and the number of tubers and Orobanche minor parasitizing the roots was measured.

[0974] The results are shown in Figure 1-2 In the figure, "p" indicates the result of Dunnett's multiple test, "*" indicates that there is a significant difference at the 5% level in Dunnett's multiple test. In the figure, "○" indicates the average value.

[0975] [Example 4] Germination inducing activity of Orobanche ramosa L based on compound 1

[0976] In this example, the germination inducing activity of Orobanche ramosa L based on compound 1 was analyzed by measuring the germination rate. Orobanche ramosa L is a parasitic plant that parasitizes tomatoes and is currently classified as Phelipancheramosa (L) Pomel. As Orobanche ramosa L, seeds of Orobanche ramosa L that parasitize naturally grown tomatoes in Portugal were used. The dried seeds of Orobanche ramosa L were placed in water for one week in a dark place with high humidity at 20°C to 26°C. 2 mL of the test compound was added to the culture dish in such a way that the final concentration became 1 μM or 100nM (compound 1) or 0.34 μM (GR24). After adding the treatment solution, incubate for one week in a dark place with high humidity at 20°C to 26°C, and then count the number of germinated seeds under a stereomicroscope to evaluate the germination rate.

[0977] The results are shown in Table 7. In the table, "germination" indicates the germination inducing activity of Compound 1, and when the relative value of the germination rate is 4% or more, it is regarded as (+). Compound 1 exhibited germination inducing activity of Orobanche ramos a L.

[0978] [Table 7]

[0979] Table 7 Germination inducing activity of compound 1 on Orobanche ramosa L.

[0980]

[0981] Industrial Applicability

[0982] According to the present invention, useful results in the field of agronomy and horticulture, such as controlling parasitic plants, can be obtained.

Claims

1. A composition for controlling parasitic plants, comprising the following components (A), (B) or (C): (A) a compound represented by the following general formula (I); (B) a compound represented by the following general formula (II); (C) amino acid fermentation byproducts, [Chemical formula 1] In formula (I), X represents an interatomic bond or an oxycarbonyl group (OC(=O)), Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (NMe), R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2), [Chemical formula 2] In formula (R2-1), n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5, In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group, [Chemical formula 3] In formula (R2-2), a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms, R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms, [Chemical formula 4] In formula (II), X1 represents an interatomic bond or a methyleneoxy group (CH2O), X2 represents an interatomic bond or a carbonyl group (C(=O)), Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom, R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2), bc represents CH-CH2 or C=CH.

2. The composition according to claim 1, which controls the parasitic plant by inducing suicide germination of the parasitic plant or inhibiting germination of the parasitic plant.

3. The composition according to claim 1 or 2, wherein The parasitic plant is a plant of the family Orobanchaceae, a plant of the family Scrophulariaceae or a plant of the family Convolvulaceae.

4. The composition according to any one of claims 1 to 3, wherein The parasitic plant is a plant of the genus Striga, the genus Orobanche, the genus Phelipanche, the genus Alectra or the genus Cuscuta.

5. The composition according to any one of claims 1 to 4, wherein The parasitic plants are Striga asiatica, Striga gesnerioides, Striga hermonthica, Striga aspera, Striga asiatica, Striga curvi flora, Striga parviflora, Striga angustifolia, Striga latericea, Strigaaequinoctialis, Striga angolensis, Striga bilabiate,Striga brachycalyx,Strigachrsantha,Striga dalzielii,Striga elegans,Striga forbesii,Striga gas tonii,Striga gracillima,Striga hallaei,Striga hirsuta,Striga junodii,Strigaklingii,Striga lepidagathidis,Striga lutea,Striga macrantha,Striga passargei,Striga pinnatifida,Striga primuloides, Striga yemenica, Striga pubiflora, Orobanche ramosa, Orobanche minor, Orobanche crenata, Or obanche cumana, Orobanche foetida, Orobanche aegyptiaca, Orobanche cernua, Phelipanche ramosa, Phelipanche aegyptiaca, Alectra vogelii, Alectrapicta, Alectra sessiliflora, Alectra orobanchoides, Alectra fluminensis, Cuscuta australis, Cuscuta campestris, Cuscuta achinensis, Cuscuta indecora, Cuscuta epithymum, Cuscuta epilinum, Cuscutagronovii), Cuscuta planiflora, single-stemmed dodder (Cuscuta monogyna), Cuscuta pedicellata, Cuscuta palaestina or Cuscuta rejlexa.

6. The composition according to any one of claims 1 to 5, wherein In the component (A), Y is NH and R1 is methyl.

7. The composition according to any one of claims 1 to 6, wherein The component (A) satisfies any one of the following conditions: (1) X is an interatomic bond or an oxycarbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group; (2) X is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group; (3) X is an interatomic bond, and R2 is an amino acid bonded via a hydroxyl group; (4) X is an interatomic bond, and R2 is an amino acid bonded via a thiol group; (5) X is an interatomic bond, and R2 is an amino acid bonded via an amide group; (6) X is an interatomic bond or an oxycarbonyl group, and R2 is a structure represented by formula (R2-1); (7) X is an interatomic bond, and R2 is a structure represented by the formula (R2-2).

8. The composition according to any one of claims 1 to 7, wherein The component (A) satisfies any one of the following conditions: (1) X is an interatomic bond, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, guanidine bonded via an amino group, or a structure represented by formula (R2-1); (2) X is an oxycarbonyl group, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via a carboxyl group or a structure represented by formula (R2-2).

9. The composition according to any one of claims 1 to 8, wherein In the component (B), Y is NH, bc is CH-CH2, and R1 is H.

10. The composition according to any one of claims 1 to 9, wherein The component (B) satisfies any one of the following conditions: (1) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group; (2) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group; (3) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an aliphatic alcohol; (4) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a fatty acid; (5) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is a structure represented by formula (R2-1); (6) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a structure represented by formula (R2-2); (7) X1 is an interatomic bond, X2 is an interatomic bond, and R2 is a guanidine bonded via an amino group.

11. The composition according to any one of claims 1 to 10, wherein The component (B) satisfies any one of the following conditions: (1) X1 is an interatomic bond, X2 is a carbonyl group, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, guanidine bonded via an amino group, or a structure represented by formula (R2-1); (2) X1 is a methyleneoxy group, X2 is an interatomic bond, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via a carboxyl group, a fatty acid having 2 to 18 carbon atoms, or a structure represented by formula (R2-2); (3) X1 is an interatomic bond, X2 is an interatomic bond, Y is an oxygen atom (O), bc is C═CH, R1 is a methyl group, and R2 is a guanidine bonded via an amino group.

12. The composition according to any one of claims 1 to 11, wherein Except for the case where the component (B) is a compound represented by the following formula (Compound 41), (Compound 50), (Compound 52), (Compound 54), (Compound 55) and (Compound 77), [Chemical formula 5] [Chemical formula 6] [Chemical formula 7] [Chemical formula 8] [Chemical formula 9] [Chemical formula 10] 13. The composition according to any one of claims 1 to 12, wherein The component (A) or (B) is selected from the compounds represented by the following formulae: (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 40), (Compound 42) to (Compound 49), (Compound 51), (Compound 53), (Compound 56) to (Compound 76), (Compound 78) to (Compound 80), and (Compound 82) to (Compound 90), [Chemical formula 11] [Chemical formula 12] [Chemical formula 13] [Chemical formula 14] [Chemical formula 15] [Chemical formula 16] [Chemical formula 17] [Chemical formula 18] [Chemical formula 19] [Chemical formula 20] [Chemical formula 21] [Chemical formula 22] [Chemical formula 23] [Chemical formula 24] [Chemical formula 25] [Chemical formula 26] [Chemical formula 27] [Chemical formula 28] [Chemical formula 29] [Chemical formula 30] [Chemical formula 31] [Chemical formula 32] [Chemical formula 33] [Chemical formula 34] [Chemical formula 35] [Chemical formula 36] [Chemical formula 37] [Chemical formula 38] [Chemical formula 39] [Chemical formula 40] [Chemical formula 41] [Chemical formula 42] [Chemical formula 43] [Chemical formula 44] [Chemical formula 45] [Chemical formula 46] [Chemical formula 47] [Chemical formula 48] [Chemical formula 49] [Chemical formula 50] [Chemical formula 51] [Chemical formula 52] [Chemical formula 53] [Chemical formula 54] [Chemical formula 55] [Chemical formula 56] [Chemical formula 57] [Chemical formula 58] [Chemical formula 59] [Chemical formula 60] [Chemical formula 61] [Chemical formula 62] [Chemical formula 63] [Chemical formula 64] [Chemical formula 65] [Chemical formula 66] [Chemical formula 67] [Chemical formula 68] [Chemical formula 69] [Chemical formula 70] [Chemical formula 71] [Chemical formula 72] [Chemical formula 73] [Chemical formula 74] [Chemical formula 75] [Chemical formula 76] [Chemical formula 77] [Chemical formula 78] [Chemical formula 79] [Chemical formula 80] [Chemical formula 81] [Chemical formula 82] [Chemical formula 83] [Chemical formula 84] [Chemical formula 85] [Chemical formula 86] [Chemical formula 87] [Chemical formula 88] [Chemical formula 89] 14. The composition according to any one of claims 1 to 13, wherein The component (C) is a fermentation byproduct of lysine, tryptophan, threonine, valine, leucine or isoleucine. 15 . The composition according to claim 1 , which is used in the form of a liquid containing the component (A), (B) or (C) at a concentration of 10 nM to 10 mM.

16. A method for controlling parasitic plants, comprising: Applying the following ingredients (A), (B) or (C) to the seeds of the parasitic plant: (A) a compound represented by the following general formula (I); (B) a compound represented by the following general formula (II); (C) amino acid fermentation byproducts, [Chemical formula 90] In formula (I), X represents an interatomic bond or an oxycarbonyl group (OC(=O)), Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (NMe), R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2), [Chemical formula 91] In formula (R2-1), n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5, In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group, [Chemical formula 92] In formula (R2-2), a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms, R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms, [Chemical formula 93] In formula (II), X1 represents an interatomic bond or a methyleneoxy group (CH2O), X2 represents an interatomic bond or a carbonyl group (C(=O)), Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom, R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2), bc represents CH-CH2 or C=CH.

17. A method for producing a plant body, comprising: Applying the following component (A), (B) or (C) to the seeds of a parasitic plant to induce suicide germination of the parasitic plant; cultivating a plant to be parasitized by the parasitic plant after the application; and harvesting the plant body of the plant that is the target of parasitism of the parasitic plant, (A) a compound represented by the following general formula (I); (B) a compound represented by the following general formula (II); (C) amino acid fermentation byproducts, [Chemical formula 94] In formula (I), X represents an interatomic bond or an oxycarbonyl group (OC(=O)), Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (NMe), R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2), [Chemical formula 95] In formula (R2-1), n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5, In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group, [Chemical formula 96] In formula (R2-2), a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms, R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms, [Chemical formula 97] In formula (II), X1 represents an interatomic bond or a methyleneoxy group (CH2O), X2 represents an interatomic bond or a carbonyl group (C(=O)), Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom, R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2), bc represents CH-CH2 or C=CH.

18. A method for producing a plant body, comprising: Cultivate plants that become targets of parasites; Applying the following component (A), (B) or (C) to the seeds of the parasitic plant in the later stage of the cultivation to induce germination of the parasitic plant; and harvesting the plant body of the plant that is the target of parasitism of the parasitic plant, (A) a compound represented by the following general formula (I); (B) a compound represented by the following general formula (II); (C) amino acid fermentation byproducts, [Chemical formula 98] In formula (I), X represents an interatomic bond or an oxycarbonyl group (OC(=O)), Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (NMe), R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2), [Chemical formula 99] In formula (R2-1), n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5, In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group, [Chemical formula 100] In formula (R2-2), a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms, R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms, [Chemical Formula 101] In formula (II), X1 represents an interatomic bond or a methyleneoxy group (CH2O), X2 represents an interatomic bond or a carbonyl group (C(=O)), Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom, R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2), bc represents CH-CH2 or C=CH.

19. A method for producing a plant body, comprising: Cultivate plants that become targets of parasites; During the cultivation, the following component (A), (B) or (C) is applied to seeds of parasitic plants to inhibit germination of the parasitic plants; and harvesting the plant body of the plant that is the target of parasitism of the parasitic plant, (A) a compound represented by the following general formula (I); (B) a compound represented by the following general formula (II); (C) amino acid fermentation byproducts, [Chemical formula 102] In formula (I), X represents an interatomic bond or an oxycarbonyl group (OC(=O)), Y represents an oxygen atom (O), a nitrogen atom bonded with a hydrogen atom (NH), or a nitrogen atom bonded with a methyl group (NMe), R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, a structure represented by the following general formula (R2-1), or a structure represented by the following general formula (R2-2), [Chemical formula 103] In formula (R2-1), n represents an integer from 2 to 5, i.e., 2, 3, 4 or 5, In formula (R2-1), R3 and R4 each independently represent a hydrogen atom or an acyl group, [Chemical formula 104] In formula (R2-2), a represents an optionally substituted alkylene group having 1 to 4 carbon atoms or an optionally substituted alkenylene group having 2 to 4 carbon atoms, R5 represents a hydrogen atom (H) or an optionally substituted alkyl group having 1 to 4 carbon atoms, [Chemical formula 105] In formula (II), X1 represents an interatomic bond or a methyleneoxy group (CH2O), X2 represents an interatomic bond or a carbonyl group (C(=O)), Y represents an oxygen atom (O) or a nitrogen atom (NH) bonded with a hydrogen atom, R1 represents a hydrogen atom (H) or a methyl group, R2 represents an amino acid, agmatine, guanidine, an aliphatic alcohol, a fatty acid, the structure represented by the general formula (R2-1) or the structure represented by the general formula (R2-2), bc represents CH-CH2 or C=CH.

20. The method according to claim 16, which controls the parasitic plant by inducing suicide germination of the parasitic plant or inhibiting germination of the parasitic plant.

21. The method according to any one of claims 17 to 19, wherein the parasitic plants are controlled by the applying.

22. The method according to any one of claims 16 to 21, wherein: The parasitic plant is a plant of the family Orobanchaceae, a plant of the family Scrophulariaceae or a plant of the family Convolvulaceae.

23. The method according to any one of claims 16 to 22, wherein: The parasitic plant is a plant of the genus Striga, the genus Orobanche, the genus Phelipanche, the genus Alectra or the genus Cuscuta.

24. The method according to any one of claims 16 to 23, wherein: The parasitic plants are Striga asiatica, Striga gesnerioid es, Striga hermonthica, Striga aspera, Striga asiatica, Striga curvi flora, Striga parviflora, Striga angustifolia, Striga latericea, Strigaaequinoctialis, Striga angolensis, Striga bilabiate,Striga brachycalyx,Strigachrsantha,Striga dalzielii,Striga elegans,Striga forbesii,Striga gas tonii,Striga gracillima,Striga hallaei,Striga hirsuta,Striga junodii,Strigaklingii,Striga lepidagathidis,Striga lutea,Striga macrantha,Striga passargei,Striga pinnatifida,Striga primuloides, Striga yemenica, Striga pubiflora, Orobanche ramosa, Orobanche minor, Orobanche crenata, Orobanche cumana, Orobanche foetida, Orobanche aegyptiaca, Orobanche cernua, Phelipanche ramosa, Phelipanche aegyptiaca, Alectra vogelii, Alectrapicta, Alectra sessiliflora, Alectra orobanchoides, Alectra fluminensis, Cuscuta australis, Cuscuta campestris, Cuscuta achinensis, Cuscuta indecora, Cuscuta epithymum, Cuscuta epilinum, Cuscutagronovii), Cuscuta planiflora, Cuscuta monogyna, Cuscuta pedicellata, Cuscuta palaestina or Cuscuta rejlexa.

25. The method according to any one of claims 16 to 24, wherein: In the component (A), Y is NH and R1 is methyl.

26. The method according to any one of claims 16 to 25, wherein: The component (A) satisfies any one of the following conditions: (1) X is an interatomic bond or an oxycarbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group; (2) X is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group; (3) X is an interatomic bond, and R2 is an amino acid bonded via a hydroxyl group; (4) X is an interatomic bond, and R2 is an amino acid bonded via a thiol group; (5) X is an interatomic bond, and R2 is an amino acid bonded via an amide group; (6) X is an interatomic bond or an oxycarbonyl group, and R2 is a structure represented by formula (R2-1); (7) X is an interatomic bond, and R2 is a structure represented by the formula (R2-2).

27. The method according to any one of claims 16 to 26, wherein: The component (A) satisfies any one of the following conditions: (1) X is an interatomic bond, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, guanidine bonded via an amino group, or a structure represented by formula (R2-1); (2) X is an oxycarbonyl group, Y is NH, R1 is a methyl group, and R2 is an amino acid bonded via a carboxyl group or a structure represented by formula (R2-2).

28. The composition according to any one of claims 16 to 27, wherein In the component (B), Y is NH, bc is CH-CH2, and R1 is H.

29. The method according to any one of claims 16 to 28, wherein: The component (B) satisfies any one of the following conditions: (1) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or guanidine bonded via an amino group; (2) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is an amino acid bonded via a carboxyl group; (3) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is an aliphatic alcohol; (4) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a fatty acid; (5) X1 is an interatomic bond, X2 is a carbonyl group, and R2 is a structure represented by formula (R2-1); (6) X1 is a methyleneoxy group, X2 is an interatomic bond, and R2 is a structure represented by formula (R2-2); (7) X1 is an interatomic bond, X2 is an interatomic bond, and R2 is a guanidine bonded via an amino group.

30. The method according to any one of claims 16 to 29, wherein: The component (B) satisfies any one of the following conditions: (1) X1 is an interatomic bond, X2 is a carbonyl group, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via an amino group, agmatine bonded via an amino group, or a structure represented by formula (R2-1); (2) X1 is a methyleneoxy group, X2 is an interatomic bond, Y is NH, bc is CH-CH2, R1 is H, and R2 is an amino acid bonded via a carboxyl group, a fatty acid having 2 to 18 carbon atoms, or a structure represented by formula (R2-2); (3) X1 is an interatomic bond, X2 is an interatomic bond, Y is an oxygen atom (O), bc is C═CH, R1 is a methyl group, and R2 is a guanidine bonded via an amino group.

31. The method according to any one of claims 16 to 30, wherein: Except for the case where the component (B) is a compound represented by the following formula (Compound 41), (Compound 50), (Compound 52), (Compound 54), (Compound 55) and (Compound 77), [Chemical formula 106] [Chemical formula 107] [Chemical formula 108] [Chemical formula 109] [Chemical formula 110] [Chemical formula 111] 32. The method according to any one of claims 16 to 31, wherein: The component (A) or (B) is selected from the compounds represented by the following formulae: (Compound 1) to (Compound 20), (Compound 23), (Compound 26) to (Compound 40), (Compound 42) to (Compound 49), (Compound 51), (Compound 53), (Compound 56) to (Compound 76), (Compound 78) to (Compound 80), and (Compound 82) to (Compound 90), [Chemical formula 112] [Chemical formula 113] [Chemical formula 114] [Chemical formula 115] [Chemical formula 116] [Chemical formula 117] [Chemical formula 118] [Chemical formula 119] [Chemical formula 120] [Chemical formula 121] [Chemical formula 122] [Chemical formula 123] [Chemical formula 124] [Chemical formula 125] [Chemical formula 126] [Chemical formula 127] [Chemical formula 128] [Chemical formula 129] [Chemical formula 130] [Chemical formula 131] [Chemical formula 132] [Chemical formula 133] [Chemical formula 134] [Chemical formula 135] [Chemical formula 136] [Chemical formula 137] [Chemical formula 138] [Chemical formula 139] [Chemical formula 140] [Chemical formula 141] [Chemical formula 142] [Chemical formula 143] [Chemical formula 144] [Chemical formula 145] [Chemical formula 146] [Chemical formula 147] [Chemical formula 148] [Chemical formula 149] [Chemical formula 150] [Chemical formula 151] [Chemical formula 152] [Chemical formula 153] [Chemical formula 154] [Chemical formula 155] [Chemical formula 156] [Chemical formula 157] [Chemical formula 158] [Chemical formula 159] [Chemical formula 160] [Chemical formula 161] [Chemical formula 162] [Chemical formula 163] [Chemical formula 164] [Chemical formula 165] [Chemical formula 166] [Chemical formula 167] [Chemical formula 168] [Chemical formula 169] [Chemical formula 170] [Chemical formula 171] [Chemical formula 172] [Chemical formula 173] [Chemical formula 174] [Chemical formula 175] [Chemical formula 176] [Chemical formula 177] [Chemical formula 178] [Chemical formula 179] [Chemical formula 180] [Chemical formula 181] [Chemical formula 182] [Chemical formula 183] [Chemical formula 184] [Chemical formula 185] [Chemical formula 186] [Chemical formula 187] [Chemical formula 188] [Chemical formula 189] [Chemical formula 190] 33. The method according to any one of claims 16 to 32, wherein: The component (C) is a fermentation byproduct of lysine, tryptophan, threonine, valine, leucine or isoleucine.

34. The method according to any one of claims 16 to 33, wherein: The component (A), (B) or (C) is used in the form of a liquid containing the component (A), (B) or (C) at a concentration of 10 nM to 10 mM.